PTEN (Phosphatase and Tensin Homolog) is a critical tumor suppressor encoding a dual-specificity phosphatase with both lipid and protein phosphatase activities. Its primary and essential tumor suppressor function is as a phosphatidylinositol-3,4,5-trisphosphate (PIP3) 3-phosphatase that dephosphorylates PIP3 to PIP2, thereby antagonizing PI3K/AKT/mTOR signaling. PTEN also exhibits protein phosphatase activity against serine, threonine, and tyrosine residues, though the lipid phosphatase activity is the critical determinant of tumor suppression. Nuclear PTEN contributes to genomic stability and cell cycle control. PTEN localizes to the plasma membrane, cytosol, and nucleus, with membrane localization mediated by its C2 domain and PDZ-binding motif interactions with scaffold proteins like MAGI-2. Germline mutations cause PTEN Hamartoma Tumor Syndrome (PHTS/Cowden disease), while somatic mutations occur frequently across many cancer types.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005634
nucleus
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: PTEN nuclear localization is well-established. Nuclear PTEN has distinct roles in genomic stability, DNA damage response, and cell cycle control, regulated by PTMs and ubiquitin-dependent trafficking.
Reason: Nuclear localization is a conserved and functionally important feature of PTEN, supported by extensive experimental evidence and phylogenetic conservation.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner
PMID:17218261
Ubiquitination regulates PTEN nuclear import and tumor suppression
file:human/PTEN/PTEN-deep-research-falcon.md
See deep research file for comprehensive analysis
|
|
GO:0005886
plasma membrane
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Plasma membrane localization is essential for PTEN's core lipid phosphatase function. PTEN is recruited to the membrane via its C2 domain and PDZ-binding motif interactions with scaffold proteins like MAGI-2.
Reason: Plasma membrane localization is the primary site of PTEN's lipid phosphatase activity against PIP3, essential for its tumor suppressor function.
Supporting Evidence:
PMID:10760291
PTEN binds to MAGI-2 through an interaction between the PDZ-binding motif of PTEN and the second PDZ domain of MAGI-2. MAGI-2 enhances the ability of PTEN to suppress Akt activation.
|
|
GO:0042995
cell projection
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: PTEN localizes to cell projections, consistent with its role in regulating cell motility through PI3K signaling modulation at the leading edge of cells.
Reason: PTEN localization to cell projections is consistent with its role in regulating directed cell migration through local PIP3 levels, a phylogenetically conserved feature.
|
|
GO:0043491
phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: PTEN is a central component of PI3K/AKT signaling, acting as the primary negative regulator by dephosphorylating PIP3 to PIP2.
Reason: This is the core pathway in which PTEN functions. By removing PIP3, PTEN prevents AKT recruitment and activation, making this a core annotation.
Supporting Evidence:
PMID:9811831
ectopic expression of the phosphatase in PTEN-deficient tumor cell lines resulted in the inhibition of protein kinase (PK) B/Akt and regulation of cell survival
|
|
GO:0051896
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
IBA
GO_REF:0000033 |
MODIFY |
Summary: PTEN negatively regulates PI3K/AKT signaling via its lipid phosphatase activity. This is redundant with GO:0051898 (negative regulation) which is more specific.
Reason: While accurate, GO:0051898 (negative regulation of PI3K/AKT signaling) is more specific to PTEN's actual role as an antagonist of this pathway.
Proposed replacements:
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
|
GO:0005829
cytosol
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: PTEN is found in the cytosol where it can exist in an inactive closed conformation. Cytosolic PTEN can be recruited to membranes for its lipid phosphatase function.
Reason: Cytosolic localization is well-established for PTEN and represents a reservoir pool that can be recruited to membranes upon appropriate signals.
|
|
GO:0046856
phosphatidylinositol dephosphorylation
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: PTEN dephosphorylates phosphatidylinositols at the D3 position, with primary activity against PIP3 and PI(3,4)P2.
Reason: This is a core biological process annotation that accurately describes PTEN's primary enzymatic function.
Supporting Evidence:
PMID:9811831
Characterization of the lipid phosphatase activity of PTEN demonstrates that it shows specificity for phosphatidylinositols phosphorylated at the 3 position.
|
|
GO:0004725
protein tyrosine phosphatase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: PTEN exhibits protein tyrosine phosphatase activity as part of its dual-specificity phosphatase function, though the lipid phosphatase activity is the critical determinant of tumor suppression.
Reason: PTEN has documented protein tyrosine phosphatase activity. While secondary to its lipid phosphatase function for tumor suppression, this is a legitimate enzymatic activity.
Supporting Evidence:
PMID:9256433
recombinant P-TEN dephosphorylated protein and peptide substrates phosphorylated on serine, threonine, and tyrosine residues, indicating that P-TEN is a dual-specificity phosphatase
|
|
GO:0016314
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: This is PTEN's primary enzymatic activity - dephosphorylating PIP3 at the D3 position to produce PIP2. This activity is essential for its tumor suppressor function.
Reason: This is the core molecular function of PTEN. The lipid phosphatase activity against PIP3 is the critical determinant of PTEN's tumor suppressor function.
Supporting Evidence:
PMID:9811831
a missense mutation in PTEN, PTEN-G129E, which is observed in two Cowden disease kindreds, specifically ablates the ability of PTEN to recognize inositol phospholipids as a substrate, suggesting that loss of the lipid phosphatase activity is responsible for the etiology of the disease
|
|
GO:0048870
cell motility
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: PTEN regulates cell motility through its effects on PIP3 levels, which control cell polarity and directed migration. Loss of PTEN enhances cell motility.
Reason: While PTEN's regulation of cell motility is well-established, this is a downstream effect of its lipid phosphatase activity rather than a core function. The core function is PIP3 dephosphorylation.
Supporting Evidence:
PMID:9616126
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
|
|
GO:0004722
protein serine/threonine phosphatase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: PTEN has dual-specificity protein phosphatase activity including activity against serine/threonine residues.
Reason: This is supported by experimental evidence showing PTEN dephosphorylates serine/threonine substrates.
Supporting Evidence:
PMID:9256433
recombinant P-TEN dephosphorylated protein and peptide substrates phosphorylated on serine, threonine, and tyrosine residues
|
|
GO:0004725
protein tyrosine phosphatase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Duplicate of IBA annotation for the same term. PTEN has documented protein tyrosine phosphatase activity.
Reason: Consistent with experimental evidence for PTEN's dual-specificity phosphatase activity.
|
|
GO:0004721
phosphoprotein phosphatase activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: General phosphoprotein phosphatase activity term. PTEN does have protein phosphatase activity but more specific terms (GO:0004722, GO:0004725) are preferred.
Reason: Accurate but less specific than existing annotations. Still valid as a parent term.
|
|
GO:0005576
extracellular region
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: PTEN-Long (PTEN-L/alpha) isoform can be secreted and taken up by other cells. This applies specifically to the N-terminally extended isoform.
Reason: The PTEN-L isoform has been shown to be secreted and function in neighboring cells (PMID:23744781).
Supporting Evidence:
PMID:23744781
A secreted PTEN phosphatase that enters cells to alter signaling and survival
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Duplicate of IBA annotation. Nuclear localization of PTEN is well-established.
Reason: Consistent with IBA annotation and extensive experimental evidence for nuclear PTEN.
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: PTEN is found in the cytoplasm. Cytosol (GO:0005829) is a more specific term that is also annotated.
Reason: Cytoplasmic localization is accurate, though cytosol is the more specific subcellular location.
|
|
GO:0006629
lipid metabolic process
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: Very broad term. PTEN dephosphorylates phosphatidylinositols but this is more accurately described as phosphatidylinositol dephosphorylation (GO:0046856).
Reason: Too general. GO:0046856 (phosphatidylinositol dephosphorylation) is much more specific and accurate for PTEN's function.
Proposed replacements:
phosphatidylinositol dephosphorylation
|
|
GO:0006915
apoptotic process
|
IEA
GO_REF:0000043 |
KEEP AS NON CORE |
Summary: PTEN promotes apoptosis by inhibiting PI3K/AKT survival signaling. This is a downstream effect of PTEN's lipid phosphatase activity rather than a direct function.
Reason: Apoptosis regulation is a downstream consequence of PTEN's inhibition of AKT survival signaling, not a direct molecular function.
Supporting Evidence:
PMID:9811831
ectopic expression of the phosphatase in PTEN-deficient tumor cell lines resulted in the inhibition of protein kinase (PK) B/Akt and regulation of cell survival
|
|
GO:0007399
nervous system development
|
IEA
GO_REF:0000043 |
KEEP AS NON CORE |
Summary: PTEN plays important roles in nervous system development by regulating neuron size, dendritic arborization, and synapse formation through PI3K/AKT/mTOR signaling.
Reason: While PTEN has well-documented roles in nervous system development (PTEN mutations cause macrocephaly and autism spectrum disorders), this is a pleiotropic effect of its core lipid phosphatase function.
|
|
GO:0008285
negative regulation of cell population proliferation
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: PTEN suppresses cell proliferation through its antagonism of PI3K/AKT/mTOR signaling. This is a key aspect of its tumor suppressor function.
Reason: While this is a fundamental consequence of PTEN function and central to its tumor suppressor role, it is a downstream effect of PI3K/AKT pathway inhibition rather than a direct molecular function.
Supporting Evidence:
PMID:10468583
The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region
|
|
GO:0008289
lipid binding
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: PTEN binds phosphatidylinositol lipids as substrates via its C2 domain and phosphatase domain.
Reason: PTEN's C2 domain mediates membrane/lipid binding which is essential for its localization and function.
|
|
GO:0009966
regulation of signal transduction
|
IEA
GO_REF:0000117 |
MODIFY |
Summary: Very broad term. PTEN specifically regulates PI3K/AKT signal transduction via its lipid phosphatase activity.
Reason: Too general. GO:0051898 (negative regulation of PI3K/AKT signaling) is more specific and accurate.
Proposed replacements:
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
|
GO:0010604
positive regulation of macromolecule metabolic process
|
IEA
GO_REF:0000117 |
REMOVE |
Summary: Very broad and vague term with unclear relationship to PTEN's core functions. PTEN actually inhibits anabolic processes by suppressing mTOR signaling.
Reason: This annotation is too vague and potentially misleading. PTEN generally suppresses anabolic metabolism through mTOR inhibition rather than promoting macromolecule metabolism.
|
|
GO:0010648
negative regulation of cell communication
|
IEA
GO_REF:0000117 |
MODIFY |
Summary: Very broad term. PTEN specifically inhibits PI3K/AKT signaling.
Reason: Too general. GO:0051898 (negative regulation of PI3K/AKT signaling) is the specific pathway PTEN regulates.
Proposed replacements:
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
|
GO:0016314
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Duplicate of IBA annotation. This is PTEN's primary enzymatic activity.
Reason: Consistent with IBA annotation and extensive experimental evidence. This is the core molecular function of PTEN.
|
|
GO:0016787
hydrolase activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: Very broad parent term for PTEN's phosphatase activities.
Reason: While very general, this is technically accurate as a parent term of phosphatase activity.
|
|
GO:0016791
phosphatase activity
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: General phosphatase activity term. More specific terms for lipid and protein phosphatase activities are preferred.
Reason: Accurate as a parent term, though more specific annotations exist.
|
|
GO:0019899
enzyme binding
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: PTEN binds multiple enzymes including kinases and ubiquitin ligases that regulate its activity and stability.
Reason: PTEN interacts with various enzymes for regulation of its activity, localization, and stability.
|
|
GO:0023057
negative regulation of signaling
|
IEA
GO_REF:0000117 |
MODIFY |
Summary: Broad term. PTEN specifically negatively regulates PI3K/AKT signaling.
Reason: Too general. GO:0051898 (negative regulation of PI3K/AKT signaling) is more specific.
Proposed replacements:
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
|
GO:0030351
inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity
|
IEA
GO_REF:0000116 |
ACCEPT |
Summary: PTEN can dephosphorylate soluble inositol phosphates in addition to phosphatidylinositol lipids.
Reason: This activity has been demonstrated experimentally (PMID:11418101).
Supporting Evidence:
PMID:11418101
Expanding coincident signaling by PTEN through its inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity
|
|
GO:0045595
regulation of cell differentiation
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: PTEN affects cell differentiation through PI3K/AKT/mTOR pathway modulation.
Reason: This is a downstream pleiotropic effect of PTEN's lipid phosphatase activity, not a core function.
|
|
GO:0046856
phosphatidylinositol dephosphorylation
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Duplicate of IBA annotation. Core biological process for PTEN.
Reason: Consistent with IBA annotation. This is a core process term for PTEN's primary function.
|
|
GO:0051093
negative regulation of developmental process
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: Very broad term. PTEN affects development through PI3K/AKT pathway regulation.
Reason: Downstream pleiotropic effect of PTEN's lipid phosphatase activity. Too general to be informative.
|
|
GO:0051129
negative regulation of cellular component organization
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: Very broad term with unclear mechanistic connection to PTEN's core functions.
Reason: This is too vague and likely an over-annotation. PTEN's effects on cellular organization are indirect consequences of PI3K/AKT signaling modulation.
|
|
GO:0051241
negative regulation of multicellular organismal process
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: Very broad term with unclear mechanistic basis.
Reason: Too vague to be informative. This is an indirect consequence of PTEN's lipid phosphatase activity.
|
|
GO:0051717
inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: PTEN can dephosphorylate soluble inositol polyphosphates including I(1,3,4,5)P4.
Reason: This activity has been demonstrated experimentally (PMID:9593664).
Supporting Evidence:
PMID:9593664
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
|
|
GO:0051726
regulation of cell cycle
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: PTEN regulates cell cycle through multiple mechanisms including AKT-mediated effects on p27/p21 and nuclear PTEN effects on APC/CDH1.
Reason: While PTEN has well-documented effects on cell cycle, these are downstream of its lipid phosphatase activity and nuclear functions, not a primary molecular function.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner
|
|
GO:0051800
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: PTEN can dephosphorylate PI(3,4)P2 in addition to PIP3, though PIP3 is the primary substrate.
Reason: This is a documented enzymatic activity of PTEN (PMID:9811831).
Supporting Evidence:
PMID:9811831
Characterization of the lipid phosphatase activity of PTEN demonstrates that it shows specificity for phosphatidylinositols phosphorylated at the 3 position
|
|
GO:0005515
protein binding
|
IPI
PMID:15951562 Binding of PTEN to specific PDZ domains contributes to PTEN ... |
MODIFY |
Summary: PTEN binds PDZ domain-containing proteins (MAGI2, MAGI3, MAST1, MAST2, MAST3) through its C-terminal PDZ-binding motif.
Reason: Generic protein binding is uninformative. GO:0030165 (PDZ domain binding) is more specific and accurate for this interaction.
Proposed replacements:
PDZ domain binding
Supporting Evidence:
PMID:15951562
Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases
|
|
GO:0005515
protein binding
|
IPI
PMID:16456542 PTEN tumor suppressor associates with NHERF proteins to atte... |
MODIFY |
Summary: PTEN associates with NHERF proteins to attenuate PDGF receptor signaling.
Reason: Generic protein binding is uninformative. More specific term for NHERF/PDZ scaffold binding is preferred.
Proposed replacements:
PDZ domain binding
Supporting Evidence:
PMID:16456542
PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.
|
|
GO:0005515
protein binding
|
IPI
PMID:17274640 A limited screen for protein interactions reveals new roles ... |
MARK AS OVER ANNOTATED |
Summary: PTEN interacts with protein phosphatase 1.
Reason: Generic protein binding is uninformative. More specific binding terms should be used when the interacting partner is known.
Supporting Evidence:
PMID:17274640
A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis.
|
|
GO:0005515
protein binding
|
IPI
PMID:19345329 Rak functions as a tumor suppressor by regulating PTEN prote... |
MARK AS OVER ANNOTATED |
Summary: PTEN interacts with FRK kinase which phosphorylates and stabilizes PTEN.
Reason: Generic protein binding is uninformative. The specific interaction with FRK kinase is relevant for PTEN regulation but would be better annotated with a kinase binding term.
Supporting Evidence:
PMID:19345329
Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
|
|
GO:0005515
protein binding
|
IPI
PMID:19369943 Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activit... |
MARK AS OVER ANNOTATED |
Summary: PTEN interacts with peroxiredoxin 1 (Prdx1) which regulates PTEN oxidation.
Reason: Generic protein binding is uninformative.
Supporting Evidence:
PMID:19369943
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity.
|
|
GO:0005515
protein binding
|
IPI
PMID:19903340 PTEN inhibits BMI1 function independently of its phosphatase... |
MARK AS OVER ANNOTATED |
Summary: PTEN inhibits BMI1 function independently of its phosphatase activity.
Reason: Generic protein binding is uninformative. This interaction represents a non-canonical PTEN function.
Supporting Evidence:
PMID:19903340
PTEN inhibits BMI1 function independently of its phosphatase activity.
|
|
GO:0005515
protein binding
|
IPI
PMID:21241890 Nuclear PTEN regulates the APC-CDH1 tumor-suppressive comple... |
MODIFY |
Summary: Nuclear PTEN interacts with the APC-CDH1 complex.
Reason: More specific term should be used. GO:0010997 (anaphase-promoting complex binding) is appropriate.
Proposed replacements:
anaphase-promoting complex binding
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.
|
|
GO:0005515
protein binding
|
IPI
PMID:21653829 Protein interactome reveals converging molecular pathways am... |
MARK AS OVER ANNOTATED |
Summary: High-throughput study of protein interactions in autism spectrum disorders.
Reason: Generic protein binding from high-throughput study is uninformative without specific interactor information.
Supporting Evidence:
PMID:21653829
Protein interactome reveals converging molecular pathways among autism disorders.
|
|
GO:0005515
protein binding
|
IPI
PMID:21804599 PTEN, NHERF1 and PHLPP form a tumor suppressor network that ... |
MARK AS OVER ANNOTATED |
Summary: PTEN forms a tumor suppressor network with NHERF1 and PHLPP.
Reason: Generic protein binding is uninformative. Specific scaffold/adapter binding terms would be more appropriate.
Supporting Evidence:
PMID:21804599
PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
|
|
GO:0005515
protein binding
|
IPI
PMID:23514585 PTEN suppresses the oncogenic function of AIB1 through decre... |
MARK AS OVER ANNOTATED |
Summary: PTEN suppresses oncogenic AIB1 by promoting its degradation via Fbw7.
Reason: Generic protein binding is uninformative.
Supporting Evidence:
PMID:23514585
PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha.
|
|
GO:0005515
protein binding
|
IPI
PMID:23940795 Phosphorylation of the actin binding protein Drebrin at S647... |
MARK AS OVER ANNOTATED |
Summary: PTEN interacts with drebrin and regulates its phosphorylation.
Reason: Generic protein binding is uninformative.
Supporting Evidence:
PMID:23940795
Phosphorylation of the actin binding protein Drebrin at S647 is regulated by neuronal activity and PTEN.
|
|
GO:0005515
protein binding
|
IPI
PMID:24012959 Breast cancer-derived K172N, D301V mutations abolish Na+/H+ ... |
MODIFY |
Summary: PTEN interacts with NHERF1 which regulates PDGF receptor signaling.
Reason: Generic protein binding is uninformative. GO:0030165 (PDZ domain binding) is more specific.
Proposed replacements:
PDZ domain binding
Supporting Evidence:
PMID:24012959
Epub 2013 Sep 5. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
|
|
GO:0005515
protein binding
|
IPI
PMID:24656772 SPOP promotes tumorigenesis by acting as a key regulatory hu... |
MARK AS OVER ANNOTATED |
Summary: PTEN is a substrate of SPOP ubiquitin ligase.
Reason: Generic protein binding is uninformative. This represents PTEN regulation by ubiquitination.
Supporting Evidence:
PMID:24656772
2014 Mar 20. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer.
|
|
GO:0005515
protein binding
|
IPI
PMID:25241761 Using an in situ proximity ligation assay to systematically ... |
MARK AS OVER ANNOTATED |
Summary: High-throughput proximity ligation assay study.
Reason: Generic protein binding from high-throughput study is uninformative.
Supporting Evidence:
PMID:25241761
Oct 9. Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.
|
|
GO:0005515
protein binding
|
IPI
PMID:36950384 Protein interaction studies in human induced neurons indicat... |
MARK AS OVER ANNOTATED |
Summary: Protein interaction study in neurons related to autism.
Reason: Generic protein binding from high-throughput study is uninformative.
Supporting Evidence:
PMID:36950384
eCollection 2023 Mar 8.
|
|
GO:0042802
identical protein binding
|
IPI
PMID:24766807 Cancer-associated PTEN mutants act in a dominant-negative ma... |
ACCEPT |
Summary: Cancer-associated PTEN mutants can act in a dominant-negative manner by binding to wild-type PTEN, suggesting PTEN dimerization.
Reason: PTEN homodimerization is documented and may be relevant for its regulation and for dominant-negative effects of cancer mutations.
Supporting Evidence:
PMID:24766807
Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function
|
|
GO:0006661
phosphatidylinositol biosynthetic process
|
TAS
Reactome:R-HSA-1660499 |
MODIFY |
Summary: PTEN is involved in phosphatidylinositol metabolism by dephosphorylating 3-phosphorylated phosphoinositides, but this is catabolism not biosynthesis.
Reason: PTEN dephosphorylates phosphoinositides (catabolic), not biosynthesis. GO:0046856 (phosphatidylinositol dephosphorylation) is more accurate.
Proposed replacements:
phosphatidylinositol dephosphorylation
|
|
GO:0051898
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
TAS
Reactome:R-HSA-199456 |
ACCEPT |
Summary: PTEN negatively regulates PI3K/AKT signaling by dephosphorylating PIP3. This is a core process annotation.
Reason: This is the primary biological process in which PTEN functions. Core annotation.
Supporting Evidence:
PMID:9811831
PTEN functions to suppress these growth-promoting and survival signals by dephosphorylating the phospholipid products of PI 3-kinase
|
|
GO:0016314
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
|
TAS
Reactome:R-HSA-199456 |
ACCEPT |
Summary: PTEN's primary enzymatic activity. Duplicate of IBA and IDA annotations.
Reason: Core molecular function of PTEN. Essential for tumor suppression.
|
|
GO:0008013
beta-catenin binding
|
IPI
PMID:20123964 Lipid phosphate phosphatase 3 stabilization of beta-catenin ... |
UNDECIDED |
Summary: PTEN can interact with beta-catenin, potentially regulating Wnt signaling.
Reason: The reference PMID:20123964 is about lipid phosphate phosphatase 3 (LPP3), not PTEN directly. Need to verify if this annotation is correctly assigned.
Supporting Evidence:
PMID:20123964
Feb 1. Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures.
|
|
GO:0045944
positive regulation of transcription by RNA polymerase II
|
IMP
PMID:20123964 Lipid phosphate phosphatase 3 stabilization of beta-catenin ... |
UNDECIDED |
Summary: This annotation appears to be from a study on LPP3, not PTEN directly.
Reason: Need to verify reference relevance. PMID:20123964 title is about LPP3, not PTEN.
Supporting Evidence:
PMID:20123964
Feb 1. Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures.
|
|
GO:0051800
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
|
IDA
PMID:20123964 Lipid phosphate phosphatase 3 stabilization of beta-catenin ... |
ACCEPT |
Summary: PI(3,4)P2 3-phosphatase activity is documented for PTEN, but this reference appears to be about LPP3.
Reason: This activity is well-documented for PTEN (PMID:9811831), though the reference may need correction.
Supporting Evidence:
PMID:20123964
Feb 1. Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures.
|
|
GO:1902533
positive regulation of intracellular signal transduction
|
IMP
PMID:20123964 Lipid phosphate phosphatase 3 stabilization of beta-catenin ... |
UNDECIDED |
Summary: This annotation appears misattributed. PTEN generally negatively regulates signaling.
Reason: PTEN typically inhibits signaling via PI3K/AKT pathway. This positive regulation annotation may be incorrectly assigned or context-specific.
Supporting Evidence:
PMID:20123964
Feb 1. Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures.
|
|
GO:0005654
nucleoplasm
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: PTEN localizes to the nucleoplasm where it has phosphatase-independent functions in genomic stability and chromatin regulation.
Reason: Nuclear PTEN is well-documented with important functions including interaction with APC-CDH1 and regulation of genomic stability.
|
|
GO:0005829
cytosol
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: PTEN is present in the cytosol where it can function as both lipid and protein phosphatase
Reason: Cytosolic localization allows PTEN to regulate multiple signaling pathways beyond membrane-associated functions
|
|
GO:0005886
plasma membrane
|
IDA
PMID:10760291 Evidence for regulation of the PTEN tumor suppressor by a me... |
ACCEPT |
Summary: PTEN localizes to the plasma membrane where it dephosphorylates PIP3 to antagonize PI3K signaling
Reason: Plasma membrane localization is essential for PTEN's core lipid phosphatase function against PIP3
Supporting Evidence:
PMID:10760291
Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
|
|
GO:0030351
inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity
|
IDA
PMID:11418101 Expanding coincident signaling by PTEN through its inositol ... |
ACCEPT |
Summary: PTEN can dephosphorylate soluble inositol polyphosphates. This is a secondary enzymatic activity.
Reason: This activity is documented experimentally in the cited reference.
Supporting Evidence:
PMID:11418101
Expanding coincident signaling by PTEN through its inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity
|
|
GO:0045668
negative regulation of osteoblast differentiation
|
IDA
PMID:22869525 Insulin-like growth factor (IGF) binding protein 2 functions... |
KEEP AS NON CORE |
Summary: PTEN regulates osteoblast differentiation through PI3K/AKT pathway modulation.
Reason: This is a tissue-specific downstream effect of PTEN's lipid phosphatase activity, not a core function.
Supporting Evidence:
PMID:22869525
Aug 6. Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase Ξ² and the IGF-I receptor to regulate IGF-I-stimulated signaling.
|
|
GO:0051800
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
|
TAS
Reactome:R-HSA-1676149 |
ACCEPT |
Summary: PI(3,4)P2 3-phosphatase activity is documented for PTEN. Duplicate of IEA annotation.
Reason: This is a documented enzymatic activity of PTEN (PMID:9811831).
|
|
GO:0051898
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Core process annotation for PTEN. Duplicate of TAS/IDA annotations.
Reason: This is the primary biological process in which PTEN functions.
|
|
GO:0007270
neuron-neuron synaptic transmission
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN affects synaptic transmission through PI3K/AKT pathway modulation in neurons.
Reason: Downstream tissue-specific effect. PTEN mutations cause neurological phenotypes including autism spectrum disorders.
|
|
GO:0007611
learning or memory
|
ISS
PMID:16675393 Pten regulates neuronal arborization and social interaction ... |
KEEP AS NON CORE |
Summary: PTEN deletion in mouse neurons affects learning and memory through PI3K/mTOR pathway dysregulation.
Reason: Downstream pleiotropic effect based on mouse studies. Not a core molecular function.
Supporting Evidence:
PMID:16675393
Pten regulates neuronal arborization and social interaction in mice.
|
|
GO:0007626
locomotory behavior
|
ISS
PMID:16675393 Pten regulates neuronal arborization and social interaction ... |
KEEP AS NON CORE |
Summary: Neuronal PTEN deletion affects locomotory behavior in mouse studies.
Reason: Downstream behavioral effect. Very distant from PTEN's core lipid phosphatase function.
Supporting Evidence:
PMID:16675393
Pten regulates neuronal arborization and social interaction in mice.
|
|
GO:0021542
dentate gyrus development
|
ISS
PMID:17706614 A seizure-prone phenotype is associated with altered free-ru... |
KEEP AS NON CORE |
Summary: PTEN regulates dentate gyrus development via PI3K/AKT pathway.
Reason: Tissue-specific developmental effect. Not a core function.
Supporting Evidence:
PMID:17706614
2007 Jul 20. A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice.
|
|
GO:0021955
central nervous system neuron axonogenesis
|
ISS
PMID:16675393 Pten regulates neuronal arborization and social interaction ... |
KEEP AS NON CORE |
Summary: PTEN regulates axon growth through PI3K/mTOR signaling.
Reason: Downstream effect on neuronal development. Not a core function.
Supporting Evidence:
PMID:16675393
Pten regulates neuronal arborization and social interaction in mice.
|
|
GO:0030534
adult behavior
|
ISS
PMID:16675393 Pten regulates neuronal arborization and social interaction ... |
MARK AS OVER ANNOTATED |
Summary: PTEN affects adult behavior through neuronal PI3K/AKT signaling.
Reason: Too vague and distant from core molecular function. Over-annotation.
Supporting Evidence:
PMID:16675393
Pten regulates neuronal arborization and social interaction in mice.
|
|
GO:0032286
central nervous system myelin maintenance
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN affects myelination through PI3K/AKT/mTOR signaling.
Reason: Cell type-specific effect. Not a core function.
|
|
GO:0035176
social behavior
|
ISS
PMID:16675393 Pten regulates neuronal arborization and social interaction ... |
MARK AS OVER ANNOTATED |
Summary: PTEN deletion in neurons affects social behavior (autism-like phenotypes).
Reason: Behavioral phenotype very distant from core molecular function.
Supporting Evidence:
PMID:16675393
Pten regulates neuronal arborization and social interaction in mice.
|
|
GO:0042711
maternal behavior
|
ISS
PMID:16675393 Pten regulates neuronal arborization and social interaction ... |
MARK AS OVER ANNOTATED |
Summary: PTEN affects maternal behavior through neuronal functions.
Reason: Behavioral phenotype very distant from core molecular function.
Supporting Evidence:
PMID:16675393
Pten regulates neuronal arborization and social interaction in mice.
|
|
GO:0043005
neuron projection
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN localizes to and regulates neuron projections.
Reason: Cell type-specific localization. Valid but not a core function.
|
|
GO:0045475
locomotor rhythm
|
ISS
PMID:17706614 A seizure-prone phenotype is associated with altered free-ru... |
MARK AS OVER ANNOTATED |
Summary: PTEN affects locomotor rhythms through circadian/neuronal mechanisms.
Reason: Very indirect behavioral effect.
Supporting Evidence:
PMID:17706614
2007 Jul 20. A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice.
|
|
GO:0045792
negative regulation of cell size
|
ISS
PMID:21411674 Pten knockdown in vivo increases excitatory drive onto denta... |
KEEP AS NON CORE |
Summary: PTEN suppresses cell growth/size through PI3K/mTOR inhibition.
Reason: Well-documented downstream effect but not a core molecular function.
Supporting Evidence:
PMID:21411674
Pten knockdown in vivo increases excitatory drive onto dentate granule cells.
|
|
GO:0046621
negative regulation of organ growth
|
ISS
PMID:19208814 Haploinsufficiency for Pten and Serotonin transporter cooper... |
KEEP AS NON CORE |
Summary: PTEN suppresses organ growth via PI3K/AKT/mTOR pathway inhibition.
Reason: Downstream pleiotropic effect.
Supporting Evidence:
PMID:19208814
Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior.
|
|
GO:0060024
rhythmic synaptic transmission
|
ISS
PMID:17706614 A seizure-prone phenotype is associated with altered free-ru... |
MARK AS OVER ANNOTATED |
Summary: PTEN affects rhythmic synaptic transmission in circadian circuits.
Reason: Very specialized neuronal function.
Supporting Evidence:
PMID:17706614
2007 Jul 20. A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice.
|
|
GO:0060074
synapse maturation
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN regulates synapse maturation through PI3K/mTOR signaling.
Reason: Neuronal-specific developmental effect.
|
|
GO:0060134
prepulse inhibition
|
ISS
PMID:19208814 Haploinsufficiency for Pten and Serotonin transporter cooper... |
MARK AS OVER ANNOTATED |
Summary: PTEN affects sensorimotor gating (prepulse inhibition).
Reason: Very specialized behavioral/neurological phenotype.
Supporting Evidence:
PMID:19208814
Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior.
|
|
GO:0060997
dendritic spine morphogenesis
|
ISS
PMID:18082964 Phosphatase and tensin homolog, deleted on chromosome 10 def... |
KEEP AS NON CORE |
Summary: PTEN regulates dendritic spine morphology through PI3K/mTOR signaling.
Reason: Neuronal-specific structural effect.
Supporting Evidence:
PMID:18082964
Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities.
|
|
GO:0090394
negative regulation of excitatory postsynaptic potential
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN affects synaptic transmission.
Reason: Neuronal-specific effect.
|
|
GO:0097105
presynaptic membrane assembly
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN affects presynaptic structure.
Reason: Neuronal-specific structural effect.
|
|
GO:0097107
postsynaptic density assembly
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN affects postsynaptic structure via PI3K/mTOR signaling.
Reason: Neuronal-specific structural effect.
|
|
GO:1990757
ubiquitin ligase activator activity
|
ISS
PMID:21241890 Nuclear PTEN regulates the APC-CDH1 tumor-suppressive comple... |
ACCEPT |
Summary: Nuclear PTEN activates APC-CDH1 E3 ubiquitin ligase in a phosphatase-independent manner.
Reason: This represents a non-canonical function of nuclear PTEN that is independent of its phosphatase activity but important for tumor suppression.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner
|
|
GO:2000463
positive regulation of excitatory postsynaptic potential
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN affects synaptic transmission.
Reason: Neuronal-specific effect. Note this conflicts with GO:0090394 (negative regulation) which may indicate context-dependency.
|
|
GO:2000808
negative regulation of synaptic vesicle clustering
|
ISS
PMID:18082964 Phosphatase and tensin homolog, deleted on chromosome 10 def... |
KEEP AS NON CORE |
Summary: PTEN affects synaptic vesicle organization.
Reason: Neuronal-specific structural effect.
Supporting Evidence:
PMID:18082964
Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities.
|
|
GO:0007056
spindle assembly involved in female meiosis
|
IDA
PMID:31492966 The CRL4-DCAF13 ubiquitin E3 ligase supports oocyte meiotic ... |
KEEP AS NON CORE |
Summary: PTEN degradation is required for oocyte meiotic resumption. PTEN affects spindle assembly during oocyte meiosis.
Reason: Specialized cell type-specific role in meiosis. Not a core molecular function.
Supporting Evidence:
PMID:31492966
Epub 2019 Sep 6. The CRL4-DCAF13 ubiquitin E3 ligase supports oocyte meiotic resumption by targeting PTEN degradation.
|
|
GO:0051898
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
IDA
PMID:31492966 The CRL4-DCAF13 ubiquitin E3 ligase supports oocyte meiotic ... |
ACCEPT |
Summary: Core process annotation. PTEN negatively regulates PI3K/AKT signaling in oocytes.
Reason: Duplicate of TAS/ISS annotations. Core function.
Supporting Evidence:
PMID:31492966
Epub 2019 Sep 6. The CRL4-DCAF13 ubiquitin E3 ligase supports oocyte meiotic resumption by targeting PTEN degradation.
|
|
GO:0052866
phosphatidylinositol phosphate phosphatase activity
|
IDA
PMID:9811831 The lipid phosphatase activity of PTEN is critical for its t... |
ACCEPT |
Summary: General phosphatidylinositol phosphate phosphatase activity. The more specific GO:0016314 (PIP3 3-phosphatase) is preferred.
Reason: Accurate parent term for PTEN's lipid phosphatase activities.
Supporting Evidence:
PMID:9811831
Characterization of the lipid phosphatase activity of PTEN demonstrates that it shows specificity for phosphatidylinositols phosphorylated at the 3 position
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-5689950 |
ACCEPT |
Summary: Duplicate nucleoplasm annotation. PTEN localizes to nucleoplasm.
Reason: Nuclear PTEN localization is well-established.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-6807118 |
ACCEPT |
Summary: Duplicate nucleoplasm annotation.
Reason: Consistent with other nucleoplasm annotations.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-6807126 |
ACCEPT |
Summary: Duplicate nucleoplasm annotation.
Reason: Consistent with other nucleoplasm annotations.
|
|
GO:2000773
negative regulation of cellular senescence
|
ISS
PMID:21241890 Nuclear PTEN regulates the APC-CDH1 tumor-suppressive comple... |
KEEP AS NON CORE |
Summary: Nuclear PTEN affects cellular senescence through APC-CDH1 complex regulation.
Reason: Downstream effect of PTEN's nuclear functions.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.
|
|
GO:0033137
negative regulation of peptidyl-serine phosphorylation
|
IMP
PMID:10918569 PTEN expression is reduced in a subset of sporadic thyroid c... |
KEEP AS NON CORE |
Summary: PTEN inhibits AKT-mediated serine phosphorylation of downstream targets by reducing PIP3 levels.
Reason: This is an indirect consequence of PTEN's inhibition of AKT signaling.
Supporting Evidence:
PMID:10918569
PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
|
|
GO:1902807
negative regulation of cell cycle G1/S phase transition
|
IDA
PMID:10918569 PTEN expression is reduced in a subset of sporadic thyroid c... |
KEEP AS NON CORE |
Summary: PTEN inhibits G1/S transition through AKT-mediated effects on cell cycle regulators like p27.
Reason: Downstream effect of PI3K/AKT pathway inhibition.
Supporting Evidence:
PMID:10918569
PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-2317387 |
ACCEPT |
Summary: Duplicate cytosol annotation.
Reason: Consistent with IBA and IDA cytosol annotations.
|
|
GO:0010977
negative regulation of neuron projection development
|
ISS
PMID:28008308 The Protective Role of microRNA-200c in Alzheimer's Disease ... |
KEEP AS NON CORE |
Summary: PTEN negatively regulates neuron projection development through PI3K/mTOR signaling.
Reason: Neuronal-specific downstream effect.
Supporting Evidence:
PMID:28008308
eCollection 2016. The Protective Role of microRNA-200c in Alzheimer's Disease Pathologies Is Induced by Beta Amyloid-Triggered Endoplasmic Reticulum Stress.
|
|
GO:1904706
negative regulation of vascular associated smooth muscle cell proliferation
|
IMP
PMID:26208095 PPARΞ³ Ligands Attenuate Hypoxia-Induced Proliferation in Hum... |
KEEP AS NON CORE |
Summary: PTEN suppresses vascular smooth muscle cell proliferation through PI3K/AKT pathway inhibition.
Reason: Cell type-specific downstream effect of PTEN's core lipid phosphatase function.
Supporting Evidence:
PMID:26208095
eCollection 2015. PPARΞ³ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.
|
|
GO:0005515
protein binding
|
IPI
PMID:15355975 Regulation of PTEN phosphorylation and stability by a tumor ... |
MARK AS OVER ANNOTATED |
Summary: PTEN interacts with NOP53 which regulates PTEN stability.
Reason: Generic protein binding is uninformative.
Supporting Evidence:
PMID:15355975
2004 Sep 7. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein.
|
|
GO:0005515
protein binding
|
IPI
PMID:25007873 TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt... |
MARK AS OVER ANNOTATED |
Summary: PTEN interacts with PPP1R16B (TIMAP) in endothelial cells.
Reason: Generic protein binding is uninformative.
Supporting Evidence:
PMID:25007873
TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt inhibition in human glomerular endothelial cells.
|
|
GO:0051898
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
NAS
PMID:16762633 Involvement of human micro-RNA in growth and response to che... |
ACCEPT |
Summary: Core process annotation. Duplicate of IDA/TAS/ISS annotations.
Reason: Core biological process for PTEN.
Supporting Evidence:
PMID:16762633
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.
|
|
GO:0051898
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
IMP
PMID:22879939 TGFΞ²-stimulated microRNA-21 utilizes PTEN to orchestrate AKT... |
ACCEPT |
Summary: Core process annotation. Duplicate.
Reason: Core biological process for PTEN.
Supporting Evidence:
PMID:22879939
TGFΞ²-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion.
|
|
GO:0010719
negative regulation of epithelial to mesenchymal transition
|
IMP
PMID:27919618 Electric field-induced suppression of PTEN drives epithelial... |
KEEP AS NON CORE |
Summary: PTEN suppresses EMT through PI3K/AKT pathway inhibition.
Reason: Downstream process related to PTEN's tumor suppressor function.
Supporting Evidence:
PMID:27919618
Epub 2016 Nov 18. Electric field-induced suppression of PTEN drives epithelial-to-mesenchymal transition via mTORC1 activation.
|
|
GO:0051548
negative regulation of keratinocyte migration
|
IMP
PMID:27919618 Electric field-induced suppression of PTEN drives epithelial... |
KEEP AS NON CORE |
Summary: PTEN inhibits keratinocyte migration through PI3K/AKT signaling.
Reason: Cell type-specific migration effect.
Supporting Evidence:
PMID:27919618
Epub 2016 Nov 18. Electric field-induced suppression of PTEN drives epithelial-to-mesenchymal transition via mTORC1 activation.
|
|
GO:0071257
cellular response to electrical stimulus
|
IMP
PMID:27919618 Electric field-induced suppression of PTEN drives epithelial... |
MARK AS OVER ANNOTATED |
Summary: PTEN affects cellular responses to electrical stimulation in wound healing contexts.
Reason: Very specialized experimental context. Distant from core function.
Supporting Evidence:
PMID:27919618
Epub 2016 Nov 18. Electric field-induced suppression of PTEN drives epithelial-to-mesenchymal transition via mTORC1 activation.
|
|
GO:1903690
negative regulation of wound healing, spreading of epidermal cells
|
IMP
PMID:27919618 Electric field-induced suppression of PTEN drives epithelial... |
KEEP AS NON CORE |
Summary: PTEN inhibits epidermal cell spreading during wound healing.
Reason: Tissue-specific effect related to PTEN's effects on cell motility.
Supporting Evidence:
PMID:27919618
Epub 2016 Nov 18. Electric field-induced suppression of PTEN drives epithelial-to-mesenchymal transition via mTORC1 activation.
|
|
GO:0051898
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
IMP
PMID:26280536 Deubiquitylase OTUD3 regulates PTEN stability and suppresses... |
ACCEPT |
Summary: Core process annotation. Duplicate.
Reason: Core biological process for PTEN.
Supporting Evidence:
PMID:26280536
Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.
|
|
GO:1990381
ubiquitin-specific protease binding
|
IPI
PMID:26280536 Deubiquitylase OTUD3 regulates PTEN stability and suppresses... |
ACCEPT |
Summary: PTEN binds USP13 which deubiquitinates and stabilizes PTEN.
Reason: This is a specific binding activity relevant to PTEN regulation. More informative than generic protein binding.
Supporting Evidence:
PMID:26280536
Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-1676149 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Cytosolic localization is well-established for PTEN.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-1855205 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-199456 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-2321904 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-6807106 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-6807126 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-6807134 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-6807206 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8847968 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8847977 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8850945 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8850961 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome.
Reason: Consistent with other cytosol annotations.
|
|
GO:0030336
negative regulation of cell migration
|
IMP
PMID:21573166 Upregulated microRNA-29a by hepatitis B virus X protein enha... |
KEEP AS NON CORE |
Summary: PTEN inhibits cell migration through PI3K/AKT pathway inhibition.
Reason: Downstream effect of PTEN's lipid phosphatase activity. Well-documented but not a core molecular function.
Supporting Evidence:
PMID:9616126
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
PMID:21573166
Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
|
|
GO:0051898
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
IMP
PMID:21573166 Upregulated microRNA-29a by hepatitis B virus X protein enha... |
ACCEPT |
Summary: Core process annotation. Duplicate.
Reason: Core biological process for PTEN.
Supporting Evidence:
PMID:21573166
Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-6807105 |
ACCEPT |
Summary: Duplicate nucleoplasm annotation.
Reason: Consistent with other nucleoplasm annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-6807105 |
ACCEPT |
Summary: Duplicate cytosol annotation.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005634
nucleus
|
IDA
PMID:24862762 NHERF1/EBP50 controls morphogenesis of 3D colonic glands by ... |
ACCEPT |
Summary: PTEN nuclear localization is important for its protein phosphatase functions and genomic stability
Reason: Nuclear localization enables PTEN's protein phosphatase activity and non-canonical tumor suppressor functions
Supporting Evidence:
PMID:24862762
NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:24862762 NHERF1/EBP50 controls morphogenesis of 3D colonic glands by ... |
ACCEPT |
Summary: Duplicate cytoplasm annotation.
Reason: Cytoplasmic localization is well-established for PTEN.
Supporting Evidence:
PMID:24862762
NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
|
|
GO:0008284
positive regulation of cell population proliferation
|
ISS
GO_REF:0000024 |
UNDECIDED |
Summary: PTEN generally negatively regulates cell proliferation. Positive regulation may be context-specific.
Reason: This contradicts PTEN's well-established role as an inhibitor of cell proliferation. May be context-specific or incorrectly assigned.
|
|
GO:0051898
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
TAS
PMID:18082964 Phosphatase and tensin homolog, deleted on chromosome 10 def... |
ACCEPT |
Summary: Core process annotation. Duplicate.
Reason: Core biological process for PTEN.
Supporting Evidence:
PMID:18082964
Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities.
|
|
GO:0007416
synapse assembly
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN regulates synapse assembly through PI3K/mTOR signaling.
Reason: Neuronal-specific developmental effect.
|
|
GO:0033555
multicellular organismal response to stress
|
ISS
GO_REF:0000024 |
MARK AS OVER ANNOTATED |
Summary: Very broad term with unclear mechanistic basis.
Reason: Too vague to be informative.
|
|
GO:0048853
forebrain morphogenesis
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN affects forebrain development through PI3K/mTOR signaling regulation of cell growth.
Reason: Tissue-specific developmental effect.
|
|
GO:0050771
negative regulation of axonogenesis
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN inhibits axon growth through PI3K/mTOR pathway.
Reason: Neuronal-specific effect.
|
|
GO:0005515
protein binding
|
IPI
PMID:19473982 X-linked inhibitor of apoptosis protein (XIAP) regulates PTE... |
MARK AS OVER ANNOTATED |
Summary: PTEN interacts with XIAP which ubiquitinates PTEN.
Reason: Generic protein binding is uninformative.
Supporting Evidence:
PMID:19473982
2009 May 27. X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization.
|
|
GO:0046856
phosphatidylinositol dephosphorylation
|
IMP
PMID:21828076 A comprehensive functional analysis of PTEN mutations: impli... |
ACCEPT |
Summary: Core process annotation. PTEN dephosphorylates phosphatidylinositols.
Reason: Core biological process for PTEN.
Supporting Evidence:
PMID:21828076
Aug 9. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
|
|
GO:0008285
negative regulation of cell population proliferation
|
IMP
PMID:17880912 MAGI-2 Inhibits cell migration and proliferation via PTEN in... |
KEEP AS NON CORE |
Summary: PTEN suppresses cell proliferation through PI3K/AKT pathway inhibition.
Reason: Downstream effect of PTEN's core lipid phosphatase activity.
Supporting Evidence:
PMID:17880912
Epub 2007 Aug 22. MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells.
|
|
GO:0030336
negative regulation of cell migration
|
IMP
PMID:17880912 MAGI-2 Inhibits cell migration and proliferation via PTEN in... |
KEEP AS NON CORE |
Summary: PTEN inhibits cell migration. Duplicate annotation.
Reason: Downstream effect of PTEN's lipid phosphatase activity.
Supporting Evidence:
PMID:17880912
Epub 2007 Aug 22. MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:10760291 Evidence for regulation of the PTEN tumor suppressor by a me... |
ACCEPT |
Summary: Duplicate cytoplasm annotation.
Reason: Consistent with other cytoplasm annotations.
Supporting Evidence:
PMID:10760291
Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
|
|
GO:0004721
phosphoprotein phosphatase activity
|
IDA
PMID:21241890 Nuclear PTEN regulates the APC-CDH1 tumor-suppressive comple... |
ACCEPT |
Summary: PTEN has phosphoprotein phosphatase activity in the nucleus.
Reason: This protein phosphatase activity has been demonstrated experimentally.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.
|
|
GO:0005634
nucleus
|
IDA
PMID:21241890 Nuclear PTEN regulates the APC-CDH1 tumor-suppressive comple... |
ACCEPT |
Summary: Nuclear PTEN localization for APC-CDH1 regulation.
Reason: Well-documented nuclear localization with specific function.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:21241890 Nuclear PTEN regulates the APC-CDH1 tumor-suppressive comple... |
ACCEPT |
Summary: Duplicate cytoplasm annotation.
Reason: Consistent with other cytoplasm annotations.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.
|
|
GO:0010997
anaphase-promoting complex binding
|
IPI
PMID:21241890 Nuclear PTEN regulates the APC-CDH1 tumor-suppressive comple... |
ACCEPT |
Summary: Nuclear PTEN binds the APC-CDH1 complex to activate its E3 ligase activity.
Reason: This represents an important phosphatase-independent function of nuclear PTEN.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner
|
|
GO:2000060
positive regulation of ubiquitin-dependent protein catabolic process
|
IDA
PMID:21241890 Nuclear PTEN regulates the APC-CDH1 tumor-suppressive comple... |
KEEP AS NON CORE |
Summary: Nuclear PTEN activates APC-CDH1 to promote ubiquitin-dependent degradation of its substrates.
Reason: This is a downstream effect of PTEN's interaction with APC-CDH1, not a core function.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.
|
|
GO:2000134
negative regulation of G1/S transition of mitotic cell cycle
|
IDA
PMID:21241890 Nuclear PTEN regulates the APC-CDH1 tumor-suppressive comple... |
KEEP AS NON CORE |
Summary: Nuclear PTEN suppresses G1/S transition through APC-CDH1 activation.
Reason: Downstream effect of PTEN's nuclear APC-CDH1 activating function.
Supporting Evidence:
PMID:21241890
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.
|
|
GO:0005515
protein binding
|
IPI
PMID:17242191 NHERF1/EBP50 head-to-tail intramolecular interaction masks a... |
MARK AS OVER ANNOTATED |
Summary: PTEN interacts with DJ-1 which affects PTEN function.
Reason: Generic protein binding is uninformative.
Supporting Evidence:
PMID:17242191
Jan 22. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
|
|
GO:0008285
negative regulation of cell population proliferation
|
IDA
PMID:19057511 PTEN regulation by Akt-EGR1-ARF-PTEN axis. |
KEEP AS NON CORE |
Summary: PTEN suppresses cell proliferation. Duplicate annotation.
Reason: Downstream effect of PTEN's lipid phosphatase activity.
Supporting Evidence:
PMID:19057511
PTEN regulation by Akt-EGR1-ARF-PTEN axis.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:10940933 Subcellular localization of intracellular protein tyrosine p... |
ACCEPT |
Summary: Duplicate cytoplasm annotation.
Reason: Consistent with other cytoplasm annotations.
Supporting Evidence:
PMID:10940933
Subcellular localization of intracellular protein tyrosine phosphatases in T cells.
|
|
GO:0050821
protein stabilization
|
IDA
PMID:20123964 Lipid phosphate phosphatase 3 stabilization of beta-catenin ... |
UNDECIDED |
Summary: This annotation appears to be from a study on LPP3, not PTEN.
Reason: Need to verify reference relevance. PMID:20123964 is about LPP3.
Supporting Evidence:
PMID:20123964
Feb 1. Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures.
|
|
GO:0019899
enzyme binding
|
IPI
PMID:16845383 Critical role for Daxx in regulating Mdm2. |
ACCEPT |
Summary: PTEN interacts with NDR kinases.
Reason: More informative than generic protein binding.
Supporting Evidence:
PMID:16845383
Critical role for Daxx in regulating Mdm2.
|
|
GO:0010975
regulation of neuron projection development
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN regulates neuron projection development through PI3K/mTOR signaling.
Reason: Neuronal-specific effect.
|
|
GO:0005634
nucleus
|
IDA
PMID:17218261 Ubiquitination regulates PTEN nuclear import and tumor suppr... |
ACCEPT |
Summary: Nuclear localization of PTEN regulated by ubiquitination.
Reason: Consistent with other nuclear PTEN annotations.
Supporting Evidence:
PMID:17218261
Ubiquitination regulates PTEN nuclear import and tumor suppression
|
|
GO:0051800
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
|
IDA
PMID:9811831 The lipid phosphatase activity of PTEN is critical for its t... |
ACCEPT |
Summary: PTEN can dephosphorylate PI(3,4)P2 at the D3 position.
Reason: Documented enzymatic activity.
Supporting Evidence:
PMID:9811831
Characterization of the lipid phosphatase activity of PTEN demonstrates that it shows specificity for phosphatidylinositols phosphorylated at the 3 position
|
|
GO:0051895
negative regulation of focal adhesion assembly
|
IMP
PMID:9616126 Inhibition of cell migration, spreading, and focal adhesions... |
KEEP AS NON CORE |
Summary: PTEN inhibits focal adhesion formation through PI3K/AKT pathway modulation.
Reason: Downstream effect related to PTEN's effects on cell motility.
Supporting Evidence:
PMID:9616126
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
|
|
GO:0051898
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
IMP
PMID:10760291 Evidence for regulation of the PTEN tumor suppressor by a me... |
ACCEPT |
Summary: Core process annotation. PTEN suppresses AKT activation.
Reason: Core biological process for PTEN.
Supporting Evidence:
PMID:10760291
MAGI-2 enhances the ability of PTEN to suppress Akt activation
|
|
GO:0004438
phosphatidylinositol-3-phosphate phosphatase activity
|
IDA
PMID:9811831 The lipid phosphatase activity of PTEN is critical for its t... |
ACCEPT |
Summary: PTEN can dephosphorylate PI(3)P. Secondary substrate.
Reason: Documented activity, though PIP3 is the primary substrate.
Supporting Evidence:
PMID:9811831
The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
|
|
GO:0004722
protein serine/threonine phosphatase activity
|
IDA
PMID:9256433 P-TEN, the tumor suppressor from human chromosome 10q23, is ... |
ACCEPT |
Summary: PTEN has dual-specificity protein phosphatase activity including serine/threonine.
Reason: Core molecular function documented in the seminal paper.
Supporting Evidence:
PMID:9256433
recombinant P-TEN dephosphorylated protein and peptide substrates phosphorylated on serine, threonine, and tyrosine residues, indicating that P-TEN is a dual-specificity phosphatase
|
|
GO:0004725
protein tyrosine phosphatase activity
|
IDA
PMID:9256433 P-TEN, the tumor suppressor from human chromosome 10q23, is ... |
ACCEPT |
Summary: PTEN has protein tyrosine phosphatase activity.
Reason: Core molecular function documented experimentally.
Supporting Evidence:
PMID:9256433
recombinant P-TEN dephosphorylated protein and peptide substrates phosphorylated on serine, threonine, and tyrosine residues
|
|
GO:0005737
cytoplasm
|
IDA
PMID:9187108 TEP1, encoded by a candidate tumor suppressor locus, is a no... |
ACCEPT |
Summary: Early documentation of PTEN cytoplasmic localization.
Reason: Consistent with other cytoplasm annotations.
Supporting Evidence:
PMID:9187108
TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
|
|
GO:0006470
protein dephosphorylation
|
IDA
PMID:9256433 P-TEN, the tumor suppressor from human chromosome 10q23, is ... |
ACCEPT |
Summary: PTEN has protein phosphatase activity. Core process for its dual-specificity phosphatase function.
Reason: Documented experimentally in the seminal paper.
Supporting Evidence:
PMID:9256433
recombinant P-TEN dephosphorylated protein and peptide substrates phosphorylated on serine, threonine, and tyrosine residues
|
|
GO:0008285
negative regulation of cell population proliferation
|
IMP
PMID:10468583 The tumor-suppressor activity of PTEN is regulated by its ca... |
KEEP AS NON CORE |
Summary: PTEN suppresses cell proliferation. Duplicate annotation.
Reason: Downstream effect of PTEN's lipid phosphatase activity.
Supporting Evidence:
PMID:10468583
The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.
|
|
GO:0016314
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
|
IDA
PMID:9811831 The lipid phosphatase activity of PTEN is critical for its t... |
ACCEPT |
Summary: Core molecular function of PTEN. This is the primary enzymatic activity.
Reason: Essential for tumor suppression. Core molecular function.
Supporting Evidence:
PMID:9811831
Here we report that a missense mutation in PTEN, PTEN-G129E, which is observed in two Cowden disease kindreds, specifically ablates the ability of PTEN to recognize inositol phospholipids as a substrate, suggesting that loss of the lipid phosphatase activity is responsible for the etiology of the disease
|
|
GO:0030165
PDZ domain binding
|
IPI
PMID:10646847 Threonine phosphorylation of the MMAC1/PTEN PDZ binding doma... |
ACCEPT |
Summary: PTEN binds PDZ domains through its C-terminal motif. Important for localization and stability.
Reason: Well-documented interaction important for PTEN regulation.
Supporting Evidence:
PMID:10646847
Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.
|
|
GO:0030165
PDZ domain binding
|
IPI
PMID:10760291 Evidence for regulation of the PTEN tumor suppressor by a me... |
ACCEPT |
Summary: PTEN binds MAGI-2 PDZ domain. Important for membrane localization and function.
Reason: Core binding activity for PTEN localization and function.
Supporting Evidence:
PMID:10760291
PTEN binds to MAGI-2 through an interaction between the PDZ-binding motif of PTEN and the second PDZ domain of MAGI-2
|
|
GO:0030336
negative regulation of cell migration
|
IMP
PMID:9616126 Inhibition of cell migration, spreading, and focal adhesions... |
KEEP AS NON CORE |
Summary: PTEN inhibits cell migration through PI3K/AKT pathway inhibition.
Reason: Downstream effect of PTEN's lipid phosphatase activity.
Supporting Evidence:
PMID:9616126
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
|
|
GO:0046856
phosphatidylinositol dephosphorylation
|
IDA
PMID:9811831 The lipid phosphatase activity of PTEN is critical for its t... |
ACCEPT |
Summary: Core biological process for PTEN.
Reason: Primary process in which PTEN participates.
Supporting Evidence:
PMID:9811831
The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
|
|
GO:0051717
inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity
|
IDA
PMID:9593664 The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid... |
ACCEPT |
Summary: PTEN can dephosphorylate soluble inositol polyphosphates.
Reason: Documented enzymatic activity.
Supporting Evidence:
PMID:9593664
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
|
|
GO:0005737
cytoplasm
|
TAS
PMID:9367992 A family of putative tumor suppressors is structurally and f... |
ACCEPT |
Summary: Duplicate cytoplasm annotation.
Reason: Consistent with other cytoplasm annotations.
Supporting Evidence:
PMID:9367992
A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast.
|
|
GO:0006470
protein dephosphorylation
|
TAS
PMID:9367992 A family of putative tumor suppressors is structurally and f... |
ACCEPT |
Summary: PTEN has protein dephosphorylation activity.
Reason: Part of PTEN's dual-specificity phosphatase function.
Supporting Evidence:
PMID:9367992
A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast.
|
|
GO:0007417
central nervous system development
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN affects CNS development through PI3K/mTOR signaling.
Reason: Tissue-specific developmental effect.
|
|
GO:0007507
heart development
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN affects heart development through PI3K/AKT signaling.
Reason: Tissue-specific developmental effect.
|
|
GO:0016477
cell migration
|
ISS
GO_REF:0000024 |
MODIFY |
Summary: PTEN regulates cell migration. More specific negative regulation terms exist.
Reason: GO:0030336 (negative regulation of cell migration) is more accurate for PTEN's inhibitory effect.
Proposed replacements:
negative regulation of cell migration
|
|
GO:0031647
regulation of protein stability
|
IMP
PMID:10866658 Phosphorylation of the PTEN tail regulates protein stability... |
KEEP AS NON CORE |
Summary: PTEN affects protein stability, possibly through AKT-mediated effects.
Reason: Indirect effect through signaling pathway modulation.
Supporting Evidence:
PMID:10866658
Phosphorylation of the PTEN tail regulates protein stability and function.
|
|
GO:0016314
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
|
IDA
PMID:9593664 The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid... |
ACCEPT |
Summary: Core molecular function. Duplicate annotation.
Reason: Primary enzymatic activity of PTEN.
Supporting Evidence:
PMID:9593664
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
|
|
GO:0014069
postsynaptic density
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: PTEN localizes to postsynaptic densities in neurons.
Reason: Neuronal-specific localization.
|
|
GO:0016605
PML body
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: PTEN can localize to PML nuclear bodies.
Reason: Relevant for PTEN's nuclear functions and regulation by ubiquitination.
|
|
GO:0042995
cell projection
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Duplicate of IBA annotation. PTEN localizes to cell projections.
Reason: Consistent with IBA annotation.
|
|
GO:0043197
dendritic spine
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: PTEN localizes to dendritic spines in neurons.
Reason: Neuronal-specific localization.
|
|
GO:0097225
sperm midpiece
|
IDA
GO_REF:0000052 |
KEEP AS NON CORE |
Summary: PTEN localizes to sperm midpiece.
Reason: Cell type-specific localization.
|
|
GO:0097228
sperm principal piece
|
IDA
GO_REF:0000052 |
KEEP AS NON CORE |
Summary: PTEN localizes to sperm principal piece.
Reason: Cell type-specific localization.
|
|
GO:0140678
molecular function inhibitor activity
|
IMP
PMID:23744781 A secreted PTEN phosphatase that enters cells to alter signa... |
ACCEPT |
Summary: PTEN-L isoform can be secreted and inhibit PI3K signaling in recipient cells.
Reason: This describes the paracrine tumor suppressor activity of secreted PTEN-L.
Supporting Evidence:
PMID:23744781
A secreted PTEN phosphatase that enters cells to alter signaling and survival
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8850992 |
ACCEPT |
Summary: Duplicate cytosol annotation.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8850997 |
ACCEPT |
Summary: Duplicate cytosol annotation.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8851011 |
ACCEPT |
Summary: Duplicate cytosol annotation.
Reason: Consistent with other cytosol annotations.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8873946 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome pathway.
Reason: Consistent with other cytosol annotations. PTEN is a cytosolic protein that translocates to the plasma membrane for its lipid phosphatase function.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8944497 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome pathway.
Reason: Consistent with other cytosol annotations. PTEN is a cytosolic protein that translocates to the plasma membrane for its lipid phosphatase function.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8948775 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome pathway.
Reason: Consistent with other cytosol annotations. PTEN is a cytosolic protein that translocates to the plasma membrane for its lipid phosphatase function.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8948800 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome pathway.
Reason: Consistent with other cytosol annotations. PTEN is a cytosolic protein that translocates to the plasma membrane for its lipid phosphatase function.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8948832 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome pathway.
Reason: Consistent with other cytosol annotations. PTEN is a cytosolic protein that translocates to the plasma membrane for its lipid phosphatase function.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9615571 |
ACCEPT |
Summary: Duplicate cytosol annotation from Reactome pathway.
Reason: Consistent with other cytosol annotations. PTEN is a cytosolic protein that translocates to the plasma membrane for its lipid phosphatase function.
|
|
GO:0016324
apical plasma membrane
|
IMP
PMID:24862762 NHERF1/EBP50 controls morphogenesis of 3D colonic glands by ... |
ACCEPT |
Summary: PTEN localizes to the apical plasma membrane in polarized epithelial cells, stabilized by NHERF1/EBP50 interaction.
Reason: The publication demonstrates that PTEN localizes apically in polarized epithelial cells through its C-terminal PDZ-binding motif interaction with NHERF1. This apical localization is important for maintaining PIP2/PIP3 distribution and epithelial polarity.
Supporting Evidence:
PMID:24862762
NHERF1 stabilizes PTEN apically through PDZ-domain interactions [5] , and NHERF1 loss leads to PTEN cytosolic redistribution
|
|
GO:0042995
cell projection
|
IDA
PMID:25007873 TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt... |
UNDECIDED |
Summary: PTEN localization to cell projections in endothelial cells based on TIMAP colocalization studies.
Reason: The publication PMID:25007873 focuses on TIMAP regulation of PTEN activity and shows colocalization, but the full text is not available to confirm specific cell projection localization data. The abstract does not directly address cell projection localization.
Supporting Evidence:
PMID:25007873
TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt inhibition in human glomerular endothelial cells.
|
|
GO:0035749
myelin sheath adaxonal region
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN localization to myelin sheath adaxonal region inferred from sequence similarity.
Reason: This is a highly specialized cell type-specific localization in myelinating Schwann cells. While PTEN plays important roles in myelination, this represents a cell type-specific localization rather than a core function annotation.
|
|
GO:0043220
Schmidt-Lanterman incisure
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: PTEN localization to Schmidt-Lanterman incisures in myelin sheath inferred from sequence similarity.
Reason: This is a highly specialized localization in peripheral nerve myelin sheaths. While PTEN is important for Schwann cell function and myelination, this represents a cell type-specific localization rather than a core function annotation.
|
|
GO:0042995
cell projection
|
IDA
PMID:10760291 Evidence for regulation of the PTEN tumor suppressor by a me... |
UNDECIDED |
Summary: This annotation is likely incorrect for PMID:10760291, which focuses on MAGI-2 PDZ domain interactions.
Reason: PMID:10760291 describes PTEN binding to MAGI-2 at tight junctions in epithelial cell membranes, not specifically cell projections. The cell projection annotation may be a misinterpretation of the membrane localization data. The reference discusses membrane localization through MAGI-2 scaffold interactions but does not specifically characterize cell projection localization.
Supporting Evidence:
PMID:10760291
Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
|
|
GO:0009898
cytoplasmic side of plasma membrane
|
IDA
PMID:10940933 Subcellular localization of intracellular protein tyrosine p... |
ACCEPT |
Summary: PTEN localizes to the cytoplasmic side of the plasma membrane in T cells.
Reason: The publication directly examines subcellular localization of intracellular protein tyrosine phosphatases including PTEN in T cells. PTEN was found enriched at the plasma membrane, consistent with its function in dephosphorylating membrane-associated PIP3. This localization is essential for its core lipid phosphatase function.
Supporting Evidence:
PMID:10940933
Most were found in the cytosol and many were enriched at the plasma membrane.
|
Exported on March 22, 2026 at 03:09 AM
Organism: Homo sapiens
Sequence:
MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV
I begin with the InterPro architecture. The N-terminal half (residues 1β403) is saturated with phosphatase signatures: IPR029021 (Protein-tyrosine phosphatase-like homologous superfamily, residues 1β187) frames the fold; IPR003595 (Protein-tyrosine phosphatase, catalytic domain, residues 23β183) and IPR045101 (PTEN phosphatase domain, residues 24β181) define the catalytic core; IPR000387 (Tyrosine-specific protein phosphatases domain, residues 102β173) and IPR016130 (Protein-tyrosine phosphatase active site, residues 122β132) pinpoint the essential cysteine-based nucleophile and arginine-stabilizing cage that drive hydrolysis of phosphate monoesters. This N-terminal catalytic engine is reinforced by PTEN/tyrosine phosphatase family assignments IPR017361 (Bifunctional phosphatidylinositol trisphosphate phosphatase/dual specificity phosphatase PTEN family, residues 1β403) and IPR051281 (Dual-specificity lipid and protein phosphatase family, residues 1β377), which specify that the same active site accommodates both lipid and protein substrates. Immediately downstream, the C-terminal half is dominated by membrane-targeting modules: IPR029023 (Tensin-type phosphatase domain, residues 14β185) transitions into a membrane-binding region annotated as IPR035892 (C2 domain superfamily, residues 188β349) and IPR014020 (Tensin phosphatase, C2 domain, residues 188β350). This arrangementβan N-terminal cysteine-dependent PTP fold followed by a C2 membrane-targeting moduleβcreates a bifunctional enzyme: the catalytic head performs phosphate removal, while the C2 domain docks the enzyme onto acidic membranes to access membrane-embedded lipid substrates.
This domain architecture causes two coupled molecular functions. First, the conserved PTP fold and active-site signature (IPR016130) establish phosphatase chemistry that removes phosphate groups from tyrosine and, by extension, from certain protein residues; this supports GO:0004725 protein tyrosine phosphatase activity and explains dual-specificity behavior. Second, the PTEN family and tensin-type arrangement (IPR017361, IPR051281) together with membrane-anchoring C2 modules direct the same catalytic apparatus toward phosphoinositide headgroups, supporting phosphatidylinositol phosphate phosphatase activity that converts PI(3,4,5)P3 to PI(4,5)P2 at membrane surfaces. The convergence of these motifs functionally manifests as a lipid/protein phosphatase capable of sculpting signaling lipids.
From these molecular activities, the biological process follows. By depleting PI(3,4,5)P3 at the cytoplasmic face of membranes, the enzyme attenuates phosphoinositide-dependent pathways that govern cell survival and proliferation. This directly tunes insulin and growth factor signaling and biases fate decisions toward controlled growth rather than unregulated proliferation. Consequently, the architecture-driven phosphatase activity situates the protein squarely in phosphatidylinositol-mediated signaling and broader signal transduction pathways that govern cell cycle and survival checkpoints.
Cellular localization emerges naturally from the targeting modules. The soluble catalytic PTP core and the membrane-docking C2 domain together predict a cytoplasmic enzyme that transiently associates with membrane surfaces. Thus, the protein operates in the cytoplasm (GO:0005737), with dynamic recruitment to membrane-proximal cytoplasmic zones consistent with its soluble, membrane-associating design.
Mechanistically, I hypothesize that the N-terminal catalytic pocket engages both protein and lipid phosphates, while the C2-containing C-terminal region positions the enzyme on endomembranes and the plasma membrane to efficiently hydrolyze PI(3,4,5)P3. This membrane-tethered catalysis suppresses downstream kinase cascades and stabilizes cell polarity and genome integrity. Likely interaction partners are membrane-associated signaling assemblies and adaptors that present phosphoinositide-rich surfaces and scaffolds: insulin receptor complexes and PI3K products would be proximate; cytoskeletal and focal-adhesion organizers (tensins) would recruit the C2-bearing module; and polarity/scaffold proteins at membrane-cytoplasm interfaces would transiently bind to coordinate pathway attenuation.
A cytoplasmic dual-specificity phosphatase that couples a cysteine-dependent catalytic core with a membrane-targeting module to remove phosphate groups from both protein and lipid substrates. By docking to membrane surfaces via a C2-containing region, it hydrolyzes signaling phosphoinositides to dampen growth-factor and insulin pathways, thereby constraining proliferation, sustaining proper cell-cycle and polarity control, and preserving genome integrity through attenuation of PI3KβAkt signaling.
Acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-phosphorylated cellular substrates, as well as cellular and non-cellular phosphatidylinositol phosphates. PTEN is a bifunctional lipid- and protein-phosphatase which down-regulates PI3K-dependent signal transduction pathways. Translocates to the membrane of the endoplasmic reticulum in response to insulin depletion. The membrane-associated form is the major form found in cells (By similarity). Influences cell survival and proliferation, and is implicated in maintenance of cell polarity, control of the cell cycle, and genomic integrity.
IPR029021, homologous_superfamily) β residues 1-187IPR017361, family) β residues 1-403IPR051281, family) β residues 1-377IPR029023, domain) β residues 14-185IPR003595, domain) β residues 23-183IPR045101, domain) β residues 24-181IPR000387, domain) β residues 102-173IPR016130, active_site) β residues 122-132IPR035892, homologous_superfamily) β residues 188-349IPR014020, domain) β residues 188-350Molecular Function: molecular_function (GO:0003674), catalytic activity (GO:0003824), molecular function regulator activity (GO:0098772), binding (GO:0005488), molecular function inhibitor activity (GO:0140678), hydrolase activity (GO:0016787), protein-containing complex binding (GO:0044877), catalytic activity, acting on a protein (GO:0140096), protein binding (GO:0005515), phosphoprotein phosphatase activity (GO:0004721), identical protein binding (GO:0042802), hydrolase activity, acting on ester bonds (GO:0016788), protein domain specific binding (GO:0019904), enzyme binding (GO:0019899), phosphoric ester hydrolase activity (GO:0042578), PDZ domain binding (GO:0030165), protease binding (GO:0002020), protein serine/threonine phosphatase activity (GO:0004722), protein tyrosine phosphatase activity (GO:0004725), ubiquitin-specific protease binding (GO:1990381), phosphatase activity (GO:0016791), phosphatidylinositol phosphate phosphatase activity (GO:0052866), inositol phosphate phosphatase activity (GO:0052745), phosphatidylinositol monophosphate phosphatase activity (GO:0052744), phosphatidylinositol bisphosphate phosphatase activity (GO:0034593), phosphatidylinositol trisphosphate phosphatase activity (GO:0034594), phosphatidylinositol-3-phosphate phosphatase activity (GO:0004438)
Biological Process: biological_process (GO:0008150), localization (GO:0051179), positive regulation of biological process (GO:0048518), regulation of biological process (GO:0050789), signaling (GO:0023052), biological regulation (GO:0065007), response to stimulus (GO:0050896), cellular process (GO:0009987), metabolic process (GO:0008152), negative regulation of biological process (GO:0048519), negative regulation of signaling (GO:0023057), nitrogen compound metabolic process (GO:0006807), negative regulation of multicellular organismal process (GO:0051241), regulation of multicellular organismal process (GO:0051239), negative regulation of metabolic process (GO:0009892), cell-cell signaling (GO:0007267), regulation of developmental process (GO:0050793), regulation of biological quality (GO:0065008), regulation of cellular process (GO:0050794), regulation of response to stimulus (GO:0048583), negative regulation of locomotion (GO:0040013), cellular response to stimulus (GO:0051716), regulation of signaling (GO:0023051), negative regulation of developmental process (GO:0051093), negative regulation of cellular process (GO:0048523), signal transduction (GO:0007165), regulation of locomotion (GO:0040012), response to abiotic stimulus (GO:0009628), positive regulation of signaling (GO:0023056), biosynthetic process (GO:0009058), positive regulation of response to stimulus (GO:0048584), regulation of metabolic process (GO:0019222), organic substance metabolic process (GO:0071704), catabolic process (GO:0009056), cellular metabolic process (GO:0044237), small molecule metabolic process (GO:0044281), positive regulation of metabolic process (GO:0009893), regulation of molecular function (GO:0065009), negative regulation of response to stimulus (GO:0048585), cell communication (GO:0007154), primary metabolic process (GO:0044238), positive regulation of cellular process (GO:0048522), response to electrical stimulus (GO:0051602), negative regulation of signal transduction (GO:0009968), positive regulation of cell death (GO:0010942), negative regulation of cellular component organization (GO:0051129), regulation of cell motility (GO:2000145), regulation of response to stress (GO:0080134), regulation of signal transduction (GO:0009966), regulation of cell adhesion (GO:0030155), cellular lipid metabolic process (GO:0044255), negative regulation of epithelial to mesenchymal transition (GO:0010719), regulation of macromolecule metabolic process (GO:0060255), regulation of response to external stimulus (GO:0032101), carbohydrate metabolic process (GO:0005975), negative regulation of cell cycle process (GO:0010948), regulation of cellular component biogenesis (GO:0044087), phosphorus metabolic process (GO:0006793), regulation of catabolic process (GO:0009894), regulation of epithelial cell migration (GO:0010632), regulation of cell cycle (GO:0051726), negative regulation of cell adhesion (GO:0007162), negative regulation of macromolecule metabolic process (GO:0010605), cellular response to abiotic stimulus (GO:0071214), negative regulation of epithelial cell migration (GO:0010633), regulation of nitrogen compound metabolic process (GO:0051171), regulation of cell differentiation (GO:0045595), cell surface receptor signaling pathway (GO:0007166), negative regulation of cell cycle (GO:0045786), regulation of cellular component organization (GO:0051128), organic substance catabolic process (GO:1901575), regulation of cell cycle process (GO:0010564), negative regulation of cell motility (GO:2000146), positive regulation of nitrogen compound metabolic process (GO:0051173), cellular carbohydrate metabolic process (GO:0044262), positive regulation of signal transduction (GO:0009967), organic hydroxy compound metabolic process (GO:1901615), negative regulation of cell communication (GO:0010648), regulation of catalytic activity (GO:0050790), negative regulation of nitrogen compound metabolic process (GO:0051172), positive regulation of molecular function (GO:0044093), organic substance biosynthetic process (GO:1901576), organonitrogen compound metabolic process (GO:1901564), small molecule catabolic process (GO:0044282), positive regulation of macromolecule metabolic process (GO:0010604), cell-cell signaling by wnt (GO:0198738), negative regulation of cell population proliferation (GO:0008285), organophosphate metabolic process (GO:0019637), protein metabolic process (GO:0019538), negative regulation of molecular function (GO:0044092), cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114), cellular biosynthetic process (GO:0044249), alcohol metabolic process (GO:0006066), regulation of protein stability (GO:0031647), negative regulation of cellular metabolic process (GO:0031324), macromolecule metabolic process (GO:0043170), cellular response to environmental stimulus (GO:0104004), regulation of cell population proliferation (GO:0042127), lipid metabolic process (GO:0006629), regulation of cell death (GO:0010941), regulation of cell communication (GO:0010646), positive regulation of cellular metabolic process (GO:0031325), negative regulation of cell differentiation (GO:0045596), regulation of DNA-binding transcription factor activity (GO:0051090), regulation of biosynthetic process (GO:0009889), regulation of cellular metabolic process (GO:0031323), positive regulation of cell communication (GO:0010647), regulation of primary metabolic process (GO:0080090), negative regulation of response to wounding (GO:1903035), positive regulation of catabolic process (GO:0009896), negative regulation of response to external stimulus (GO:0032102), regulation of mitotic cell cycle (GO:0007346), negative regulation of wound healing (GO:0061045), regulation of macromolecule biosynthetic process (GO:0010556), regulation of protein metabolic process (GO:0051246), regulation of cell-substrate adhesion (GO:0010810), regulation of programmed cell death (GO:0043067), Wnt signaling pathway (GO:0016055), phospholipid metabolic process (GO:0006644), regulation of cell migration (GO:0030334), cellular response to electrical stimulus (GO:0071257), negative regulation of smooth muscle cell proliferation (GO:0048662), regulation of cell-substrate junction organization (GO:0150116), glycerolipid biosynthetic process (GO:0045017), regulation of gene expression (GO:0010468), phosphorylated carbohydrate dephosphorylation (GO:0046838), inositol phosphate metabolic process (GO:0043647), regulation of smooth muscle cell proliferation (GO:0048660), macromolecule modification (GO:0043412), glycerolipid metabolic process (GO:0046486), alcohol catabolic process (GO:0046164), negative regulation of mitotic cell cycle (GO:0045930), organophosphate biosynthetic process (GO:0090407), negative regulation of phosphorus metabolic process (GO:0010563), lipid modification (GO:0030258), regulation of RNA metabolic process (GO:0051252), positive regulation of catalytic activity (GO:0043085), lipid biosynthetic process (GO:0008610), positive regulation of DNA-binding transcription factor activity (GO:0051091), negative regulation of cell-substrate adhesion (GO:0010812), negative regulation of catalytic activity (GO:0043086), regulation of response to wounding (GO:1903034), positive regulation of programmed cell death (GO:0043068), regulation of cell junction assembly (GO:1901888), negative regulation of protein metabolic process (GO:0051248), positive regulation of apoptotic signaling pathway (GO:2001235), phosphate-containing compound metabolic process (GO:0006796), negative regulation of intracellular signal transduction (GO:1902532), regulation of apoptotic signaling pathway (GO:2001233), negative regulation of cell junction assembly (GO:1901889), negative regulation of cell migration (GO:0030336), protein modification process (GO:0036211), organic hydroxy compound catabolic process (GO:1901616), regulation of cyclin-dependent protein kinase activity (GO:1904029), polyol metabolic process (GO:0019751), regulation of cell cycle phase transition (GO:1901987), regulation of cellular biosynthetic process (GO:0031326), positive regulation of protein metabolic process (GO:0051247), regulation of nucleobase-containing compound metabolic process (GO:0019219), positive regulation of cellular catabolic process (GO:0031331), protein stabilization (GO:0050821), regulation of transferase activity (GO:0051338), regulation of cellular catabolic process (GO:0031329), organophosphate catabolic process (GO:0046434), regulation of epithelial to mesenchymal transition (GO:0010717), regulation of intracellular signal transduction (GO:1902531), regulation of phosphorus metabolic process (GO:0051174), negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736), negative regulation of cell cycle phase transition (GO:1901988), negative regulation of cell-matrix adhesion (GO:0001953), regulation of phosphatidylinositol 3-kinase signaling (GO:0014066), regulation of apoptotic process (GO:0042981), regulation of vascular associated smooth muscle cell proliferation (GO:1904705), regulation of proteolysis (GO:0030162), negative regulation of cyclin-dependent protein kinase activity (GO:1904030), negative regulation of protein modification process (GO:0031400), regulation of RNA biosynthetic process (GO:2001141), regulation of cell-matrix adhesion (GO:0001952), phosphatidylinositol-mediated signaling (GO:0006470), regulation of ubiquitin-protein transferase activity (GO:0051438), inositol phosphate catabolic process (GO:0071545), canonical Wnt signaling pathway (GO:0060070), phospholipid biosynthetic process (GO:0008654), regulation of kinase activity (GO:0043549), regulation of protein kinase B signaling (GO:0051896), negative regulation of transferase activity (GO:0051348), regulation of ubiquitin-dependent protein catabolic process (GO:2000058), positive regulation of protein modification process (GO:0031401), phospholipid dephosphorylation (GO:0046839), regulation of wound healing (GO:0061041), inositol phosphate dephosphorylation (GO:0046855), negative regulation of MAPK cascade (GO:0043409), dephosphorylation (GO:0016311), regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079), regulation of MAPK cascade (GO:0043408), positive regulation of apoptotic process (GO:0043065), positive regulation of transferase activity (GO:0051347), regulation of protein modification process (GO:0031399), negative regulation of mitotic cell cycle phase transition (GO:1901991), positive regulation of extrinsic apoptotic signaling pathway (GO:2001238), negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706), glycerophospholipid biosynthetic process (GO:0046474), regulation of DNA-templated transcription (GO:0006355), regulation of phosphate metabolic process (GO:0019220), glycerophospholipid metabolic process (GO:0006650), negative regulation of protein kinase B signaling (GO:0051898), negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067), positive regulation of proteolysis (GO:0045862), regulation of mitotic cell cycle phase transition (GO:1901990), regulation of cell-substrate junction assembly (GO:0090109), positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060), regulation of extrinsic apoptotic signaling pathway (GO:2001236), polyol catabolic process (GO:0046174), regulation of cell cycle G1/S phase transition (GO:1902806), negative regulation of cell cycle G1/S phase transition (GO:1902807), negative regulation of phosphate metabolic process (GO:0045936), regulation of protein phosphorylation (GO:0001932), negative regulation of G1/S transition of mitotic cell cycle (GO:2000134), negative regulation of phosphorylation (GO:0042326), regulation of protein kinase activity (GO:0045859), regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041), positive regulation of protein modification by small protein conjugation or removal (GO:1903322), positive regulation of ubiquitin-protein transferase activity (GO:0051443), regulation of focal adhesion assembly (GO:0051893), regulation of nucleic acid-templated transcription (GO:1903506), regulation of ERK1 and ERK2 cascade (GO:0070372), regulation of phosphorylation (GO:0042325), negative regulation of protein phosphorylation (GO:0001933), regulation of protein modification by small protein conjugation or removal (GO:1903320), positive regulation of proteolysis involved in protein catabolic process (GO:1903052), negative regulation of kinase activity (GO:0033673), phosphatidylinositol dephosphorylation (GO:0046856), phosphatidylinositol metabolic process (GO:0046488), regulation of proteolysis involved in protein catabolic process (GO:1903050), negative regulation of ERK1 and ERK2 cascade (GO:0070373), regulation of G1/S transition of mitotic cell cycle (GO:2000045), regulation of ubiquitin protein ligase activity (GO:1904666), phosphatidylinositol biosynthetic process (GO:0006661), regulation of protein serine/threonine kinase activity (GO:0071900), regulation of protein ubiquitination (GO:0031396), negative regulation of peptidyl-serine phosphorylation (GO:0033137), regulation of peptidyl-serine phosphorylation (GO:0033135), negative regulation of protein kinase activity (GO:0006469), positive regulation of protein ubiquitination (GO:0031398), negative regulation of protein serine/threonine kinase activity (GO:0071901)
Cellular Component: cellular_component (GO:0005575), cellular anatomical entity (GO:0110165), side of membrane (GO:0098552), intracellular anatomical structure (GO:0005622), organelle (GO:0043226), apical part of cell (GO:0045177), cell projection (GO:0042995), membrane (GO:0016020), cytosol (GO:0005829), cytoplasm (GO:0005737), cell periphery (GO:0071944), membrane-enclosed lumen (GO:0031974), nucleoplasm (GO:0005654), plasma membrane region (GO:0098590), organelle lumen (GO:0043233), intracellular organelle (GO:0043229), cytoplasmic side of membrane (GO:0098562), membrane-bounded organelle (GO:0043227), plasma membrane (GO:0005886), apical plasma membrane (GO:0016324), cytoplasmic side of plasma membrane (GO:0009898), intracellular membrane-bounded organelle (GO:0043231), intracellular organelle lumen (GO:0070013), nuclear lumen (GO:0031981), nucleus (GO:0005634)
Generated by BioReason
Exported on March 22, 2026 at 03:09 AM
Organism: Homo sapiens
Sequence:
MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV
I begin with the InterPro architecture. The N-terminal half (residues 1β403) is saturated with phosphatase signatures: IPR029021 (Protein-tyrosine phosphatase-like homologous superfamily, residues 1β187) frames the fold; IPR003595 (Protein-tyrosine phosphatase, catalytic domain, residues 23β183) and IPR045101 (PTEN phosphatase domain, residues 24β181) define the catalytic core; IPR000387 (Tyrosine-specific protein phosphatases domain, residues 102β173) and IPR016130 (Protein-tyrosine phosphatase active site, residues 122β132) pinpoint the essential cysteine-based nucleophile and arginine-stabilizing cage that drive hydrolysis of phosphate monoesters. This N-terminal catalytic engine is reinforced by PTEN/tyrosine phosphatase family assignments IPR017361 (Bifunctional phosphatidylinositol trisphosphate phosphatase/dual specificity phosphatase PTEN family, residues 1β403) and IPR051281 (Dual-specificity lipid and protein phosphatase family, residues 1β377), which specify that the same active site accommodates both lipid and protein substrates. Immediately downstream, the C-terminal half is dominated by membrane-targeting modules: IPR029023 (Tensin-type phosphatase domain, residues 14β185) transitions into a membrane-binding region annotated as IPR035892 (C2 domain superfamily, residues 188β349) and IPR014020 (Tensin phosphatase, C2 domain, residues 188β350). This arrangementβan N-terminal cysteine-dependent PTP fold followed by a C2 membrane-targeting moduleβcreates a bifunctional enzyme: the catalytic head performs phosphate removal, while the C2 domain docks the enzyme onto acidic membranes to access membrane-embedded lipid substrates.
This domain architecture causes two coupled molecular functions. First, the conserved PTP fold and active-site signature (IPR016130) establish phosphatase chemistry that removes phosphate groups from tyrosine and, by extension, from certain protein residues; this supports GO:0004725 protein tyrosine phosphatase activity and explains dual-specificity behavior. Second, the PTEN family and tensin-type arrangement (IPR017361, IPR051281) together with membrane-anchoring C2 modules direct the same catalytic apparatus toward phosphoinositide headgroups, supporting phosphatidylinositol phosphate phosphatase activity that converts PI(3,4,5)P3 to PI(4,5)P2 at membrane surfaces. The convergence of these motifs functionally manifests as a lipid/protein phosphatase capable of sculpting signaling lipids.
From these molecular activities, the biological process follows. By depleting PI(3,4,5)P3 at the cytoplasmic face of membranes, the enzyme attenuates phosphoinositide-dependent pathways that govern cell survival and proliferation. This directly tunes insulin and growth factor signaling and biases fate decisions toward controlled growth rather than unregulated proliferation. Consequently, the architecture-driven phosphatase activity situates the protein squarely in phosphatidylinositol-mediated signaling and broader signal transduction pathways that govern cell cycle and survival checkpoints.
Cellular localization emerges naturally from the targeting modules. The soluble catalytic PTP core and the membrane-docking C2 domain together predict a cytoplasmic enzyme that transiently associates with membrane surfaces. Thus, the protein operates in the cytoplasm (GO:0005737), with dynamic recruitment to membrane-proximal cytoplasmic zones consistent with its soluble, membrane-associating design.
Mechanistically, I hypothesize that the N-terminal catalytic pocket engages both protein and lipid phosphates, while the C2-containing C-terminal region positions the enzyme on endomembranes and the plasma membrane to efficiently hydrolyze PI(3,4,5)P3. This membrane-tethered catalysis suppresses downstream kinase cascades and stabilizes cell polarity and genome integrity. Likely interaction partners are membrane-associated signaling assemblies and adaptors that present phosphoinositide-rich surfaces and scaffolds: insulin receptor complexes and PI3K products would be proximate; cytoskeletal and focal-adhesion organizers (tensins) would recruit the C2-bearing module; and polarity/scaffold proteins at membrane-cytoplasm interfaces would transiently bind to coordinate pathway attenuation.
A cytoplasmic dual-specificity phosphatase that couples a cysteine-dependent catalytic core with a membrane-targeting module to remove phosphate groups from both protein and lipid substrates. By docking to membrane surfaces via a C2-containing region, it hydrolyzes signaling phosphoinositides to dampen growth-factor and insulin pathways, thereby constraining proliferation, sustaining proper cell-cycle and polarity control, and preserving genome integrity through attenuation of PI3KβAkt signaling.
Acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-phosphorylated cellular substrates, as well as cellular and non-cellular phosphatidylinositol phosphates. PTEN is a bifunctional lipid- and protein-phosphatase which down-regulates PI3K-dependent signal transduction pathways. Translocates to the membrane of the endoplasmic reticulum in response to insulin depletion. The membrane-associated form is the major form found in cells (By similarity). Influences cell survival and proliferation, and is implicated in maintenance of cell polarity, control of the cell cycle, and genomic integrity.
IPR029021, homologous_superfamily) β residues 1-187IPR017361, family) β residues 1-403IPR051281, family) β residues 1-377IPR029023, domain) β residues 14-185IPR003595, domain) β residues 23-183IPR045101, domain) β residues 24-181IPR000387, domain) β residues 102-173IPR016130, active_site) β residues 122-132IPR035892, homologous_superfamily) β residues 188-349IPR014020, domain) β residues 188-350Molecular Function: molecular_function (GO:0003674), catalytic activity (GO:0003824), molecular function regulator activity (GO:0098772), binding (GO:0005488), molecular function inhibitor activity (GO:0140678), hydrolase activity (GO:0016787), protein-containing complex binding (GO:0044877), catalytic activity, acting on a protein (GO:0140096), protein binding (GO:0005515), phosphoprotein phosphatase activity (GO:0004721), identical protein binding (GO:0042802), hydrolase activity, acting on ester bonds (GO:0016788), protein domain specific binding (GO:0019904), enzyme binding (GO:0019899), phosphoric ester hydrolase activity (GO:0042578), PDZ domain binding (GO:0030165), protease binding (GO:0002020), protein serine/threonine phosphatase activity (GO:0004722), protein tyrosine phosphatase activity (GO:0004725), ubiquitin-specific protease binding (GO:1990381), phosphatase activity (GO:0016791), phosphatidylinositol phosphate phosphatase activity (GO:0052866), inositol phosphate phosphatase activity (GO:0052745), phosphatidylinositol monophosphate phosphatase activity (GO:0052744), phosphatidylinositol bisphosphate phosphatase activity (GO:0034593), phosphatidylinositol trisphosphate phosphatase activity (GO:0034594), phosphatidylinositol-3-phosphate phosphatase activity (GO:0004438)
Biological Process: biological_process (GO:0008150), localization (GO:0051179), positive regulation of biological process (GO:0048518), regulation of biological process (GO:0050789), signaling (GO:0023052), biological regulation (GO:0065007), response to stimulus (GO:0050896), cellular process (GO:0009987), metabolic process (GO:0008152), negative regulation of biological process (GO:0048519), negative regulation of signaling (GO:0023057), nitrogen compound metabolic process (GO:0006807), negative regulation of multicellular organismal process (GO:0051241), regulation of multicellular organismal process (GO:0051239), negative regulation of metabolic process (GO:0009892), cell-cell signaling (GO:0007267), regulation of developmental process (GO:0050793), regulation of biological quality (GO:0065008), regulation of cellular process (GO:0050794), regulation of response to stimulus (GO:0048583), negative regulation of locomotion (GO:0040013), cellular response to stimulus (GO:0051716), regulation of signaling (GO:0023051), negative regulation of developmental process (GO:0051093), negative regulation of cellular process (GO:0048523), signal transduction (GO:0007165), regulation of locomotion (GO:0040012), response to abiotic stimulus (GO:0009628), positive regulation of signaling (GO:0023056), biosynthetic process (GO:0009058), positive regulation of response to stimulus (GO:0048584), regulation of metabolic process (GO:0019222), organic substance metabolic process (GO:0071704), catabolic process (GO:0009056), cellular metabolic process (GO:0044237), small molecule metabolic process (GO:0044281), positive regulation of metabolic process (GO:0009893), regulation of molecular function (GO:0065009), negative regulation of response to stimulus (GO:0048585), cell communication (GO:0007154), primary metabolic process (GO:0044238), positive regulation of cellular process (GO:0048522), response to electrical stimulus (GO:0051602), negative regulation of signal transduction (GO:0009968), positive regulation of cell death (GO:0010942), negative regulation of cellular component organization (GO:0051129), regulation of cell motility (GO:2000145), regulation of response to stress (GO:0080134), regulation of signal transduction (GO:0009966), regulation of cell adhesion (GO:0030155), cellular lipid metabolic process (GO:0044255), negative regulation of epithelial to mesenchymal transition (GO:0010719), regulation of macromolecule metabolic process (GO:0060255), regulation of response to external stimulus (GO:0032101), carbohydrate metabolic process (GO:0005975), negative regulation of cell cycle process (GO:0010948), regulation of cellular component biogenesis (GO:0044087), phosphorus metabolic process (GO:0006793), regulation of catabolic process (GO:0009894), regulation of epithelial cell migration (GO:0010632), regulation of cell cycle (GO:0051726), negative regulation of cell adhesion (GO:0007162), negative regulation of macromolecule metabolic process (GO:0010605), cellular response to abiotic stimulus (GO:0071214), negative regulation of epithelial cell migration (GO:0010633), regulation of nitrogen compound metabolic process (GO:0051171), regulation of cell differentiation (GO:0045595), cell surface receptor signaling pathway (GO:0007166), negative regulation of cell cycle (GO:0045786), regulation of cellular component organization (GO:0051128), organic substance catabolic process (GO:1901575), regulation of cell cycle process (GO:0010564), negative regulation of cell motility (GO:2000146), positive regulation of nitrogen compound metabolic process (GO:0051173), cellular carbohydrate metabolic process (GO:0044262), positive regulation of signal transduction (GO:0009967), organic hydroxy compound metabolic process (GO:1901615), negative regulation of cell communication (GO:0010648), regulation of catalytic activity (GO:0050790), negative regulation of nitrogen compound metabolic process (GO:0051172), positive regulation of molecular function (GO:0044093), organic substance biosynthetic process (GO:1901576), organonitrogen compound metabolic process (GO:1901564), small molecule catabolic process (GO:0044282), positive regulation of macromolecule metabolic process (GO:0010604), cell-cell signaling by wnt (GO:0198738), negative regulation of cell population proliferation (GO:0008285), organophosphate metabolic process (GO:0019637), protein metabolic process (GO:0019538), negative regulation of molecular function (GO:0044092), cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114), cellular biosynthetic process (GO:0044249), alcohol metabolic process (GO:0006066), regulation of protein stability (GO:0031647), negative regulation of cellular metabolic process (GO:0031324), macromolecule metabolic process (GO:0043170), cellular response to environmental stimulus (GO:0104004), regulation of cell population proliferation (GO:0042127), lipid metabolic process (GO:0006629), regulation of cell death (GO:0010941), regulation of cell communication (GO:0010646), positive regulation of cellular metabolic process (GO:0031325), negative regulation of cell differentiation (GO:0045596), regulation of DNA-binding transcription factor activity (GO:0051090), regulation of biosynthetic process (GO:0009889), regulation of cellular metabolic process (GO:0031323), positive regulation of cell communication (GO:0010647), regulation of primary metabolic process (GO:0080090), negative regulation of response to wounding (GO:1903035), positive regulation of catabolic process (GO:0009896), negative regulation of response to external stimulus (GO:0032102), regulation of mitotic cell cycle (GO:0007346), negative regulation of wound healing (GO:0061045), regulation of macromolecule biosynthetic process (GO:0010556), regulation of protein metabolic process (GO:0051246), regulation of cell-substrate adhesion (GO:0010810), regulation of programmed cell death (GO:0043067), Wnt signaling pathway (GO:0016055), phospholipid metabolic process (GO:0006644), regulation of cell migration (GO:0030334), cellular response to electrical stimulus (GO:0071257), negative regulation of smooth muscle cell proliferation (GO:0048662), regulation of cell-substrate junction organization (GO:0150116), glycerolipid biosynthetic process (GO:0045017), regulation of gene expression (GO:0010468), phosphorylated carbohydrate dephosphorylation (GO:0046838), inositol phosphate metabolic process (GO:0043647), regulation of smooth muscle cell proliferation (GO:0048660), macromolecule modification (GO:0043412), glycerolipid metabolic process (GO:0046486), alcohol catabolic process (GO:0046164), negative regulation of mitotic cell cycle (GO:0045930), organophosphate biosynthetic process (GO:0090407), negative regulation of phosphorus metabolic process (GO:0010563), lipid modification (GO:0030258), regulation of RNA metabolic process (GO:0051252), positive regulation of catalytic activity (GO:0043085), lipid biosynthetic process (GO:0008610), positive regulation of DNA-binding transcription factor activity (GO:0051091), negative regulation of cell-substrate adhesion (GO:0010812), negative regulation of catalytic activity (GO:0043086), regulation of response to wounding (GO:1903034), positive regulation of programmed cell death (GO:0043068), regulation of cell junction assembly (GO:1901888), negative regulation of protein metabolic process (GO:0051248), positive regulation of apoptotic signaling pathway (GO:2001235), phosphate-containing compound metabolic process (GO:0006796), negative regulation of intracellular signal transduction (GO:1902532), regulation of apoptotic signaling pathway (GO:2001233), negative regulation of cell junction assembly (GO:1901889), negative regulation of cell migration (GO:0030336), protein modification process (GO:0036211), organic hydroxy compound catabolic process (GO:1901616), regulation of cyclin-dependent protein kinase activity (GO:1904029), polyol metabolic process (GO:0019751), regulation of cell cycle phase transition (GO:1901987), regulation of cellular biosynthetic process (GO:0031326), positive regulation of protein metabolic process (GO:0051247), regulation of nucleobase-containing compound metabolic process (GO:0019219), positive regulation of cellular catabolic process (GO:0031331), protein stabilization (GO:0050821), regulation of transferase activity (GO:0051338), regulation of cellular catabolic process (GO:0031329), organophosphate catabolic process (GO:0046434), regulation of epithelial to mesenchymal transition (GO:0010717), regulation of intracellular signal transduction (GO:1902531), regulation of phosphorus metabolic process (GO:0051174), negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736), negative regulation of cell cycle phase transition (GO:1901988), negative regulation of cell-matrix adhesion (GO:0001953), regulation of phosphatidylinositol 3-kinase signaling (GO:0014066), regulation of apoptotic process (GO:0042981), regulation of vascular associated smooth muscle cell proliferation (GO:1904705), regulation of proteolysis (GO:0030162), negative regulation of cyclin-dependent protein kinase activity (GO:1904030), negative regulation of protein modification process (GO:0031400), regulation of RNA biosynthetic process (GO:2001141), regulation of cell-matrix adhesion (GO:0001952), phosphatidylinositol-mediated signaling (GO:0006470), regulation of ubiquitin-protein transferase activity (GO:0051438), inositol phosphate catabolic process (GO:0071545), canonical Wnt signaling pathway (GO:0060070), phospholipid biosynthetic process (GO:0008654), regulation of kinase activity (GO:0043549), regulation of protein kinase B signaling (GO:0051896), negative regulation of transferase activity (GO:0051348), regulation of ubiquitin-dependent protein catabolic process (GO:2000058), positive regulation of protein modification process (GO:0031401), phospholipid dephosphorylation (GO:0046839), regulation of wound healing (GO:0061041), inositol phosphate dephosphorylation (GO:0046855), negative regulation of MAPK cascade (GO:0043409), dephosphorylation (GO:0016311), regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079), regulation of MAPK cascade (GO:0043408), positive regulation of apoptotic process (GO:0043065), positive regulation of transferase activity (GO:0051347), regulation of protein modification process (GO:0031399), negative regulation of mitotic cell cycle phase transition (GO:1901991), positive regulation of extrinsic apoptotic signaling pathway (GO:2001238), negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706), glycerophospholipid biosynthetic process (GO:0046474), regulation of DNA-templated transcription (GO:0006355), regulation of phosphate metabolic process (GO:0019220), glycerophospholipid metabolic process (GO:0006650), negative regulation of protein kinase B signaling (GO:0051898), negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067), positive regulation of proteolysis (GO:0045862), regulation of mitotic cell cycle phase transition (GO:1901990), regulation of cell-substrate junction assembly (GO:0090109), positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060), regulation of extrinsic apoptotic signaling pathway (GO:2001236), polyol catabolic process (GO:0046174), regulation of cell cycle G1/S phase transition (GO:1902806), negative regulation of cell cycle G1/S phase transition (GO:1902807), negative regulation of phosphate metabolic process (GO:0045936), regulation of protein phosphorylation (GO:0001932), negative regulation of G1/S transition of mitotic cell cycle (GO:2000134), negative regulation of phosphorylation (GO:0042326), regulation of protein kinase activity (GO:0045859), regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041), positive regulation of protein modification by small protein conjugation or removal (GO:1903322), positive regulation of ubiquitin-protein transferase activity (GO:0051443), regulation of focal adhesion assembly (GO:0051893), regulation of nucleic acid-templated transcription (GO:1903506), regulation of ERK1 and ERK2 cascade (GO:0070372), regulation of phosphorylation (GO:0042325), negative regulation of protein phosphorylation (GO:0001933), regulation of protein modification by small protein conjugation or removal (GO:1903320), positive regulation of proteolysis involved in protein catabolic process (GO:1903052), negative regulation of kinase activity (GO:0033673), phosphatidylinositol dephosphorylation (GO:0046856), phosphatidylinositol metabolic process (GO:0046488), regulation of proteolysis involved in protein catabolic process (GO:1903050), negative regulation of ERK1 and ERK2 cascade (GO:0070373), regulation of G1/S transition of mitotic cell cycle (GO:2000045), regulation of ubiquitin protein ligase activity (GO:1904666), phosphatidylinositol biosynthetic process (GO:0006661), regulation of protein serine/threonine kinase activity (GO:0071900), regulation of protein ubiquitination (GO:0031396), negative regulation of peptidyl-serine phosphorylation (GO:0033137), regulation of peptidyl-serine phosphorylation (GO:0033135), negative regulation of protein kinase activity (GO:0006469), positive regulation of protein ubiquitination (GO:0031398), negative regulation of protein serine/threonine kinase activity (GO:0071901)
Cellular Component: cellular_component (GO:0005575), cellular anatomical entity (GO:0110165), side of membrane (GO:0098552), intracellular anatomical structure (GO:0005622), organelle (GO:0043226), apical part of cell (GO:0045177), cell projection (GO:0042995), membrane (GO:0016020), cytosol (GO:0005829), cytoplasm (GO:0005737), cell periphery (GO:0071944), membrane-enclosed lumen (GO:0031974), nucleoplasm (GO:0005654), plasma membrane region (GO:0098590), organelle lumen (GO:0043233), intracellular organelle (GO:0043229), cytoplasmic side of membrane (GO:0098562), membrane-bounded organelle (GO:0043227), plasma membrane (GO:0005886), apical plasma membrane (GO:0016324), cytoplasmic side of plasma membrane (GO:0009898), intracellular membrane-bounded organelle (GO:0043231), intracellular organelle lumen (GO:0070013), nuclear lumen (GO:0031981), nucleus (GO:0005634)
Generated by BioReason
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-24T10:19:48.062193'
end_time: '2025-12-24T10:37:05.073473'
duration_seconds: 1037.01
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: PTEN
gene_symbol: PTEN
uniprot_accession: P60484
protein_description: 'RecName: Full=Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase
and dual-specificity protein phosphatase PTEN {ECO:0000305|PubMed:9256433, ECO:0000305|PubMed:9811831};
EC=3.1.3.16 {ECO:0000269|PubMed:9256433}; EC=3.1.3.48 {ECO:0000269|PubMed:9187108,
ECO:0000269|PubMed:9256433}; EC=3.1.3.67 {ECO:0000269|PubMed:16824732, ECO:0000269|PubMed:9811831};
AltName: Full=Inositol polyphosphate 3-phosphatase {ECO:0000305|PubMed:11418101,
ECO:0000305|PubMed:9593664}; EC=3.1.3.- {ECO:0000305|PubMed:11418101, ECO:0000305|PubMed:9593664};
AltName: Full=Mutated in multiple advanced cancers 1; AltName: Full=Phosphatase
and tensin homolog;'
gene_info: Name=PTEN; Synonyms=MMAC1, TEP1;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the PTEN phosphatase protein family.
protein_domains: Bifunc_PIno_P3_Pase/Pase_PTEN. (IPR017361); C2_domain_sf. (IPR035892);
Dual-spec_lipid-protein_phosph. (IPR051281); Prot-tyrosine_phosphatase-like. (IPR029021);
PTP_PTEN. (IPR045101)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 19
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'PTEN' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene PTEN (gene ID: PTEN, UniProt: P60484) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'PTEN' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene PTEN (gene ID: PTEN, UniProt: P60484) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Research report: Human PTEN (UniProt P60484)
Verification of target identity and domain architecture
- Gene/protein identity: The requested target is human PTEN (phosphatase and tensin homolog), a 403βamino-acid dual-specificity phosphatase that belongs to the PTEN phosphatase family. Canonical domains include an Nβterminal phosphoinositide-binding region, the catalytic phosphatase domain containing the active site (approx. residues 123β130), a C2 domain that mediates membrane association, and a Cβterminal tail with a PDZ-binding motif. Noncanonical, Nβterminally extended isoforms (PTENβL/Ξ± and PTENβΞ²) exist and retain the canonical PTEN core. These features align with the UniProt P60484 description and the stated family/domains. (https://doi.org/10.1172/JCI121277, Jan 2019; https://doi.org/10.1093/hmg/ddaa127, Jun 2020) (yehia2019ptenopathiesfrombiological pages 1-2, yehia2019ptenopathiesfrombiological pages 4-5, yehia2020ptenhamartomatumour pages 5-6)
Key concepts and definitions: catalytic activities and biochemical specificity
- Enzymatic class and reaction: PTEN is a dual-specificity phosphatase with a primary lipid phosphatase activity that hydrolyzes phosphatidylinositol 3,4,5βtrisphosphate (PIP3) to PIP2 at the D3 position, thereby antagonizing PI3K signaling. PTEN also has protein phosphatase activity toward select protein substrates, but recent functional dissection in melanoma indicates the lipid phosphatase function predominates for tumor suppression in vivo. (https://doi.org/10.1172/JCI121277, Jan 2019; https://doi.org/10.1158/0008-5472.can-23-1730, Jan 2024) (yehia2019ptenopathiesfrombiological pages 1-2, xu2024ptenlipidphosphatase pages 23-30)
- Substrate context and site of action: PTENβs lipid phosphatase function requires membrane engagement via the C2 domain and Nβterminal phosphoinositide interactions, positioning the catalytic site to dephosphorylate PIP3 in the inner leaflet of the plasma membrane. (https://doi.org/10.1172/JCI121277, Jan 2019) (yehia2019ptenopathiesfrombiological pages 1-2)
Pathway roles and current understanding
- Core signaling: By converting PIP3βPIP2, PTEN reduces AKT recruitment/activation and downstream mTOR signaling, restraining cell growth, survival, metabolism, and translation. Loss or inactivation of PTEN elevates AKT/mTOR signaling and alters transcriptional and metabolic programs. (https://doi.org/10.1172/JCI121277, Jan 2019; https://doi.org/10.1158/0008-5472.can-23-1730, Jan 2024) (yehia2019ptenopathiesfrombiological pages 1-2, xu2024ptenlipidphosphatase pages 23-30)
- 2024 mechanistic update: In melanoma models, restoration of PTENβs lipid phosphatase activity suppressed proliferation, invasion, and tumor growth primarily through inhibition of an AKT/mTOR/FRA1 axis; phosphoproteomics supported the dominance of lipid phosphataseβmediated network changes over other proposed noncanonical functions. (https://doi.org/10.1158/0008-5472.can-23-1730, Jan 2024) (xu2024ptenlipidphosphatase pages 23-30)
Subcellular localization and nuclear functions
- Cytosol/membrane: PTEN localizes to cytosol and the inner plasma membrane for lipid dephosphorylation that opposes PI3K. (https://doi.org/10.1172/JCI121277, Jan 2019) (yehia2019ptenopathiesfrombiological pages 1-2)
- Nuclear functions: Nuclear PTEN contributes to genomic stability, DNA double-strand break repair, cell-cycle control, chromosomal architecture, and regulation of rDNA transcription. Nuclear localization is regulated by postβtranslational modifications (PTMs) and ubiquitin-dependent trafficking. (https://doi.org/10.1093/hmg/ddaa127, Jun 2020; https://doi.org/10.3389/or.2024.1430237, Jul 2024) (yehia2020ptenhamartomatumour pages 5-6, li2024posttranslationalmodificationof pages 8-8)
Regulation, post-translational modifications, and interactors
- Phosphorylation: Cβterminal tail phosphorylation regulates PTENβs conformation, membrane association, and catalytic activity, generally modulating stability and activity in a context-dependent manner. (https://doi.org/10.3389/or.2024.1430237, Jul 2024) (li2024posttranslationalmodificationof pages 8-8)
- Ubiquitination and nuclear import: Mono- and polyubiquitination control PTEN stability and subcellular localization; specific ubiquitin machinery promotes nuclear import, where PTEN contributes to chromosome stability (e.g., interactions with centromeric proteins). (https://doi.org/10.3389/or.2024.1430237, Jul 2024) (li2024posttranslationalmodificationof pages 8-8, li2024posttranslationalmodificationof pages 5-6)
- Oxidation: Reactive oxygen species can oxidize PTEN, disrupting membrane association and lipid phosphatase function; antioxidant systems (e.g., peroxiredoxins) can preserve PTEN activity. (https://doi.org/10.3389/or.2024.1430237, Jul 2024) (li2024posttranslationalmodificationof pages 5-6)
- SUMOylation/neddylation: SUMO and NEDD8 modifications further influence PTEN localization and activity, including promoting nuclear entry under certain metabolic conditions. (https://doi.org/10.3389/or.2024.1430237, Jul 2024) (li2024posttranslationalmodificationof pages 8-8)
- Scaffolding and membrane recruitment: PDZ-domain scaffolds (e.g., MAGI proteins) recruit PTEN to junctional complexes and membrane subdomains to efficiently deplete PIP3. (https://doi.org/10.3389/or.2024.1430237, Jul 2024) (li2024posttranslationalmodificationof pages 8-8)
Disease relevance: germline and somatic
- Germline: Pathogenic germline PTEN variants cause PTEN hamartoma tumor syndrome (PHTS), an autosomal dominant cancer-predisposition and overgrowth spectrum with elevated risks of breast, thyroid, endometrial, and other cancers; large germline deletions account for an estimated 3β10% of PHTS. Identification warrants enhanced surveillance and genetic counseling. (https://doi.org/10.1093/hmg/ddaa127, Jun 2020; https://doi.org/10.1172/JCI121277, Jan 2019) (yehia2020ptenhamartomatumour pages 5-6, yehia2019ptenopathiesfrombiological pages 4-5, yehia2019ptenopathiesfrombiological pages 1-2)
- Somatic: PTEN is among the most frequently altered tumor suppressors across sporadic cancers; functional analyses confirm that loss of lipid phosphatase activity drives AKT/mTOR activation and oncogenesis in several settings, including melanoma. (https://doi.org/10.1172/JCI121277, Jan 2019; https://doi.org/10.1158/0008-5472.can-23-1730, Jan 2024) (yehia2019ptenopathiesfrombiological pages 1-2, xu2024ptenlipidphosphatase pages 23-30)
Recent developments (emphasis 2023β2024) and expert perspectives
- Functional dominance of lipid phosphatase activity in melanoma (2024): Genetic rescue and phosphoproteomics demonstrate that PTENβs lipid phosphatase activity is the principal mediator of tumor suppression via AKT/mTOR/FRA1 control, informing expectations for pathway-directed therapies in PTEN-deficient melanomas. (https://doi.org/10.1158/0008-5472.can-23-1730, Jan 2024) (xu2024ptenlipidphosphatase pages 23-30)
- PTEN proteoform and PTM-centric regulation (2024): Mechanistic review highlights how multi-site phosphorylation, ubiquitination, oxidation, SUMOylation, and neddylation dynamically tune PTENβs abundance, conformation, localization (including nuclear import), and activity. This regulatory complexity underlies variable PTEN function across tissues and disease states. (https://doi.org/10.3389/or.2024.1430237, Jul 2024) (li2024posttranslationalmodificationof pages 8-8, li2024posttranslationalmodificationof pages 5-6)
Current applications and real-world implementations
- Diagnostic assessment: PTEN status is commonly assessed by next-generation sequencing (NGS) to detect mutations and copy-number loss. Immunohistochemistry (IHC) is used in clinical practice to gauge PTEN protein loss as a pragmatic screening tool when NGS material is limited, with confirmatory molecular testing where appropriate. These uses are framed within geneβinformed management for PHTS and pathwayβinformed therapy considerations in sporadic cancers. (https://doi.org/10.1172/JCI121277, Jan 2019; https://doi.org/10.3389/or.2024.1430237, Jul 2024) (yehia2019ptenopathiesfrombiological pages 1-2, li2024posttranslationalmodificationof pages 8-8)
- Therapeutic implications: PTEN loss indicates upregulated PI3KβAKTβmTOR signaling. Although direct PTEN restoration is not a current therapy, pathway inhibitors (e.g., AKT/mTOR inhibitors) are of interest; however, network feedback and contextβspecific dependencies necessitate careful clinical evaluation. (https://doi.org/10.1172/JCI121277, Jan 2019) (yehia2019ptenopathiesfrombiological pages 8-9, yehia2019ptenopathiesfrombiological pages 1-2)
Relevant statistics and data from recent studies
- Functional evidence rather than frequency summary: 2024 functional cancer research demonstrates that PTEN lipid phosphatase restoration can suppress melanoma growth and invasion via AKT/mTOR/FRA1, supporting the centrality of PI3K pathway dependence in PTENβdeficient tumors. (https://doi.org/10.1158/0008-5472.can-23-1730, Jan 2024) (xu2024ptenlipidphosphatase pages 23-30)
- Germline structural variant contribution in PHTS: Reviews report that large PTEN deletions comprise approximately 3β10% of PHTS cases, underscoring the need for copyβnumber assessment in genetic testing workflows. (https://doi.org/10.1093/hmg/ddaa127, Jun 2020) (yehia2020ptenhamartomatumour pages 5-6)
Expert analysis
- Mechanistic consensus: Across authoritative sources, PTENβs tumor suppressor function is primarily mediated by its lipid phosphatase activity restraining PI3KβAKTβmTOR signaling, with additional nuclear roles stabilizing the genome and regulating transcriptional programs. This duality explains both the metabolic/proliferative phenotypes of PTEN deficiency and the genomic instability seen in PHTS spectrum disorders. (https://doi.org/10.1172/JCI121277, Jan 2019; https://doi.org/10.1093/hmg/ddaa127, Jun 2020; https://doi.org/10.1158/0008-5472.can-23-1730, Jan 2024) (yehia2019ptenopathiesfrombiological pages 1-2, yehia2020ptenhamartomatumour pages 5-6, xu2024ptenlipidphosphatase pages 23-30)
- Regulatory layers shape phenotype: PTMs (phosphorylation, ubiquitination, oxidation, SUMO/neddylation) and scaffolding interactions modulate PTENβs localization, stability, and conformational state, providing plausible mechanistic bases for tissueβspecific effects and variable penetrance in disease. (https://doi.org/10.3389/or.2024.1430237, Jul 2024) (li2024posttranslationalmodificationof pages 8-8, li2024posttranslationalmodificationof pages 5-6)
Embedded summary table
| Topic | Key points (1β3 bullets) | Prime sources (journal, year) | URL |
|---|---|---|---|
| Identity & domains | - PTEN: 403 aa, PIP2βbinding region; phosphatase (catalytic) domain; C2 domain; Cβterminal tail with PDZ motif - Nβterminally extended isoforms (PTENβL/Ξ±, PTENβΞ²) exist |
J Clin Invest, 2019; Hum Mol Genet, 2020 (reviews) (yehia2019ptenopathiesfrombiological pages 4-5, yehia2020ptenhamartomatumour pages 5-6) | https://doi.org/10.1172/JCI121277 https://doi.org/10.1093/hmg/ddaa127 (yehia2019ptenopathiesfrombiological pages 4-5, yehia2020ptenhamartomatumour pages 5-6) |
| Enzymatic activity & substrates | - Dualβspecificity phosphatase: lipid phosphatase (PIP3 β PIP2) and protein dephosphorylation - Catalytic pocket β residues 123β130; lipid activity is key for tumor suppression |
Cancer Research, 2024; J Clin Invest, 2019 (xu2024ptenlipidphosphatase pages 23-30, yehia2019ptenopathiesfrombiological pages 4-5) | https://doi.org/10.1158/0008-5472.can-23-1730 https://doi.org/10.1172/JCI121277 (xu2024ptenlipidphosphatase pages 23-30, yehia2019ptenopathiesfrombiological pages 4-5) |
| Core pathway roles (PI3KβAKTβmTOR) | - Antagonizes PI3KβAKTβmTOR by depleting PIP3; loss β AKT/mTOR activation and increased proliferation/metabolism - PTEN loss contributes to immunomodulation and therapy resistance |
J Clin Invest, 2019; Cancer Research, 2024 (yehia2019ptenopathiesfrombiological pages 1-2, xu2024ptenlipidphosphatase pages 23-30) | https://doi.org/10.1172/JCI121277 https://doi.org/10.1158/0008-5472.can-23-1730 (yehia2019ptenopathiesfrombiological pages 1-2, xu2024ptenlipidphosphatase pages 23-30) |
| Subcellular localization & nuclear functions | - Active at plasma membrane/cytosol for lipid phosphatase function - Nuclear PTEN roles: genomic stability, DNAβdamage response, cellβcycle control, rDNA transcription; localization regulated by PTMs/ubiquitination |
Hum Mol Genet, 2020; Oncology Reviews, 2024 (yehia2020ptenhamartomatumour pages 5-6, li2024posttranslationalmodificationof pages 8-8) | https://doi.org/10.1093/hmg/ddaa127 https://doi.org/10.3389/or.2024.1430237 (yehia2020ptenhamartomatumour pages 5-6, li2024posttranslationalmodificationof pages 8-8) |
| Regulation by PTMs (phospho, ubiq, ox, SUMO/neddylation) | - Cβterminal phosphorylation modulates stability/activity; ubiquitination controls degradation and nuclear import - Oxidation inactivates lipid activity; SUMOylation/neddylation affect localization; exosomal miRNAs modulate PTEN levels |
Oncology Reviews, 2024 (mechanistic review) (li2024posttranslationalmodificationof pages 8-8, li2024posttranslationalmodificationof pages 5-6) | https://doi.org/10.3389/or.2024.1430237 (li2024posttranslationalmodificationof pages 8-8, li2024posttranslationalmodificationof pages 5-6) |
| Disease relevance (somatic cancers; PHTS germline) | - Germline PTEN pathogenic variants β PTEN Hamartoma Tumor Syndrome (PHTS) with elevated breast, thyroid, endometrial cancer risk; variable penetrance - Somatic PTEN loss/mutation common across cancers (melanoma, prostate, glioblastoma, others) |
J Clin Invest, 2019; Cancer Research, 2024 (yehia2019ptenopathiesfrombiological pages 4-5, xu2024ptenlipidphosphatase pages 23-30) | https://doi.org/10.1172/JCI121277 https://doi.org/10.1158/0008-5472.can-23-1730 (yehia2019ptenopathiesfrombiological pages 4-5, xu2024ptenlipidphosphatase pages 23-30) |
| Clinical applications (IHC / NGS; therapy implications) | - PTEN status assessed by IHC and NGS in diagnostics; IHC can be pragmatic when NGS not possible - PTEN loss guides genetic counseling for PHTS and may inform use of PI3K/AKT/mTOR pathway inhibitors (clinical exploration) |
J Clin Invest, 2019; Oncology Reviews, 2024 (yehia2019ptenopathiesfrombiological pages 1-2, li2024posttranslationalmodificationof pages 8-8) | https://doi.org/10.1172/JCI121277 https://doi.org/10.3389/or.2024.1430237 (yehia2019ptenopathiesfrombiological pages 1-2, li2024posttranslationalmodificationof pages 8-8) |
| Recent statistics/findings (2023β2024) | - 2024: PTEN lipid phosphatase activity shown essential to suppress melanoma via AKT/mTOR/FRA1 axis (functional rescue/ phosphoproteomics) - Germline PHTS detection rates vary; large deletions ~3β10% of PHTS cases; reported germline detection ranges widely in reviews |
Cancer Research, 2024; Hum Mol Genet, 2020 (xu2024ptenlipidphosphatase pages 23-30, yehia2020ptenhamartomatumour pages 5-6) | https://doi.org/10.1158/0008-5472.can-23-1730 https://doi.org/10.1093/hmg/ddaa127 (xu2024ptenlipidphosphatase pages 23-30, yehia2020ptenhamartomatumour pages 5-6) |
Table: A concise, sourceβlinked table summarizing identity, enzymatic function, pathway roles, localization, regulation, disease relevance, clinical uses, and recent 2023β2024 findings for human PTEN (UniProt P60484), with citations to the core evidence used.
Notes on scope and limitations of the present synthesis
- The report prioritizes 2023β2024 peerβreviewed sources and authoritative recent reviews. We focused on sources available in the provided context with accessible URLs and publication dates. Some panβcancer frequency statistics from large clinicogenomic cohorts are beyond the scope of the included evidence set; where highβlevel prevalence statements are made, they derive from consensus reviews (2019β2020) rather than a specific 2023β2024 frequency table. (https://doi.org/10.1172/JCI121277, Jan 2019; https://doi.org/10.1093/hmg/ddaa127, Jun 2020) (yehia2019ptenopathiesfrombiological pages 1-2, yehia2020ptenhamartomatumour pages 5-6)
References
(yehia2019ptenopathiesfrombiological pages 1-2): Lamis Yehia, Joanne Ngeow, and Charis Eng. Pten-opathies: from biological insights to evidence-based precision medicine. The Journal of clinical investigation, 129 2:452-464, Jan 2019. URL: https://doi.org/10.1172/jci121277, doi:10.1172/jci121277. This article has 199 citations.
(yehia2019ptenopathiesfrombiological pages 4-5): Lamis Yehia, Joanne Ngeow, and Charis Eng. Pten-opathies: from biological insights to evidence-based precision medicine. The Journal of clinical investigation, 129 2:452-464, Jan 2019. URL: https://doi.org/10.1172/jci121277, doi:10.1172/jci121277. This article has 199 citations.
(yehia2020ptenhamartomatumour pages 5-6): Lamis Yehia and Charis Eng. Pten hamartoma tumour syndrome: what happens when there is no pten germline mutation? Human molecular genetics, 29:R150-R157, Jun 2020. URL: https://doi.org/10.1093/hmg/ddaa127, doi:10.1093/hmg/ddaa127. This article has 24 citations and is from a domain leading peer-reviewed journal.
(xu2024ptenlipidphosphatase pages 23-30): Xiaonan Xu, Ilah Bok, Neel Jasani, Kaizhen Wang, Manon Chadourne, Nicol Mecozzi, Ou Deng, Eric A. Welsh, Fumi Kinose, Uwe Rix, and Florian A. Karreth. Pten lipid phosphatase activity suppresses melanoma formation by opposing an akt/mtor/fra1 signaling axis. Cancer research, 84:OF1-OF17, Jan 2024. URL: https://doi.org/10.1158/0008-5472.can-23-1730, doi:10.1158/0008-5472.can-23-1730. This article has 16 citations and is from a highest quality peer-reviewed journal.
(li2024posttranslationalmodificationof pages 8-8): Xiao Li, Pu Yang, Xiaoli Hou, and Shaoping Ji. Post-translational modification of pten protein: quantity and activity. Oncology Reviews, Jul 2024. URL: https://doi.org/10.3389/or.2024.1430237, doi:10.3389/or.2024.1430237. This article has 6 citations.
(li2024posttranslationalmodificationof pages 5-6): Xiao Li, Pu Yang, Xiaoli Hou, and Shaoping Ji. Post-translational modification of pten protein: quantity and activity. Oncology Reviews, Jul 2024. URL: https://doi.org/10.3389/or.2024.1430237, doi:10.3389/or.2024.1430237. This article has 6 citations.
(yehia2019ptenopathiesfrombiological pages 8-9): Lamis Yehia, Joanne Ngeow, and Charis Eng. Pten-opathies: from biological insights to evidence-based precision medicine. The Journal of clinical investigation, 129 2:452-464, Jan 2019. URL: https://doi.org/10.1172/jci121277, doi:10.1172/jci121277. This article has 199 citations.
Source: PTEN-deep-research-bioreason-rl.md
The BioReason functional summary states:
A cytoplasmic dual-specificity phosphatase that couples a cysteine-dependent catalytic core with a membrane-targeting module to remove phosphate groups from both protein and lipid substrates. By docking to membrane surfaces via a C2-containing region, it hydrolyzes signaling phosphoinositides to dampen growth-factor and insulin pathways, thereby constraining proliferation, sustaining proper cell-cycle and polarity control, and preserving genome integrity through attenuation of PI3K-Akt signaling.
This is an excellent summary that accurately captures PTEN's core biology. The curated review describes PTEN as "a critical tumor suppressor encoding a dual-specificity phosphatase with both lipid and protein phosphatase activities" whose "primary and essential tumor suppressor function is as a phosphatidylinositol-3,4,5-trisphosphate (PIP3) 3-phosphatase that dephosphorylates PIP3 to PIP2, thereby antagonizing PI3K/AKT/mTOR signaling."
BioReason correctly identifies:
1. Dual-specificity phosphatase activity (protein and lipid substrates)
2. The PTP catalytic domain with cysteine-based mechanism
3. The C2 membrane-targeting domain
4. PI3K-Akt pathway attenuation as the core biological function
5. Roles in proliferation control and cell polarity
6. Cytoplasmic localization with membrane association
The mention of "genome integrity" is also appropriate, as PTEN has roles in DNA repair and maintaining chromosomal stability.
Minor gaps:
1. The nuclear pool of PTEN and its nuclear functions are not mentioned
2. PTEN's protein phosphatase activity toward specific substrates (FAK, SHC) is not detailed
3. The Wnt signaling regulation role from the curated review is absent
4. PTEN's scaffolding functions independent of catalytic activity are not captured
Comparison with interpro2go:
The interpro2go annotations from IPR003595 (PTP catalytic domain) and IPR045101 (PTEN phosphatase domain) would map to protein tyrosine phosphatase activity and phosphatidylinositol phosphate phosphatase activity. BioReason arrives at exactly these functions and adds valuable mechanistic context about the C2 domain membrane-targeting and PI3K pathway attenuation. This represents genuine value-add over raw interpro2go output.
The trace demonstrates excellent reasoning through the layered phosphatase signatures and the C2 domain. The identification of both lipid and protein phosphatase activities from the domain architecture is well-supported. The mechanistic hypothesis about membrane-tethered catalysis of PI(3,4,5)P3 is accurate.
id: P60484
gene_symbol: PTEN
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: PTEN (Phosphatase and Tensin Homolog) is a critical tumor
suppressor encoding a dual-specificity phosphatase with both lipid and protein
phosphatase activities. Its primary and essential tumor suppressor function is
as a phosphatidylinositol-3,4,5-trisphosphate (PIP3) 3-phosphatase that
dephosphorylates PIP3 to PIP2, thereby antagonizing PI3K/AKT/mTOR signaling.
PTEN also exhibits protein phosphatase activity against serine, threonine, and
tyrosine residues, though the lipid phosphatase activity is the critical
determinant of tumor suppression. Nuclear PTEN contributes to genomic
stability and cell cycle control. PTEN localizes to the plasma membrane,
cytosol, and nucleus, with membrane localization mediated by its C2 domain and
PDZ-binding motif interactions with scaffold proteins like MAGI-2. Germline
mutations cause PTEN Hamartoma Tumor Syndrome (PHTS/Cowden disease), while
somatic mutations occur frequently across many cancer types.
existing_annotations:
- term:
id: GO:0005634
label: nucleus
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: PTEN nuclear localization is well-established. Nuclear PTEN has
distinct roles in genomic stability, DNA damage response, and cell cycle
control, regulated by PTMs and ubiquitin-dependent trafficking.
action: ACCEPT
reason: Nuclear localization is a conserved and functionally important
feature of PTEN, supported by extensive experimental evidence and
phylogenetic conservation.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner
- reference_id: PMID:17218261
supporting_text: Ubiquitination regulates PTEN nuclear import and
tumor suppression
- reference_id: file:human/PTEN/PTEN-deep-research-falcon.md
supporting_text: See deep research file for comprehensive analysis
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Plasma membrane localization is essential for PTEN's core lipid
phosphatase function. PTEN is recruited to the membrane via its C2
domain and PDZ-binding motif interactions with scaffold proteins like
MAGI-2.
action: ACCEPT
reason: Plasma membrane localization is the primary site of PTEN's lipid
phosphatase activity against PIP3, essential for its tumor suppressor
function.
supported_by:
- reference_id: PMID:10760291
supporting_text: PTEN binds to MAGI-2 through an interaction between
the PDZ-binding motif of PTEN and the second PDZ domain of MAGI-2.
MAGI-2 enhances the ability of PTEN to suppress Akt activation.
- term:
id: GO:0042995
label: cell projection
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: PTEN localizes to cell projections, consistent with its role in
regulating cell motility through PI3K signaling modulation at the
leading edge of cells.
action: ACCEPT
reason: PTEN localization to cell projections is consistent with its role
in regulating directed cell migration through local PIP3 levels, a
phylogenetically conserved feature.
- term:
id: GO:0043491
label: phosphatidylinositol 3-kinase/protein kinase B signal transduction
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: PTEN is a central component of PI3K/AKT signaling, acting as the
primary negative regulator by dephosphorylating PIP3 to PIP2.
action: ACCEPT
reason: This is the core pathway in which PTEN functions. By removing
PIP3, PTEN prevents AKT recruitment and activation, making this a core
annotation.
supported_by:
- reference_id: PMID:9811831
supporting_text: ectopic expression of the phosphatase in
PTEN-deficient tumor cell lines resulted in the inhibition of
protein kinase (PK) B/Akt and regulation of cell survival
- term:
id: GO:0051896
label: regulation of phosphatidylinositol 3-kinase/protein kinase B signal
transduction
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: PTEN negatively regulates PI3K/AKT signaling via its lipid
phosphatase activity. This is redundant with GO:0051898 (negative
regulation) which is more specific.
action: MODIFY
reason: While accurate, GO:0051898 (negative regulation of PI3K/AKT
signaling) is more specific to PTEN's actual role as an antagonist of
this pathway.
proposed_replacement_terms:
- id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein
kinase B signal transduction
- term:
id: GO:0005829
label: cytosol
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: PTEN is found in the cytosol where it can exist in an inactive
closed conformation. Cytosolic PTEN can be recruited to membranes for
its lipid phosphatase function.
action: ACCEPT
reason: Cytosolic localization is well-established for PTEN and represents
a reservoir pool that can be recruited to membranes upon appropriate
signals.
- term:
id: GO:0046856
label: phosphatidylinositol dephosphorylation
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: PTEN dephosphorylates phosphatidylinositols at the D3 position,
with primary activity against PIP3 and PI(3,4)P2.
action: ACCEPT
reason: This is a core biological process annotation that accurately
describes PTEN's primary enzymatic function.
supported_by:
- reference_id: PMID:9811831
supporting_text: Characterization of the lipid phosphatase activity of
PTEN demonstrates that it shows specificity for
phosphatidylinositols phosphorylated at the 3 position.
- term:
id: GO:0004725
label: protein tyrosine phosphatase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: PTEN exhibits protein tyrosine phosphatase activity as part of
its dual-specificity phosphatase function, though the lipid phosphatase
activity is the critical determinant of tumor suppression.
action: ACCEPT
reason: PTEN has documented protein tyrosine phosphatase activity. While
secondary to its lipid phosphatase function for tumor suppression, this
is a legitimate enzymatic activity.
supported_by:
- reference_id: PMID:9256433
supporting_text: recombinant P-TEN dephosphorylated protein and
peptide substrates phosphorylated on serine, threonine, and tyrosine
residues, indicating that P-TEN is a dual-specificity phosphatase
- term:
id: GO:0016314
label: phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: This is PTEN's primary enzymatic activity - dephosphorylating
PIP3 at the D3 position to produce PIP2. This activity is essential for
its tumor suppressor function.
action: ACCEPT
reason: This is the core molecular function of PTEN. The lipid phosphatase
activity against PIP3 is the critical determinant of PTEN's tumor
suppressor function.
supported_by:
- reference_id: PMID:9811831
supporting_text: a missense mutation in PTEN, PTEN-G129E, which is
observed in two Cowden disease kindreds, specifically ablates the
ability of PTEN to recognize inositol phospholipids as a substrate,
suggesting that loss of the lipid phosphatase activity is
responsible for the etiology of the disease
- term:
id: GO:0048870
label: cell motility
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: PTEN regulates cell motility through its effects on PIP3 levels,
which control cell polarity and directed migration. Loss of PTEN
enhances cell motility.
action: KEEP_AS_NON_CORE
reason: While PTEN's regulation of cell motility is well-established, this
is a downstream effect of its lipid phosphatase activity rather than a
core function. The core function is PIP3 dephosphorylation.
supported_by:
- reference_id: PMID:9616126
supporting_text: Inhibition of cell migration, spreading, and focal
adhesions by tumor suppressor PTEN
- term:
id: GO:0004722
label: protein serine/threonine phosphatase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: PTEN has dual-specificity protein phosphatase activity including
activity against serine/threonine residues.
action: ACCEPT
reason: This is supported by experimental evidence showing PTEN
dephosphorylates serine/threonine substrates.
supported_by:
- reference_id: PMID:9256433
supporting_text: recombinant P-TEN dephosphorylated protein and
peptide substrates phosphorylated on serine, threonine, and tyrosine
residues
- term:
id: GO:0004725
label: protein tyrosine phosphatase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Duplicate of IBA annotation for the same term. PTEN has
documented protein tyrosine phosphatase activity.
action: ACCEPT
reason: Consistent with experimental evidence for PTEN's dual-specificity
phosphatase activity.
- term:
id: GO:0004721
label: phosphoprotein phosphatase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: General phosphoprotein phosphatase activity term. PTEN does have
protein phosphatase activity but more specific terms (GO:0004722,
GO:0004725) are preferred.
action: ACCEPT
reason: Accurate but less specific than existing annotations. Still valid
as a parent term.
- term:
id: GO:0005576
label: extracellular region
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: PTEN-Long (PTEN-L/alpha) isoform can be secreted and taken up by
other cells. This applies specifically to the N-terminally extended
isoform.
action: ACCEPT
reason: The PTEN-L isoform has been shown to be secreted and function in
neighboring cells (PMID:23744781).
supported_by:
- reference_id: PMID:23744781
supporting_text: A secreted PTEN phosphatase that enters cells to
alter signaling and survival
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: Duplicate of IBA annotation. Nuclear localization of PTEN is
well-established.
action: ACCEPT
reason: Consistent with IBA annotation and extensive experimental evidence
for nuclear PTEN.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: PTEN is found in the cytoplasm. Cytosol (GO:0005829) is a more
specific term that is also annotated.
action: ACCEPT
reason: Cytoplasmic localization is accurate, though cytosol is the more
specific subcellular location.
- term:
id: GO:0006629
label: lipid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Very broad term. PTEN dephosphorylates phosphatidylinositols but
this is more accurately described as phosphatidylinositol
dephosphorylation (GO:0046856).
action: MODIFY
reason: Too general. GO:0046856 (phosphatidylinositol dephosphorylation)
is much more specific and accurate for PTEN's function.
proposed_replacement_terms:
- id: GO:0046856
label: phosphatidylinositol dephosphorylation
- term:
id: GO:0006915
label: apoptotic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: PTEN promotes apoptosis by inhibiting PI3K/AKT survival
signaling. This is a downstream effect of PTEN's lipid phosphatase
activity rather than a direct function.
action: KEEP_AS_NON_CORE
reason: Apoptosis regulation is a downstream consequence of PTEN's
inhibition of AKT survival signaling, not a direct molecular function.
supported_by:
- reference_id: PMID:9811831
supporting_text: ectopic expression of the phosphatase in
PTEN-deficient tumor cell lines resulted in the inhibition of
protein kinase (PK) B/Akt and regulation of cell survival
- term:
id: GO:0007399
label: nervous system development
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: PTEN plays important roles in nervous system development by
regulating neuron size, dendritic arborization, and synapse formation
through PI3K/AKT/mTOR signaling.
action: KEEP_AS_NON_CORE
reason: While PTEN has well-documented roles in nervous system development
(PTEN mutations cause macrocephaly and autism spectrum disorders), this
is a pleiotropic effect of its core lipid phosphatase function.
- term:
id: GO:0008285
label: negative regulation of cell population proliferation
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: PTEN suppresses cell proliferation through its antagonism of
PI3K/AKT/mTOR signaling. This is a key aspect of its tumor suppressor
function.
action: KEEP_AS_NON_CORE
reason: While this is a fundamental consequence of PTEN function and
central to its tumor suppressor role, it is a downstream effect of
PI3K/AKT pathway inhibition rather than a direct molecular function.
supported_by:
- reference_id: PMID:10468583
supporting_text: The tumor-suppressor activity of PTEN is regulated by
its carboxyl-terminal region
- term:
id: GO:0008289
label: lipid binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: PTEN binds phosphatidylinositol lipids as substrates via its C2
domain and phosphatase domain.
action: ACCEPT
reason: PTEN's C2 domain mediates membrane/lipid binding which is
essential for its localization and function.
- term:
id: GO:0009966
label: regulation of signal transduction
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Very broad term. PTEN specifically regulates PI3K/AKT signal
transduction via its lipid phosphatase activity.
action: MODIFY
reason: Too general. GO:0051898 (negative regulation of PI3K/AKT
signaling) is more specific and accurate.
proposed_replacement_terms:
- id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein
kinase B signal transduction
- term:
id: GO:0010604
label: positive regulation of macromolecule metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Very broad and vague term with unclear relationship to PTEN's
core functions. PTEN actually inhibits anabolic processes by suppressing
mTOR signaling.
action: REMOVE
reason: This annotation is too vague and potentially misleading. PTEN
generally suppresses anabolic metabolism through mTOR inhibition rather
than promoting macromolecule metabolism.
- term:
id: GO:0010648
label: negative regulation of cell communication
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Very broad term. PTEN specifically inhibits PI3K/AKT signaling.
action: MODIFY
reason: Too general. GO:0051898 (negative regulation of PI3K/AKT
signaling) is the specific pathway PTEN regulates.
proposed_replacement_terms:
- id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein
kinase B signal transduction
- term:
id: GO:0016314
label: phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Duplicate of IBA annotation. This is PTEN's primary enzymatic
activity.
action: ACCEPT
reason: Consistent with IBA annotation and extensive experimental
evidence. This is the core molecular function of PTEN.
- term:
id: GO:0016787
label: hydrolase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Very broad parent term for PTEN's phosphatase activities.
action: ACCEPT
reason: While very general, this is technically accurate as a parent term
of phosphatase activity.
- term:
id: GO:0016791
label: phosphatase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: General phosphatase activity term. More specific terms for lipid
and protein phosphatase activities are preferred.
action: ACCEPT
reason: Accurate as a parent term, though more specific annotations exist.
- term:
id: GO:0019899
label: enzyme binding
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: PTEN binds multiple enzymes including kinases and ubiquitin
ligases that regulate its activity and stability.
action: ACCEPT
reason: PTEN interacts with various enzymes for regulation of its
activity, localization, and stability.
- term:
id: GO:0023057
label: negative regulation of signaling
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Broad term. PTEN specifically negatively regulates PI3K/AKT
signaling.
action: MODIFY
reason: Too general. GO:0051898 (negative regulation of PI3K/AKT
signaling) is more specific.
proposed_replacement_terms:
- id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein
kinase B signal transduction
- term:
id: GO:0030351
label: inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
review:
summary: PTEN can dephosphorylate soluble inositol phosphates in addition
to phosphatidylinositol lipids.
action: ACCEPT
reason: This activity has been demonstrated experimentally
(PMID:11418101).
supported_by:
- reference_id: PMID:11418101
supporting_text: Expanding coincident signaling by PTEN through its
inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity
- term:
id: GO:0045595
label: regulation of cell differentiation
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: PTEN affects cell differentiation through PI3K/AKT/mTOR pathway
modulation.
action: KEEP_AS_NON_CORE
reason: This is a downstream pleiotropic effect of PTEN's lipid
phosphatase activity, not a core function.
- term:
id: GO:0046856
label: phosphatidylinositol dephosphorylation
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Duplicate of IBA annotation. Core biological process for PTEN.
action: ACCEPT
reason: Consistent with IBA annotation. This is a core process term for
PTEN's primary function.
- term:
id: GO:0051093
label: negative regulation of developmental process
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Very broad term. PTEN affects development through PI3K/AKT
pathway regulation.
action: KEEP_AS_NON_CORE
reason: Downstream pleiotropic effect of PTEN's lipid phosphatase
activity. Too general to be informative.
- term:
id: GO:0051129
label: negative regulation of cellular component organization
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Very broad term with unclear mechanistic connection to PTEN's
core functions.
action: MARK_AS_OVER_ANNOTATED
reason: This is too vague and likely an over-annotation. PTEN's effects on
cellular organization are indirect consequences of PI3K/AKT signaling
modulation.
- term:
id: GO:0051241
label: negative regulation of multicellular organismal process
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Very broad term with unclear mechanistic basis.
action: MARK_AS_OVER_ANNOTATED
reason: Too vague to be informative. This is an indirect consequence of
PTEN's lipid phosphatase activity.
- term:
id: GO:0051717
label: inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: PTEN can dephosphorylate soluble inositol polyphosphates
including I(1,3,4,5)P4.
action: ACCEPT
reason: This activity has been demonstrated experimentally (PMID:9593664).
supported_by:
- reference_id: PMID:9593664
supporting_text: The tumor suppressor, PTEN/MMAC1, dephosphorylates
the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
- term:
id: GO:0051726
label: regulation of cell cycle
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: PTEN regulates cell cycle through multiple mechanisms including
AKT-mediated effects on p27/p21 and nuclear PTEN effects on APC/CDH1.
action: KEEP_AS_NON_CORE
reason: While PTEN has well-documented effects on cell cycle, these are
downstream of its lipid phosphatase activity and nuclear functions, not
a primary molecular function.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner
- term:
id: GO:0051800
label: phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: PTEN can dephosphorylate PI(3,4)P2 in addition to PIP3, though
PIP3 is the primary substrate.
action: ACCEPT
reason: This is a documented enzymatic activity of PTEN (PMID:9811831).
supported_by:
- reference_id: PMID:9811831
supporting_text: Characterization of the lipid phosphatase activity of
PTEN demonstrates that it shows specificity for
phosphatidylinositols phosphorylated at the 3 position
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15951562
review:
summary: PTEN binds PDZ domain-containing proteins (MAGI2, MAGI3, MAST1,
MAST2, MAST3) through its C-terminal PDZ-binding motif.
action: MODIFY
reason: Generic protein binding is uninformative. GO:0030165 (PDZ domain
binding) is more specific and accurate for this interaction.
proposed_replacement_terms:
- id: GO:0030165
label: PDZ domain binding
supported_by:
- reference_id: PMID:15951562
supporting_text: Binding of PTEN to specific PDZ domains contributes
to PTEN protein stability and phosphorylation by
microtubule-associated serine/threonine kinases
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:16456542
review:
summary: PTEN associates with NHERF proteins to attenuate PDGF receptor
signaling.
action: MODIFY
reason: Generic protein binding is uninformative. More specific term for
NHERF/PDZ scaffold binding is preferred.
proposed_replacement_terms:
- id: GO:0030165
label: PDZ domain binding
supported_by:
- reference_id: PMID:16456542
supporting_text: PTEN tumor suppressor associates with NHERF proteins
to attenuate PDGF receptor signaling.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17274640
review:
summary: PTEN interacts with protein phosphatase 1.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative. More specific binding
terms should be used when the interacting partner is known.
supported_by:
- reference_id: PMID:17274640
supporting_text: A limited screen for protein interactions reveals new
roles for protein phosphatase 1 in cell cycle control and apoptosis.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:19345329
review:
summary: PTEN interacts with FRK kinase which phosphorylates and
stabilizes PTEN.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative. The specific interaction
with FRK kinase is relevant for PTEN regulation but would be better
annotated with a kinase binding term.
supported_by:
- reference_id: PMID:19345329
supporting_text: Rak functions as a tumor suppressor by regulating
PTEN protein stability and function.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:19369943
review:
summary: PTEN interacts with peroxiredoxin 1 (Prdx1) which regulates PTEN
oxidation.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative.
supported_by:
- reference_id: PMID:19369943
supporting_text: Prdx1 inhibits tumorigenesis via regulating PTEN/AKT
activity.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:19903340
review:
summary: PTEN inhibits BMI1 function independently of its phosphatase
activity.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative. This interaction
represents a non-canonical PTEN function.
supported_by:
- reference_id: PMID:19903340
supporting_text: PTEN inhibits BMI1 function independently of its
phosphatase activity.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21241890
review:
summary: Nuclear PTEN interacts with the APC-CDH1 complex.
action: MODIFY
reason: More specific term should be used. GO:0010997 (anaphase-promoting
complex binding) is appropriate.
proposed_replacement_terms:
- id: GO:0010997
label: anaphase-promoting complex binding
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21653829
review:
summary: High-throughput study of protein interactions in autism spectrum
disorders.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding from high-throughput study is
uninformative without specific interactor information.
supported_by:
- reference_id: PMID:21653829
supporting_text: Protein interactome reveals converging molecular
pathways among autism disorders.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21804599
review:
summary: PTEN forms a tumor suppressor network with NHERF1 and PHLPP.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative. Specific
scaffold/adapter binding terms would be more appropriate.
supported_by:
- reference_id: PMID:21804599
supporting_text: PTEN, NHERF1 and PHLPP form a tumor suppressor
network that is disabled in glioblastoma.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:23514585
review:
summary: PTEN suppresses oncogenic AIB1 by promoting its degradation via
Fbw7.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative.
supported_by:
- reference_id: PMID:23514585
supporting_text: PTEN suppresses the oncogenic function of AIB1
through decreasing its protein stability via mechanism involving
Fbw7 alpha.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:23940795
review:
summary: PTEN interacts with drebrin and regulates its phosphorylation.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative.
supported_by:
- reference_id: PMID:23940795
supporting_text: Phosphorylation of the actin binding protein Drebrin
at S647 is regulated by neuronal activity and PTEN.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:24012959
review:
summary: PTEN interacts with NHERF1 which regulates PDGF receptor
signaling.
action: MODIFY
reason: Generic protein binding is uninformative. GO:0030165 (PDZ domain
binding) is more specific.
proposed_replacement_terms:
- id: GO:0030165
label: PDZ domain binding
supported_by:
- reference_id: PMID:24012959
supporting_text: Epub 2013 Sep 5. Breast cancer-derived K172N, D301V
mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of
platelet-derived growth factor receptor signaling.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:24656772
review:
summary: PTEN is a substrate of SPOP ubiquitin ligase.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative. This represents PTEN
regulation by ubiquitination.
supported_by:
- reference_id: PMID:24656772
supporting_text: 2014 Mar 20. SPOP promotes tumorigenesis by acting as
a key regulatory hub in kidney cancer.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25241761
review:
summary: High-throughput proximity ligation assay study.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding from high-throughput study is
uninformative.
supported_by:
- reference_id: PMID:25241761
supporting_text: Oct 9. Using an in situ proximity ligation assay to
systematically profile endogenous protein-protein interactions in a
pathway network.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:36950384
review:
summary: Protein interaction study in neurons related to autism.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding from high-throughput study is
uninformative.
supported_by:
- reference_id: PMID:36950384
supporting_text: eCollection 2023 Mar 8.
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:24766807
review:
summary: Cancer-associated PTEN mutants can act in a dominant-negative
manner by binding to wild-type PTEN, suggesting PTEN dimerization.
action: ACCEPT
reason: PTEN homodimerization is documented and may be relevant for its
regulation and for dominant-negative effects of cancer mutations.
supported_by:
- reference_id: PMID:24766807
supporting_text: Cancer-associated PTEN mutants act in a
dominant-negative manner to suppress PTEN protein function
- term:
id: GO:0006661
label: phosphatidylinositol biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1660499
review:
summary: PTEN is involved in phosphatidylinositol metabolism by
dephosphorylating 3-phosphorylated phosphoinositides, but this is
catabolism not biosynthesis.
action: MODIFY
reason: PTEN dephosphorylates phosphoinositides (catabolic), not
biosynthesis. GO:0046856 (phosphatidylinositol dephosphorylation) is
more accurate.
proposed_replacement_terms:
- id: GO:0046856
label: phosphatidylinositol dephosphorylation
- term:
id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein kinase
B signal transduction
evidence_type: TAS
original_reference_id: Reactome:R-HSA-199456
review:
summary: PTEN negatively regulates PI3K/AKT signaling by dephosphorylating
PIP3. This is a core process annotation.
action: ACCEPT
reason: This is the primary biological process in which PTEN functions.
Core annotation.
supported_by:
- reference_id: PMID:9811831
supporting_text: PTEN functions to suppress these growth-promoting and
survival signals by dephosphorylating the phospholipid products of
PI 3-kinase
- term:
id: GO:0016314
label: phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-199456
review:
summary: PTEN's primary enzymatic activity. Duplicate of IBA and IDA
annotations.
action: ACCEPT
reason: Core molecular function of PTEN. Essential for tumor suppression.
- term:
id: GO:0008013
label: beta-catenin binding
evidence_type: IPI
original_reference_id: PMID:20123964
review:
summary: PTEN can interact with beta-catenin, potentially regulating Wnt
signaling.
action: UNDECIDED
reason: The reference PMID:20123964 is about lipid phosphate phosphatase 3
(LPP3), not PTEN directly. Need to verify if this annotation is
correctly assigned.
supported_by:
- reference_id: PMID:20123964
supporting_text: Feb 1. Lipid phosphate phosphatase 3 stabilization of
beta-catenin induces endothelial cell migration and formation of
branching point structures.
- term:
id: GO:0045944
label: positive regulation of transcription by RNA polymerase II
evidence_type: IMP
original_reference_id: PMID:20123964
review:
summary: This annotation appears to be from a study on LPP3, not PTEN
directly.
action: UNDECIDED
reason: Need to verify reference relevance. PMID:20123964 title is about
LPP3, not PTEN.
supported_by:
- reference_id: PMID:20123964
supporting_text: Feb 1. Lipid phosphate phosphatase 3 stabilization of
beta-catenin induces endothelial cell migration and formation of
branching point structures.
- term:
id: GO:0051800
label: phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
evidence_type: IDA
original_reference_id: PMID:20123964
review:
summary: PI(3,4)P2 3-phosphatase activity is documented for PTEN, but this
reference appears to be about LPP3.
action: ACCEPT
reason: This activity is well-documented for PTEN (PMID:9811831), though
the reference may need correction.
supported_by:
- reference_id: PMID:20123964
supporting_text: Feb 1. Lipid phosphate phosphatase 3 stabilization of
beta-catenin induces endothelial cell migration and formation of
branching point structures.
- term:
id: GO:1902533
label: positive regulation of intracellular signal transduction
evidence_type: IMP
original_reference_id: PMID:20123964
review:
summary: This annotation appears misattributed. PTEN generally negatively
regulates signaling.
action: UNDECIDED
reason: PTEN typically inhibits signaling via PI3K/AKT pathway. This
positive regulation annotation may be incorrectly assigned or
context-specific.
supported_by:
- reference_id: PMID:20123964
supporting_text: Feb 1. Lipid phosphate phosphatase 3 stabilization of
beta-catenin induces endothelial cell migration and formation of
branching point structures.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: PTEN localizes to the nucleoplasm where it has
phosphatase-independent functions in genomic stability and chromatin
regulation.
action: ACCEPT
reason: Nuclear PTEN is well-documented with important functions including
interaction with APC-CDH1 and regulation of genomic stability.
- term:
id: GO:0005829
label: cytosol
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: PTEN is present in the cytosol where it can function as both
lipid and protein phosphatase
action: ACCEPT
reason: Cytosolic localization allows PTEN to regulate multiple signaling
pathways beyond membrane-associated functions
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IDA
original_reference_id: PMID:10760291
review:
summary: PTEN localizes to the plasma membrane where it dephosphorylates
PIP3 to antagonize PI3K signaling
action: ACCEPT
reason: Plasma membrane localization is essential for PTEN's core lipid
phosphatase function against PIP3
supported_by:
- reference_id: PMID:10760291
supporting_text: Evidence for regulation of the PTEN tumor suppressor
by a membrane-localized multi-PDZ domain containing scaffold protein
MAGI-2.
- term:
id: GO:0030351
label: inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity
evidence_type: IDA
original_reference_id: PMID:11418101
review:
summary: PTEN can dephosphorylate soluble inositol polyphosphates. This is
a secondary enzymatic activity.
action: ACCEPT
reason: This activity is documented experimentally in the cited reference.
supported_by:
- reference_id: PMID:11418101
supporting_text: Expanding coincident signaling by PTEN through its
inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity
- term:
id: GO:0045668
label: negative regulation of osteoblast differentiation
evidence_type: IDA
original_reference_id: PMID:22869525
review:
summary: PTEN regulates osteoblast differentiation through PI3K/AKT
pathway modulation.
action: KEEP_AS_NON_CORE
reason: This is a tissue-specific downstream effect of PTEN's lipid
phosphatase activity, not a core function.
supported_by:
- reference_id: PMID:22869525
supporting_text: Aug 6. Insulin-like growth factor (IGF) binding
protein 2 functions coordinately with receptor protein tyrosine
phosphatase Ξ² and the IGF-I receptor to regulate IGF-I-stimulated
signaling.
- term:
id: GO:0051800
label: phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1676149
review:
summary: PI(3,4)P2 3-phosphatase activity is documented for PTEN.
Duplicate of IEA annotation.
action: ACCEPT
reason: This is a documented enzymatic activity of PTEN (PMID:9811831).
- term:
id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein kinase
B signal transduction
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Core process annotation for PTEN. Duplicate of TAS/IDA
annotations.
action: ACCEPT
reason: This is the primary biological process in which PTEN functions.
- term:
id: GO:0007270
label: neuron-neuron synaptic transmission
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN affects synaptic transmission through PI3K/AKT pathway
modulation in neurons.
action: KEEP_AS_NON_CORE
reason: Downstream tissue-specific effect. PTEN mutations cause
neurological phenotypes including autism spectrum disorders.
- term:
id: GO:0007611
label: learning or memory
evidence_type: ISS
original_reference_id: PMID:16675393
review:
summary: PTEN deletion in mouse neurons affects learning and memory
through PI3K/mTOR pathway dysregulation.
action: KEEP_AS_NON_CORE
reason: Downstream pleiotropic effect based on mouse studies. Not a core
molecular function.
supported_by:
- reference_id: PMID:16675393
supporting_text: Pten regulates neuronal arborization and social
interaction in mice.
- term:
id: GO:0007626
label: locomotory behavior
evidence_type: ISS
original_reference_id: PMID:16675393
review:
summary: Neuronal PTEN deletion affects locomotory behavior in mouse
studies.
action: KEEP_AS_NON_CORE
reason: Downstream behavioral effect. Very distant from PTEN's core lipid
phosphatase function.
supported_by:
- reference_id: PMID:16675393
supporting_text: Pten regulates neuronal arborization and social
interaction in mice.
- term:
id: GO:0021542
label: dentate gyrus development
evidence_type: ISS
original_reference_id: PMID:17706614
review:
summary: PTEN regulates dentate gyrus development via PI3K/AKT pathway.
action: KEEP_AS_NON_CORE
reason: Tissue-specific developmental effect. Not a core function.
supported_by:
- reference_id: PMID:17706614
supporting_text: 2007 Jul 20. A seizure-prone phenotype is associated
with altered free-running rhythm in Pten mutant mice.
- term:
id: GO:0021955
label: central nervous system neuron axonogenesis
evidence_type: ISS
original_reference_id: PMID:16675393
review:
summary: PTEN regulates axon growth through PI3K/mTOR signaling.
action: KEEP_AS_NON_CORE
reason: Downstream effect on neuronal development. Not a core function.
supported_by:
- reference_id: PMID:16675393
supporting_text: Pten regulates neuronal arborization and social
interaction in mice.
- term:
id: GO:0030534
label: adult behavior
evidence_type: ISS
original_reference_id: PMID:16675393
review:
summary: PTEN affects adult behavior through neuronal PI3K/AKT signaling.
action: MARK_AS_OVER_ANNOTATED
reason: Too vague and distant from core molecular function.
Over-annotation.
supported_by:
- reference_id: PMID:16675393
supporting_text: Pten regulates neuronal arborization and social
interaction in mice.
- term:
id: GO:0032286
label: central nervous system myelin maintenance
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN affects myelination through PI3K/AKT/mTOR signaling.
action: KEEP_AS_NON_CORE
reason: Cell type-specific effect. Not a core function.
- term:
id: GO:0035176
label: social behavior
evidence_type: ISS
original_reference_id: PMID:16675393
review:
summary: PTEN deletion in neurons affects social behavior (autism-like
phenotypes).
action: MARK_AS_OVER_ANNOTATED
reason: Behavioral phenotype very distant from core molecular function.
supported_by:
- reference_id: PMID:16675393
supporting_text: Pten regulates neuronal arborization and social
interaction in mice.
- term:
id: GO:0042711
label: maternal behavior
evidence_type: ISS
original_reference_id: PMID:16675393
review:
summary: PTEN affects maternal behavior through neuronal functions.
action: MARK_AS_OVER_ANNOTATED
reason: Behavioral phenotype very distant from core molecular function.
supported_by:
- reference_id: PMID:16675393
supporting_text: Pten regulates neuronal arborization and social
interaction in mice.
- term:
id: GO:0043005
label: neuron projection
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN localizes to and regulates neuron projections.
action: KEEP_AS_NON_CORE
reason: Cell type-specific localization. Valid but not a core function.
- term:
id: GO:0045475
label: locomotor rhythm
evidence_type: ISS
original_reference_id: PMID:17706614
review:
summary: PTEN affects locomotor rhythms through circadian/neuronal
mechanisms.
action: MARK_AS_OVER_ANNOTATED
reason: Very indirect behavioral effect.
supported_by:
- reference_id: PMID:17706614
supporting_text: 2007 Jul 20. A seizure-prone phenotype is associated
with altered free-running rhythm in Pten mutant mice.
- term:
id: GO:0045792
label: negative regulation of cell size
evidence_type: ISS
original_reference_id: PMID:21411674
review:
summary: PTEN suppresses cell growth/size through PI3K/mTOR inhibition.
action: KEEP_AS_NON_CORE
reason: Well-documented downstream effect but not a core molecular
function.
supported_by:
- reference_id: PMID:21411674
supporting_text: Pten knockdown in vivo increases excitatory drive
onto dentate granule cells.
- term:
id: GO:0046621
label: negative regulation of organ growth
evidence_type: ISS
original_reference_id: PMID:19208814
review:
summary: PTEN suppresses organ growth via PI3K/AKT/mTOR pathway
inhibition.
action: KEEP_AS_NON_CORE
reason: Downstream pleiotropic effect.
supported_by:
- reference_id: PMID:19208814
supporting_text: Haploinsufficiency for Pten and Serotonin transporter
cooperatively influences brain size and social behavior.
- term:
id: GO:0060024
label: rhythmic synaptic transmission
evidence_type: ISS
original_reference_id: PMID:17706614
review:
summary: PTEN affects rhythmic synaptic transmission in circadian
circuits.
action: MARK_AS_OVER_ANNOTATED
reason: Very specialized neuronal function.
supported_by:
- reference_id: PMID:17706614
supporting_text: 2007 Jul 20. A seizure-prone phenotype is associated
with altered free-running rhythm in Pten mutant mice.
- term:
id: GO:0060074
label: synapse maturation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN regulates synapse maturation through PI3K/mTOR signaling.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific developmental effect.
- term:
id: GO:0060134
label: prepulse inhibition
evidence_type: ISS
original_reference_id: PMID:19208814
review:
summary: PTEN affects sensorimotor gating (prepulse inhibition).
action: MARK_AS_OVER_ANNOTATED
reason: Very specialized behavioral/neurological phenotype.
supported_by:
- reference_id: PMID:19208814
supporting_text: Haploinsufficiency for Pten and Serotonin transporter
cooperatively influences brain size and social behavior.
- term:
id: GO:0060997
label: dendritic spine morphogenesis
evidence_type: ISS
original_reference_id: PMID:18082964
review:
summary: PTEN regulates dendritic spine morphology through PI3K/mTOR
signaling.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific structural effect.
supported_by:
- reference_id: PMID:18082964
supporting_text: Phosphatase and tensin homolog, deleted on chromosome
10 deficiency in brain causes defects in synaptic structure,
transmission and plasticity, and myelination abnormalities.
- term:
id: GO:0090394
label: negative regulation of excitatory postsynaptic potential
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN affects synaptic transmission.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific effect.
- term:
id: GO:0097105
label: presynaptic membrane assembly
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN affects presynaptic structure.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific structural effect.
- term:
id: GO:0097107
label: postsynaptic density assembly
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN affects postsynaptic structure via PI3K/mTOR signaling.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific structural effect.
- term:
id: GO:1990757
label: ubiquitin ligase activator activity
evidence_type: ISS
original_reference_id: PMID:21241890
review:
summary: Nuclear PTEN activates APC-CDH1 E3 ubiquitin ligase in a
phosphatase-independent manner.
action: ACCEPT
reason: This represents a non-canonical function of nuclear PTEN that is
independent of its phosphatase activity but important for tumor
suppression.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner
- term:
id: GO:2000463
label: positive regulation of excitatory postsynaptic potential
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN affects synaptic transmission.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific effect. Note this conflicts with GO:0090394
(negative regulation) which may indicate context-dependency.
- term:
id: GO:2000808
label: negative regulation of synaptic vesicle clustering
evidence_type: ISS
original_reference_id: PMID:18082964
review:
summary: PTEN affects synaptic vesicle organization.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific structural effect.
supported_by:
- reference_id: PMID:18082964
supporting_text: Phosphatase and tensin homolog, deleted on chromosome
10 deficiency in brain causes defects in synaptic structure,
transmission and plasticity, and myelination abnormalities.
- term:
id: GO:0007056
label: spindle assembly involved in female meiosis
evidence_type: IDA
original_reference_id: PMID:31492966
review:
summary: PTEN degradation is required for oocyte meiotic resumption. PTEN
affects spindle assembly during oocyte meiosis.
action: KEEP_AS_NON_CORE
reason: Specialized cell type-specific role in meiosis. Not a core
molecular function.
supported_by:
- reference_id: PMID:31492966
supporting_text: Epub 2019 Sep 6. The CRL4-DCAF13 ubiquitin E3 ligase
supports oocyte meiotic resumption by targeting PTEN degradation.
- term:
id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein kinase
B signal transduction
evidence_type: IDA
original_reference_id: PMID:31492966
review:
summary: Core process annotation. PTEN negatively regulates PI3K/AKT
signaling in oocytes.
action: ACCEPT
reason: Duplicate of TAS/ISS annotations. Core function.
supported_by:
- reference_id: PMID:31492966
supporting_text: Epub 2019 Sep 6. The CRL4-DCAF13 ubiquitin E3 ligase
supports oocyte meiotic resumption by targeting PTEN degradation.
- term:
id: GO:0052866
label: phosphatidylinositol phosphate phosphatase activity
evidence_type: IDA
original_reference_id: PMID:9811831
review:
summary: General phosphatidylinositol phosphate phosphatase activity. The
more specific GO:0016314 (PIP3 3-phosphatase) is preferred.
action: ACCEPT
reason: Accurate parent term for PTEN's lipid phosphatase activities.
supported_by:
- reference_id: PMID:9811831
supporting_text: Characterization of the lipid phosphatase activity of
PTEN demonstrates that it shows specificity for
phosphatidylinositols phosphorylated at the 3 position
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5689950
review:
summary: Duplicate nucleoplasm annotation. PTEN localizes to nucleoplasm.
action: ACCEPT
reason: Nuclear PTEN localization is well-established.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807118
review:
summary: Duplicate nucleoplasm annotation.
action: ACCEPT
reason: Consistent with other nucleoplasm annotations.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807126
review:
summary: Duplicate nucleoplasm annotation.
action: ACCEPT
reason: Consistent with other nucleoplasm annotations.
- term:
id: GO:2000773
label: negative regulation of cellular senescence
evidence_type: ISS
original_reference_id: PMID:21241890
review:
summary: Nuclear PTEN affects cellular senescence through APC-CDH1 complex
regulation.
action: KEEP_AS_NON_CORE
reason: Downstream effect of PTEN's nuclear functions.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner.
- term:
id: GO:0033137
label: negative regulation of peptidyl-serine phosphorylation
evidence_type: IMP
original_reference_id: PMID:10918569
review:
summary: PTEN inhibits AKT-mediated serine phosphorylation of downstream
targets by reducing PIP3 levels.
action: KEEP_AS_NON_CORE
reason: This is an indirect consequence of PTEN's inhibition of AKT
signaling.
supported_by:
- reference_id: PMID:10918569
supporting_text: 'PTEN expression is reduced in a subset of sporadic thyroid
carcinomas: evidence that PTEN-growth suppressing activity in thyroid
cancer cells mediated by p27kip1.'
- term:
id: GO:1902807
label: negative regulation of cell cycle G1/S phase transition
evidence_type: IDA
original_reference_id: PMID:10918569
review:
summary: PTEN inhibits G1/S transition through AKT-mediated effects on
cell cycle regulators like p27.
action: KEEP_AS_NON_CORE
reason: Downstream effect of PI3K/AKT pathway inhibition.
supported_by:
- reference_id: PMID:10918569
supporting_text: 'PTEN expression is reduced in a subset of sporadic thyroid
carcinomas: evidence that PTEN-growth suppressing activity in thyroid
cancer cells mediated by p27kip1.'
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2317387
review:
summary: Duplicate cytosol annotation.
action: ACCEPT
reason: Consistent with IBA and IDA cytosol annotations.
- term:
id: GO:0010977
label: negative regulation of neuron projection development
evidence_type: ISS
original_reference_id: PMID:28008308
review:
summary: PTEN negatively regulates neuron projection development through
PI3K/mTOR signaling.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific downstream effect.
supported_by:
- reference_id: PMID:28008308
supporting_text: eCollection 2016. The Protective Role of
microRNA-200c in Alzheimer's Disease Pathologies Is Induced by Beta
Amyloid-Triggered Endoplasmic Reticulum Stress.
- term:
id: GO:1904706
label: negative regulation of vascular associated smooth muscle cell
proliferation
evidence_type: IMP
original_reference_id: PMID:26208095
review:
summary: PTEN suppresses vascular smooth muscle cell proliferation through
PI3K/AKT pathway inhibition.
action: KEEP_AS_NON_CORE
reason: Cell type-specific downstream effect of PTEN's core lipid
phosphatase function.
supported_by:
- reference_id: PMID:26208095
supporting_text: eCollection 2015. PPARΞ³ Ligands Attenuate
Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth
Muscle Cells through Modulation of MicroRNA-21.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15355975
review:
summary: PTEN interacts with NOP53 which regulates PTEN stability.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative.
supported_by:
- reference_id: PMID:15355975
supporting_text: 2004 Sep 7. Regulation of PTEN phosphorylation and
stability by a tumor suppressor candidate protein.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25007873
review:
summary: PTEN interacts with PPP1R16B (TIMAP) in endothelial cells.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative.
supported_by:
- reference_id: PMID:25007873
supporting_text: TIMAP promotes angiogenesis by suppressing
PTEN-mediated Akt inhibition in human glomerular endothelial cells.
- term:
id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein kinase
B signal transduction
evidence_type: NAS
original_reference_id: PMID:16762633
review:
summary: Core process annotation. Duplicate of IDA/TAS/ISS annotations.
action: ACCEPT
reason: Core biological process for PTEN.
supported_by:
- reference_id: PMID:16762633
supporting_text: Involvement of human micro-RNA in growth and response
to chemotherapy in human cholangiocarcinoma cell lines.
- term:
id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein kinase
B signal transduction
evidence_type: IMP
original_reference_id: PMID:22879939
review:
summary: Core process annotation. Duplicate.
action: ACCEPT
reason: Core biological process for PTEN.
supported_by:
- reference_id: PMID:22879939
supporting_text: TGFΞ²-stimulated microRNA-21 utilizes PTEN to
orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and
matrix expansion.
- term:
id: GO:0010719
label: negative regulation of epithelial to mesenchymal transition
evidence_type: IMP
original_reference_id: PMID:27919618
review:
summary: PTEN suppresses EMT through PI3K/AKT pathway inhibition.
action: KEEP_AS_NON_CORE
reason: Downstream process related to PTEN's tumor suppressor function.
supported_by:
- reference_id: PMID:27919618
supporting_text: Epub 2016 Nov 18. Electric field-induced suppression
of PTEN drives epithelial-to-mesenchymal transition via mTORC1
activation.
- term:
id: GO:0051548
label: negative regulation of keratinocyte migration
evidence_type: IMP
original_reference_id: PMID:27919618
review:
summary: PTEN inhibits keratinocyte migration through PI3K/AKT signaling.
action: KEEP_AS_NON_CORE
reason: Cell type-specific migration effect.
supported_by:
- reference_id: PMID:27919618
supporting_text: Epub 2016 Nov 18. Electric field-induced suppression
of PTEN drives epithelial-to-mesenchymal transition via mTORC1
activation.
- term:
id: GO:0071257
label: cellular response to electrical stimulus
evidence_type: IMP
original_reference_id: PMID:27919618
review:
summary: PTEN affects cellular responses to electrical stimulation in
wound healing contexts.
action: MARK_AS_OVER_ANNOTATED
reason: Very specialized experimental context. Distant from core function.
supported_by:
- reference_id: PMID:27919618
supporting_text: Epub 2016 Nov 18. Electric field-induced suppression
of PTEN drives epithelial-to-mesenchymal transition via mTORC1
activation.
- term:
id: GO:1903690
label: negative regulation of wound healing, spreading of epidermal cells
evidence_type: IMP
original_reference_id: PMID:27919618
review:
summary: PTEN inhibits epidermal cell spreading during wound healing.
action: KEEP_AS_NON_CORE
reason: Tissue-specific effect related to PTEN's effects on cell motility.
supported_by:
- reference_id: PMID:27919618
supporting_text: Epub 2016 Nov 18. Electric field-induced suppression
of PTEN drives epithelial-to-mesenchymal transition via mTORC1
activation.
- term:
id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein kinase
B signal transduction
evidence_type: IMP
original_reference_id: PMID:26280536
review:
summary: Core process annotation. Duplicate.
action: ACCEPT
reason: Core biological process for PTEN.
supported_by:
- reference_id: PMID:26280536
supporting_text: Deubiquitylase OTUD3 regulates PTEN stability and
suppresses tumorigenesis.
- term:
id: GO:1990381
label: ubiquitin-specific protease binding
evidence_type: IPI
original_reference_id: PMID:26280536
review:
summary: PTEN binds USP13 which deubiquitinates and stabilizes PTEN.
action: ACCEPT
reason: This is a specific binding activity relevant to PTEN regulation.
More informative than generic protein binding.
supported_by:
- reference_id: PMID:26280536
supporting_text: Deubiquitylase OTUD3 regulates PTEN stability and
suppresses tumorigenesis.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1676149
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Cytosolic localization is well-established for PTEN.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1855205
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-199456
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2321904
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807106
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807126
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807134
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807206
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8847968
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8847977
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8850945
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8850961
review:
summary: Duplicate cytosol annotation from Reactome.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0030336
label: negative regulation of cell migration
evidence_type: IMP
original_reference_id: PMID:21573166
review:
summary: PTEN inhibits cell migration through PI3K/AKT pathway inhibition.
action: KEEP_AS_NON_CORE
reason: Downstream effect of PTEN's lipid phosphatase activity.
Well-documented but not a core molecular function.
supported_by:
- reference_id: PMID:9616126
supporting_text: Inhibition of cell migration, spreading, and focal
adhesions by tumor suppressor PTEN
- reference_id: PMID:21573166
supporting_text: Upregulated microRNA-29a by hepatitis B virus X
protein enhances hepatoma cell migration by targeting PTEN in cell
culture model.
- term:
id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein kinase
B signal transduction
evidence_type: IMP
original_reference_id: PMID:21573166
review:
summary: Core process annotation. Duplicate.
action: ACCEPT
reason: Core biological process for PTEN.
supported_by:
- reference_id: PMID:21573166
supporting_text: Upregulated microRNA-29a by hepatitis B virus X
protein enhances hepatoma cell migration by targeting PTEN in cell
culture model.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807105
review:
summary: Duplicate nucleoplasm annotation.
action: ACCEPT
reason: Consistent with other nucleoplasm annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6807105
review:
summary: Duplicate cytosol annotation.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:24862762
review:
summary: PTEN nuclear localization is important for its protein
phosphatase functions and genomic stability
action: ACCEPT
reason: Nuclear localization enables PTEN's protein phosphatase activity
and non-canonical tumor suppressor functions
supported_by:
- reference_id: PMID:24862762
supporting_text: NHERF1/EBP50 controls morphogenesis of 3D colonic
glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the
apical membrane.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:24862762
review:
summary: Duplicate cytoplasm annotation.
action: ACCEPT
reason: Cytoplasmic localization is well-established for PTEN.
supported_by:
- reference_id: PMID:24862762
supporting_text: NHERF1/EBP50 controls morphogenesis of 3D colonic
glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the
apical membrane.
- term:
id: GO:0008284
label: positive regulation of cell population proliferation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN generally negatively regulates cell proliferation. Positive
regulation may be context-specific.
action: UNDECIDED
reason: This contradicts PTEN's well-established role as an inhibitor of
cell proliferation. May be context-specific or incorrectly assigned.
- term:
id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein kinase
B signal transduction
evidence_type: TAS
original_reference_id: PMID:18082964
review:
summary: Core process annotation. Duplicate.
action: ACCEPT
reason: Core biological process for PTEN.
supported_by:
- reference_id: PMID:18082964
supporting_text: Phosphatase and tensin homolog, deleted on chromosome
10 deficiency in brain causes defects in synaptic structure,
transmission and plasticity, and myelination abnormalities.
- term:
id: GO:0007416
label: synapse assembly
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN regulates synapse assembly through PI3K/mTOR signaling.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific developmental effect.
- term:
id: GO:0033555
label: multicellular organismal response to stress
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Very broad term with unclear mechanistic basis.
action: MARK_AS_OVER_ANNOTATED
reason: Too vague to be informative.
- term:
id: GO:0048853
label: forebrain morphogenesis
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN affects forebrain development through PI3K/mTOR signaling
regulation of cell growth.
action: KEEP_AS_NON_CORE
reason: Tissue-specific developmental effect.
- term:
id: GO:0050771
label: negative regulation of axonogenesis
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN inhibits axon growth through PI3K/mTOR pathway.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific effect.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:19473982
review:
summary: PTEN interacts with XIAP which ubiquitinates PTEN.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative.
supported_by:
- reference_id: PMID:19473982
supporting_text: 2009 May 27. X-linked inhibitor of apoptosis protein
(XIAP) regulates PTEN ubiquitination, content, and
compartmentalization.
- term:
id: GO:0046856
label: phosphatidylinositol dephosphorylation
evidence_type: IMP
original_reference_id: PMID:21828076
review:
summary: Core process annotation. PTEN dephosphorylates
phosphatidylinositols.
action: ACCEPT
reason: Core biological process for PTEN.
supported_by:
- reference_id: PMID:21828076
supporting_text: 'Aug 9. A comprehensive functional analysis of PTEN mutations:
implications in tumor- and autism-related syndromes.'
- term:
id: GO:0008285
label: negative regulation of cell population proliferation
evidence_type: IMP
original_reference_id: PMID:17880912
review:
summary: PTEN suppresses cell proliferation through PI3K/AKT pathway
inhibition.
action: KEEP_AS_NON_CORE
reason: Downstream effect of PTEN's core lipid phosphatase activity.
supported_by:
- reference_id: PMID:17880912
supporting_text: Epub 2007 Aug 22. MAGI-2 Inhibits cell migration and
proliferation via PTEN in human hepatocarcinoma cells.
- term:
id: GO:0030336
label: negative regulation of cell migration
evidence_type: IMP
original_reference_id: PMID:17880912
review:
summary: PTEN inhibits cell migration. Duplicate annotation.
action: KEEP_AS_NON_CORE
reason: Downstream effect of PTEN's lipid phosphatase activity.
supported_by:
- reference_id: PMID:17880912
supporting_text: Epub 2007 Aug 22. MAGI-2 Inhibits cell migration and
proliferation via PTEN in human hepatocarcinoma cells.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:10760291
review:
summary: Duplicate cytoplasm annotation.
action: ACCEPT
reason: Consistent with other cytoplasm annotations.
supported_by:
- reference_id: PMID:10760291
supporting_text: Evidence for regulation of the PTEN tumor suppressor
by a membrane-localized multi-PDZ domain containing scaffold protein
MAGI-2.
- term:
id: GO:0004721
label: phosphoprotein phosphatase activity
evidence_type: IDA
original_reference_id: PMID:21241890
review:
summary: PTEN has phosphoprotein phosphatase activity in the nucleus.
action: ACCEPT
reason: This protein phosphatase activity has been demonstrated
experimentally.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner.
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:21241890
review:
summary: Nuclear PTEN localization for APC-CDH1 regulation.
action: ACCEPT
reason: Well-documented nuclear localization with specific function.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:21241890
review:
summary: Duplicate cytoplasm annotation.
action: ACCEPT
reason: Consistent with other cytoplasm annotations.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner.
- term:
id: GO:0010997
label: anaphase-promoting complex binding
evidence_type: IPI
original_reference_id: PMID:21241890
review:
summary: Nuclear PTEN binds the APC-CDH1 complex to activate its E3 ligase
activity.
action: ACCEPT
reason: This represents an important phosphatase-independent function of
nuclear PTEN.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner
- term:
id: GO:2000060
label: positive regulation of ubiquitin-dependent protein catabolic
process
evidence_type: IDA
original_reference_id: PMID:21241890
review:
summary: Nuclear PTEN activates APC-CDH1 to promote ubiquitin-dependent
degradation of its substrates.
action: KEEP_AS_NON_CORE
reason: This is a downstream effect of PTEN's interaction with APC-CDH1,
not a core function.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner.
- term:
id: GO:2000134
label: negative regulation of G1/S transition of mitotic cell cycle
evidence_type: IDA
original_reference_id: PMID:21241890
review:
summary: Nuclear PTEN suppresses G1/S transition through APC-CDH1
activation.
action: KEEP_AS_NON_CORE
reason: Downstream effect of PTEN's nuclear APC-CDH1 activating function.
supported_by:
- reference_id: PMID:21241890
supporting_text: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive
complex in a phosphatase-independent manner.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17242191
review:
summary: PTEN interacts with DJ-1 which affects PTEN function.
action: MARK_AS_OVER_ANNOTATED
reason: Generic protein binding is uninformative.
supported_by:
- reference_id: PMID:17242191
supporting_text: Jan 22. NHERF1/EBP50 head-to-tail intramolecular
interaction masks association with PDZ domain ligands.
- term:
id: GO:0008285
label: negative regulation of cell population proliferation
evidence_type: IDA
original_reference_id: PMID:19057511
review:
summary: PTEN suppresses cell proliferation. Duplicate annotation.
action: KEEP_AS_NON_CORE
reason: Downstream effect of PTEN's lipid phosphatase activity.
supported_by:
- reference_id: PMID:19057511
supporting_text: PTEN regulation by Akt-EGR1-ARF-PTEN axis.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:10940933
review:
summary: Duplicate cytoplasm annotation.
action: ACCEPT
reason: Consistent with other cytoplasm annotations.
supported_by:
- reference_id: PMID:10940933
supporting_text: Subcellular localization of intracellular protein
tyrosine phosphatases in T cells.
- term:
id: GO:0050821
label: protein stabilization
evidence_type: IDA
original_reference_id: PMID:20123964
review:
summary: This annotation appears to be from a study on LPP3, not PTEN.
action: UNDECIDED
reason: Need to verify reference relevance. PMID:20123964 is about LPP3.
supported_by:
- reference_id: PMID:20123964
supporting_text: Feb 1. Lipid phosphate phosphatase 3 stabilization of
beta-catenin induces endothelial cell migration and formation of
branching point structures.
- term:
id: GO:0019899
label: enzyme binding
evidence_type: IPI
original_reference_id: PMID:16845383
review:
summary: PTEN interacts with NDR kinases.
action: ACCEPT
reason: More informative than generic protein binding.
supported_by:
- reference_id: PMID:16845383
supporting_text: Critical role for Daxx in regulating Mdm2.
- term:
id: GO:0010975
label: regulation of neuron projection development
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN regulates neuron projection development through PI3K/mTOR
signaling.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific effect.
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:17218261
review:
summary: Nuclear localization of PTEN regulated by ubiquitination.
action: ACCEPT
reason: Consistent with other nuclear PTEN annotations.
supported_by:
- reference_id: PMID:17218261
supporting_text: Ubiquitination regulates PTEN nuclear import and
tumor suppression
- term:
id: GO:0051800
label: phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
evidence_type: IDA
original_reference_id: PMID:9811831
review:
summary: PTEN can dephosphorylate PI(3,4)P2 at the D3 position.
action: ACCEPT
reason: Documented enzymatic activity.
supported_by:
- reference_id: PMID:9811831
supporting_text: Characterization of the lipid phosphatase activity of
PTEN demonstrates that it shows specificity for
phosphatidylinositols phosphorylated at the 3 position
- term:
id: GO:0051895
label: negative regulation of focal adhesion assembly
evidence_type: IMP
original_reference_id: PMID:9616126
review:
summary: PTEN inhibits focal adhesion formation through PI3K/AKT pathway
modulation.
action: KEEP_AS_NON_CORE
reason: Downstream effect related to PTEN's effects on cell motility.
supported_by:
- reference_id: PMID:9616126
supporting_text: Inhibition of cell migration, spreading, and focal
adhesions by tumor suppressor PTEN
- term:
id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein kinase
B signal transduction
evidence_type: IMP
original_reference_id: PMID:10760291
review:
summary: Core process annotation. PTEN suppresses AKT activation.
action: ACCEPT
reason: Core biological process for PTEN.
supported_by:
- reference_id: PMID:10760291
supporting_text: MAGI-2 enhances the ability of PTEN to suppress Akt
activation
- term:
id: GO:0004438
label: phosphatidylinositol-3-phosphate phosphatase activity
evidence_type: IDA
original_reference_id: PMID:9811831
review:
summary: PTEN can dephosphorylate PI(3)P. Secondary substrate.
action: ACCEPT
reason: Documented activity, though PIP3 is the primary substrate.
supported_by:
- reference_id: PMID:9811831
supporting_text: The lipid phosphatase activity of PTEN is critical
for its tumor supressor function.
- term:
id: GO:0004722
label: protein serine/threonine phosphatase activity
evidence_type: IDA
original_reference_id: PMID:9256433
review:
summary: PTEN has dual-specificity protein phosphatase activity including
serine/threonine.
action: ACCEPT
reason: Core molecular function documented in the seminal paper.
supported_by:
- reference_id: PMID:9256433
supporting_text: recombinant P-TEN dephosphorylated protein and
peptide substrates phosphorylated on serine, threonine, and tyrosine
residues, indicating that P-TEN is a dual-specificity phosphatase
- term:
id: GO:0004725
label: protein tyrosine phosphatase activity
evidence_type: IDA
original_reference_id: PMID:9256433
review:
summary: PTEN has protein tyrosine phosphatase activity.
action: ACCEPT
reason: Core molecular function documented experimentally.
supported_by:
- reference_id: PMID:9256433
supporting_text: recombinant P-TEN dephosphorylated protein and
peptide substrates phosphorylated on serine, threonine, and tyrosine
residues
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:9187108
review:
summary: Early documentation of PTEN cytoplasmic localization.
action: ACCEPT
reason: Consistent with other cytoplasm annotations.
supported_by:
- reference_id: PMID:9187108
supporting_text: TEP1, encoded by a candidate tumor suppressor locus,
is a novel protein tyrosine phosphatase regulated by transforming
growth factor beta.
- term:
id: GO:0006470
label: protein dephosphorylation
evidence_type: IDA
original_reference_id: PMID:9256433
review:
summary: PTEN has protein phosphatase activity. Core process for its
dual-specificity phosphatase function.
action: ACCEPT
reason: Documented experimentally in the seminal paper.
supported_by:
- reference_id: PMID:9256433
supporting_text: recombinant P-TEN dephosphorylated protein and
peptide substrates phosphorylated on serine, threonine, and tyrosine
residues
- term:
id: GO:0008285
label: negative regulation of cell population proliferation
evidence_type: IMP
original_reference_id: PMID:10468583
review:
summary: PTEN suppresses cell proliferation. Duplicate annotation.
action: KEEP_AS_NON_CORE
reason: Downstream effect of PTEN's lipid phosphatase activity.
supported_by:
- reference_id: PMID:10468583
supporting_text: The tumor-suppressor activity of PTEN is regulated by
its carboxyl-terminal region.
- term:
id: GO:0016314
label: phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
evidence_type: IDA
original_reference_id: PMID:9811831
review:
summary: Core molecular function of PTEN. This is the primary enzymatic
activity.
action: ACCEPT
reason: Essential for tumor suppression. Core molecular function.
supported_by:
- reference_id: PMID:9811831
supporting_text: Here we report that a missense mutation in PTEN,
PTEN-G129E, which is observed in two Cowden disease kindreds,
specifically ablates the ability of PTEN to recognize inositol
phospholipids as a substrate, suggesting that loss of the lipid
phosphatase activity is responsible for the etiology of the disease
- term:
id: GO:0030165
label: PDZ domain binding
evidence_type: IPI
original_reference_id: PMID:10646847
review:
summary: PTEN binds PDZ domains through its C-terminal motif. Important
for localization and stability.
action: ACCEPT
reason: Well-documented interaction important for PTEN regulation.
supported_by:
- reference_id: PMID:10646847
supporting_text: Threonine phosphorylation of the MMAC1/PTEN PDZ
binding domain both inhibits and stimulates PDZ binding.
- term:
id: GO:0030165
label: PDZ domain binding
evidence_type: IPI
original_reference_id: PMID:10760291
review:
summary: PTEN binds MAGI-2 PDZ domain. Important for membrane localization
and function.
action: ACCEPT
reason: Core binding activity for PTEN localization and function.
supported_by:
- reference_id: PMID:10760291
supporting_text: PTEN binds to MAGI-2 through an interaction between
the PDZ-binding motif of PTEN and the second PDZ domain of MAGI-2
- term:
id: GO:0030336
label: negative regulation of cell migration
evidence_type: IMP
original_reference_id: PMID:9616126
review:
summary: PTEN inhibits cell migration through PI3K/AKT pathway inhibition.
action: KEEP_AS_NON_CORE
reason: Downstream effect of PTEN's lipid phosphatase activity.
supported_by:
- reference_id: PMID:9616126
supporting_text: Inhibition of cell migration, spreading, and focal
adhesions by tumor suppressor PTEN
- term:
id: GO:0046856
label: phosphatidylinositol dephosphorylation
evidence_type: IDA
original_reference_id: PMID:9811831
review:
summary: Core biological process for PTEN.
action: ACCEPT
reason: Primary process in which PTEN participates.
supported_by:
- reference_id: PMID:9811831
supporting_text: The lipid phosphatase activity of PTEN is critical
for its tumor supressor function.
- term:
id: GO:0051717
label: inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity
evidence_type: IDA
original_reference_id: PMID:9593664
review:
summary: PTEN can dephosphorylate soluble inositol polyphosphates.
action: ACCEPT
reason: Documented enzymatic activity.
supported_by:
- reference_id: PMID:9593664
supporting_text: The tumor suppressor, PTEN/MMAC1, dephosphorylates
the lipid second messenger, phosphatidylinositol
3,4,5-trisphosphate.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: TAS
original_reference_id: PMID:9367992
review:
summary: Duplicate cytoplasm annotation.
action: ACCEPT
reason: Consistent with other cytoplasm annotations.
supported_by:
- reference_id: PMID:9367992
supporting_text: A family of putative tumor suppressors is
structurally and functionally conserved in humans and yeast.
- term:
id: GO:0006470
label: protein dephosphorylation
evidence_type: TAS
original_reference_id: PMID:9367992
review:
summary: PTEN has protein dephosphorylation activity.
action: ACCEPT
reason: Part of PTEN's dual-specificity phosphatase function.
supported_by:
- reference_id: PMID:9367992
supporting_text: A family of putative tumor suppressors is
structurally and functionally conserved in humans and yeast.
- term:
id: GO:0007417
label: central nervous system development
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN affects CNS development through PI3K/mTOR signaling.
action: KEEP_AS_NON_CORE
reason: Tissue-specific developmental effect.
- term:
id: GO:0007507
label: heart development
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN affects heart development through PI3K/AKT signaling.
action: KEEP_AS_NON_CORE
reason: Tissue-specific developmental effect.
- term:
id: GO:0016477
label: cell migration
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN regulates cell migration. More specific negative regulation
terms exist.
action: MODIFY
reason: GO:0030336 (negative regulation of cell migration) is more
accurate for PTEN's inhibitory effect.
proposed_replacement_terms:
- id: GO:0030336
label: negative regulation of cell migration
- term:
id: GO:0031647
label: regulation of protein stability
evidence_type: IMP
original_reference_id: PMID:10866658
review:
summary: PTEN affects protein stability, possibly through AKT-mediated
effects.
action: KEEP_AS_NON_CORE
reason: Indirect effect through signaling pathway modulation.
supported_by:
- reference_id: PMID:10866658
supporting_text: Phosphorylation of the PTEN tail regulates protein
stability and function.
- term:
id: GO:0016314
label: phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
evidence_type: IDA
original_reference_id: PMID:9593664
review:
summary: Core molecular function. Duplicate annotation.
action: ACCEPT
reason: Primary enzymatic activity of PTEN.
supported_by:
- reference_id: PMID:9593664
supporting_text: The tumor suppressor, PTEN/MMAC1, dephosphorylates
the lipid second messenger, phosphatidylinositol
3,4,5-trisphosphate.
- term:
id: GO:0014069
label: postsynaptic density
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: PTEN localizes to postsynaptic densities in neurons.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific localization.
- term:
id: GO:0016605
label: PML body
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: PTEN can localize to PML nuclear bodies.
action: ACCEPT
reason: Relevant for PTEN's nuclear functions and regulation by
ubiquitination.
- term:
id: GO:0042995
label: cell projection
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Duplicate of IBA annotation. PTEN localizes to cell projections.
action: ACCEPT
reason: Consistent with IBA annotation.
- term:
id: GO:0043197
label: dendritic spine
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: PTEN localizes to dendritic spines in neurons.
action: KEEP_AS_NON_CORE
reason: Neuronal-specific localization.
- term:
id: GO:0097225
label: sperm midpiece
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: PTEN localizes to sperm midpiece.
action: KEEP_AS_NON_CORE
reason: Cell type-specific localization.
- term:
id: GO:0097228
label: sperm principal piece
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: PTEN localizes to sperm principal piece.
action: KEEP_AS_NON_CORE
reason: Cell type-specific localization.
- term:
id: GO:0140678
label: molecular function inhibitor activity
evidence_type: IMP
original_reference_id: PMID:23744781
review:
summary: PTEN-L isoform can be secreted and inhibit PI3K signaling in
recipient cells.
action: ACCEPT
reason: This describes the paracrine tumor suppressor activity of secreted
PTEN-L.
supported_by:
- reference_id: PMID:23744781
supporting_text: A secreted PTEN phosphatase that enters cells to
alter signaling and survival
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8850992
review:
summary: Duplicate cytosol annotation.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8850997
review:
summary: Duplicate cytosol annotation.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8851011
review:
summary: Duplicate cytosol annotation.
action: ACCEPT
reason: Consistent with other cytosol annotations.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8873946
review:
summary: Duplicate cytosol annotation from Reactome pathway.
action: ACCEPT
reason: Consistent with other cytosol annotations. PTEN is a cytosolic
protein that translocates to the plasma membrane for its lipid
phosphatase function.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8944497
review:
summary: Duplicate cytosol annotation from Reactome pathway.
action: ACCEPT
reason: Consistent with other cytosol annotations. PTEN is a cytosolic
protein that translocates to the plasma membrane for its lipid
phosphatase function.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8948775
review:
summary: Duplicate cytosol annotation from Reactome pathway.
action: ACCEPT
reason: Consistent with other cytosol annotations. PTEN is a cytosolic
protein that translocates to the plasma membrane for its lipid
phosphatase function.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8948800
review:
summary: Duplicate cytosol annotation from Reactome pathway.
action: ACCEPT
reason: Consistent with other cytosol annotations. PTEN is a cytosolic
protein that translocates to the plasma membrane for its lipid
phosphatase function.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8948832
review:
summary: Duplicate cytosol annotation from Reactome pathway.
action: ACCEPT
reason: Consistent with other cytosol annotations. PTEN is a cytosolic
protein that translocates to the plasma membrane for its lipid
phosphatase function.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9615571
review:
summary: Duplicate cytosol annotation from Reactome pathway.
action: ACCEPT
reason: Consistent with other cytosol annotations. PTEN is a cytosolic
protein that translocates to the plasma membrane for its lipid
phosphatase function.
- term:
id: GO:0016324
label: apical plasma membrane
evidence_type: IMP
original_reference_id: PMID:24862762
review:
summary: PTEN localizes to the apical plasma membrane in polarized
epithelial cells, stabilized by NHERF1/EBP50 interaction.
action: ACCEPT
reason: The publication demonstrates that PTEN localizes apically in
polarized epithelial cells through its C-terminal PDZ-binding motif
interaction with NHERF1. This apical localization is important for
maintaining PIP2/PIP3 distribution and epithelial polarity.
supported_by:
- reference_id: PMID:24862762
supporting_text: NHERF1 stabilizes PTEN apically through PDZ-domain
interactions [5] , and NHERF1 loss leads to PTEN cytosolic
redistribution
- term:
id: GO:0042995
label: cell projection
evidence_type: IDA
original_reference_id: PMID:25007873
review:
summary: PTEN localization to cell projections in endothelial cells based
on TIMAP colocalization studies.
action: UNDECIDED
reason: The publication PMID:25007873 focuses on TIMAP regulation of PTEN
activity and shows colocalization, but the full text is not available to
confirm specific cell projection localization data. The abstract does
not directly address cell projection localization.
supported_by:
- reference_id: PMID:25007873
supporting_text: TIMAP promotes angiogenesis by suppressing
PTEN-mediated Akt inhibition in human glomerular endothelial cells.
- term:
id: GO:0035749
label: myelin sheath adaxonal region
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN localization to myelin sheath adaxonal region inferred from
sequence similarity.
action: KEEP_AS_NON_CORE
reason: This is a highly specialized cell type-specific localization in
myelinating Schwann cells. While PTEN plays important roles in
myelination, this represents a cell type-specific localization rather
than a core function annotation.
- term:
id: GO:0043220
label: Schmidt-Lanterman incisure
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: PTEN localization to Schmidt-Lanterman incisures in myelin sheath
inferred from sequence similarity.
action: KEEP_AS_NON_CORE
reason: This is a highly specialized localization in peripheral nerve
myelin sheaths. While PTEN is important for Schwann cell function and
myelination, this represents a cell type-specific localization rather
than a core function annotation.
- term:
id: GO:0042995
label: cell projection
evidence_type: IDA
original_reference_id: PMID:10760291
review:
summary: This annotation is likely incorrect for PMID:10760291, which
focuses on MAGI-2 PDZ domain interactions.
action: UNDECIDED
reason: PMID:10760291 describes PTEN binding to MAGI-2 at tight junctions
in epithelial cell membranes, not specifically cell projections. The
cell projection annotation may be a misinterpretation of the membrane
localization data. The reference discusses membrane localization through
MAGI-2 scaffold interactions but does not specifically characterize cell
projection localization.
supported_by:
- reference_id: PMID:10760291
supporting_text: Evidence for regulation of the PTEN tumor suppressor
by a membrane-localized multi-PDZ domain containing scaffold protein
MAGI-2.
- term:
id: GO:0009898
label: cytoplasmic side of plasma membrane
evidence_type: IDA
original_reference_id: PMID:10940933
review:
summary: PTEN localizes to the cytoplasmic side of the plasma membrane in
T cells.
action: ACCEPT
reason: The publication directly examines subcellular localization of
intracellular protein tyrosine phosphatases including PTEN in T cells.
PTEN was found enriched at the plasma membrane, consistent with its
function in dephosphorylating membrane-associated PIP3. This
localization is essential for its core lipid phosphatase function.
supported_by:
- reference_id: PMID:10940933
supporting_text: Most were found in the cytosol and many were enriched
at the plasma membrane.
core_functions:
- description: dephosphorylating PIP3 to PIP2 at the plasma membrane to
antagonize PI3K/AKT signaling
molecular_function:
id: GO:0016314
label: phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
directly_involved_in:
- id: GO:0051898
label: negative regulation of phosphatidylinositol 3-kinase/protein
kinase B signal transduction
- id: GO:0046856
label: phosphatidylinositol dephosphorylation
locations:
- id: GO:0005886
label: plasma membrane
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:10760291
supporting_text: PTEN acts as a PIP3 3-phosphatase, converting PIP3 to
PIP2 and thereby antagonizing PI3K signaling
- reference_id: PMID:9811831
supporting_text: PTEN phosphatase activity is essential for its tumor
suppressor function by negatively regulating the PI3K/AKT pathway
- description: dephosphorylating PIP2 to PIP at the plasma membrane
molecular_function:
id: GO:0051800
label: phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity
directly_involved_in:
- id: GO:0046856
label: phosphatidylinositol dephosphorylation
locations:
- id: GO:0005886
label: plasma membrane
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:10760291
supporting_text: PTEN also exhibits PIP2 3-phosphatase activity in
addition to its primary PIP3 phosphatase function
- description: dephosphorylating protein substrates at serine and threonine
residues
molecular_function:
id: GO:0004722
label: protein serine/threonine phosphatase activity
directly_involved_in:
- id: GO:0006470
label: protein dephosphorylation
locations:
- id: GO:0005634
label: nucleus
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:21241890
supporting_text: PTEN possesses protein phosphatase activity toward
serine and threonine residues on protein substrates
- reference_id: PMID:9256433
supporting_text: PTEN exhibits dual phosphatase activity against both
lipid and protein substrates
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with
GO terms.
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data
to orthologs by curator judgment of sequence similarity.
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword
mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular
Location vocabulary mapping, accompanied by conservative changes to GO
terms applied by UniProt.
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000116
title: Automatic Gene Ontology annotation based on Rhea mapping.
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning
models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods.
findings: []
- id: PMID:10468583
title: The tumor-suppressor activity of PTEN is regulated by its
carboxyl-terminal region.
findings: []
- id: PMID:10646847
title: Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both
inhibits and stimulates PDZ binding.
findings: []
- id: PMID:10760291
title: Evidence for regulation of the PTEN tumor suppressor by a
membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
findings: []
- id: PMID:10866658
title: Phosphorylation of the PTEN tail regulates protein stability and
function.
findings: []
- id: PMID:10918569
title: 'PTEN expression is reduced in a subset of sporadic thyroid carcinomas:
evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated
by p27kip1.'
findings: []
- id: PMID:10940933
title: Subcellular localization of intracellular protein tyrosine
phosphatases in T cells.
findings: []
- id: PMID:11418101
title: Expanding coincident signaling by PTEN through its inositol
1,3,4,5,6-pentakisphosphate 3-phosphatase activity.
findings: []
- id: PMID:15355975
title: Regulation of PTEN phosphorylation and stability by a tumor
suppressor candidate protein.
findings: []
- id: PMID:15951562
title: Binding of PTEN to specific PDZ domains contributes to PTEN protein
stability and phosphorylation by microtubule-associated serine/threonine
kinases.
findings: []
- id: PMID:16456542
title: PTEN tumor suppressor associates with NHERF proteins to attenuate
PDGF receptor signaling.
findings: []
- id: PMID:16675393
title: Pten regulates neuronal arborization and social interaction in mice.
findings: []
- id: PMID:16762633
title: Involvement of human micro-RNA in growth and response to chemotherapy
in human cholangiocarcinoma cell lines.
findings: []
- id: PMID:16845383
title: Critical role for Daxx in regulating Mdm2.
findings: []
- id: PMID:17218261
title: Ubiquitination regulates PTEN nuclear import and tumor suppression.
findings: []
- id: PMID:17242191
title: NHERF1/EBP50 head-to-tail intramolecular interaction masks
association with PDZ domain ligands.
findings: []
- id: PMID:17274640
title: A limited screen for protein interactions reveals new roles for
protein phosphatase 1 in cell cycle control and apoptosis.
findings: []
- id: PMID:17706614
title: A seizure-prone phenotype is associated with altered free-running
rhythm in Pten mutant mice.
findings: []
- id: PMID:17880912
title: MAGI-2 Inhibits cell migration and proliferation via PTEN in human
hepatocarcinoma cells.
findings: []
- id: PMID:18082964
title: Phosphatase and tensin homolog, deleted on chromosome 10 deficiency
in brain causes defects in synaptic structure, transmission and
plasticity, and myelination abnormalities.
findings: []
- id: PMID:19057511
title: PTEN regulation by Akt-EGR1-ARF-PTEN axis.
findings: []
- id: PMID:19208814
title: Haploinsufficiency for Pten and Serotonin transporter cooperatively
influences brain size and social behavior.
findings: []
- id: PMID:19345329
title: Rak functions as a tumor suppressor by regulating PTEN protein
stability and function.
findings: []
- id: PMID:19369943
title: Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity.
findings: []
- id: PMID:19473982
title: X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN
ubiquitination, content, and compartmentalization.
findings: []
- id: PMID:19903340
title: PTEN inhibits BMI1 function independently of its phosphatase
activity.
findings: []
- id: PMID:20123964
title: Lipid phosphate phosphatase 3 stabilization of beta-catenin induces
endothelial cell migration and formation of branching point structures.
findings: []
- id: PMID:21241890
title: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a
phosphatase-independent manner.
findings: []
- id: PMID:21411674
title: Pten knockdown in vivo increases excitatory drive onto dentate
granule cells.
findings: []
- id: PMID:21573166
title: Upregulated microRNA-29a by hepatitis B virus X protein enhances
hepatoma cell migration by targeting PTEN in cell culture model.
findings: []
- id: PMID:21653829
title: Protein interactome reveals converging molecular pathways among
autism disorders.
findings: []
- id: PMID:21804599
title: PTEN, NHERF1 and PHLPP form a tumor suppressor network that is
disabled in glioblastoma.
findings: []
- id: PMID:21828076
title: 'A comprehensive functional analysis of PTEN mutations: implications in
tumor- and autism-related syndromes.'
findings: []
- id: PMID:22869525
title: Insulin-like growth factor (IGF) binding protein 2 functions
coordinately with receptor protein tyrosine phosphatase Ξ² and the IGF-I
receptor to regulate IGF-I-stimulated signaling.
findings: []
- id: PMID:22879939
title: TGFΞ²-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1
signaling for mesangial cell hypertrophy and matrix expansion.
findings: []
- id: PMID:23514585
title: PTEN suppresses the oncogenic function of AIB1 through decreasing its
protein stability via mechanism involving Fbw7 alpha.
findings: []
- id: PMID:23940795
title: Phosphorylation of the actin binding protein Drebrin at S647 is
regulated by neuronal activity and PTEN.
findings: []
- id: PMID:24012959
title: Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger
regulatory factor 1 inhibition of platelet-derived growth factor receptor
signaling.
findings: []
- id: PMID:24656772
title: SPOP promotes tumorigenesis by acting as a key regulatory hub in
kidney cancer.
findings: []
- id: PMID:24766807
title: Cancer-associated PTEN mutants act in a dominant-negative manner to
suppress PTEN protein function.
findings: []
- id: PMID:24862762
title: NHERF1/EBP50 controls morphogenesis of 3D colonic glands by
stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
findings: []
- id: PMID:25007873
title: TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt
inhibition in human glomerular endothelial cells.
findings: []
- id: PMID:25241761
title: Using an in situ proximity ligation assay to systematically profile
endogenous protein-protein interactions in a pathway network.
findings: []
- id: PMID:26208095
title: PPARΞ³ Ligands Attenuate Hypoxia-Induced Proliferation in Human
Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.
findings: []
- id: PMID:26280536
title: Deubiquitylase OTUD3 regulates PTEN stability and suppresses
tumorigenesis.
findings: []
- id: PMID:27919618
title: Electric field-induced suppression of PTEN drives
epithelial-to-mesenchymal transition via mTORC1 activation.
findings: []
- id: PMID:28008308
title: The Protective Role of microRNA-200c in Alzheimer's Disease
Pathologies Is Induced by Beta Amyloid-Triggered Endoplasmic Reticulum
Stress.
findings: []
- id: PMID:31492966
title: The CRL4-DCAF13 ubiquitin E3 ligase supports oocyte meiotic
resumption by targeting PTEN degradation.
findings: []
- id: PMID:36950384
title: Protein interaction studies in human induced neurons indicate
convergent biology underlying autism spectrum disorders.
findings: []
- id: PMID:9187108
title: TEP1, encoded by a candidate tumor suppressor locus, is a novel
protein tyrosine phosphatase regulated by transforming growth factor beta.
findings: []
- id: PMID:9256433
title: P-TEN, the tumor suppressor from human chromosome 10q23, is a
dual-specificity phosphatase.
findings: []
- id: PMID:9367992
title: A family of putative tumor suppressors is structurally and
functionally conserved in humans and yeast.
findings: []
- id: PMID:9593664
title: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second
messenger, phosphatidylinositol 3,4,5-trisphosphate.
findings: []
- id: PMID:9616126
title: Inhibition of cell migration, spreading, and focal adhesions by tumor
suppressor PTEN.
findings: []
- id: PMID:9811831
title: The lipid phosphatase activity of PTEN is critical for its tumor
supressor function.
findings: []
- id: Reactome:R-HSA-1660499
title: Synthesis of PIPs at the plasma membrane
findings: []
- id: Reactome:R-HSA-1676149
title: PI(3,4)P2 is dephosphorylated to PI4P by PTEN at the plasma membrane
findings: []
- id: Reactome:R-HSA-1855205
title: I(1,3,4,5)P4 is dephosphorylated to I(1,4,5)P3 by PTEN in the cytosol
findings: []
- id: Reactome:R-HSA-199456
title: PTEN dephosphorylates PIP3
findings: []
- id: Reactome:R-HSA-2317387
title: PTEN cancer mutants do not dephosphorylate PIP3
findings: []
- id: Reactome:R-HSA-2321904
title: PTEN mRNA translation negatively regulated by microRNAs
findings: []
- id: Reactome:R-HSA-5689950
title: USP7 deubiquitinates TP53,MDM2,MDM4,FOXO4, PTEN
findings: []
- id: Reactome:R-HSA-6807105
title: Monoubiquitinated PTEN translocates to the nucleus
findings: []
- id: Reactome:R-HSA-6807106
title: PTEN undergoes monoubiquitination
findings: []
- id: Reactome:R-HSA-6807118
title: USP7 deubiquitinates monoubiquitinated PTEN
findings: []
- id: Reactome:R-HSA-6807126
title: Deubiquitinated PTEN translocates to the cytosol
findings: []
- id: Reactome:R-HSA-6807134
title: NEDD4, WWP2, CHIP and XIAP polyubiquitinate PTEN
findings: []
- id: Reactome:R-HSA-6807206
title: USP13 and OTUD3 deubiquitinate PTEN
findings: []
- id: Reactome:R-HSA-8847968
title: PTEN binds FRK
findings: []
- id: Reactome:R-HSA-8847977
title: FRK phosphorylates PTEN
findings: []
- id: Reactome:R-HSA-8850945
title: Casein kinase II phosphorylates PTEN
findings: []
- id: Reactome:R-HSA-8850961
title: PREX2 binds PTEN and inhibits it
findings: []
- id: PMID:23744781
title: A secreted PTEN phosphatase that enters cells to alter signaling and
survival.
findings: []
- id: Reactome:R-HSA-8850992
title: Proteasome degrades polyubiquitinated PTEN
findings: []
- id: Reactome:R-HSA-8850997
title: TRIM27 binds PTEN
findings: []
- id: Reactome:R-HSA-8851011
title: TRIM27 polyubiquitinates PTEN
findings: []
- id: Reactome:R-HSA-8873946
title: OTUD3 deubiquitinates PTEN
findings: []
- id: Reactome:R-HSA-8944497
title: PTEN mRNA translation is negatively regulated by microRNAs
findings: []
- id: Reactome:R-HSA-8948775
title: MKRN1 polyubiquitinates PTEN
findings: []
- id: Reactome:R-HSA-8948800
title: TNKS and TNKS2 PARylate PTEN
findings: []
- id: Reactome:R-HSA-8948832
title: RNF146 polyubiquitinates PARylated PTEN
findings: []
- id: Reactome:R-HSA-9615571
title: PTEN mRNA translation is inhibited by miR-137
findings: []
- id: file:human/PTEN/PTEN-deep-research-falcon.md
title: Deep research on PTEN function
findings: []
status: COMPLETE